BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Anastas JN, Moon RT. WNT signalling pathways as therapeutic targets in cancer. Nat Rev Cancer. 2013;13:11-26. [PMID: 23258168 DOI: 10.1038/nrc3419] [Cited by in Crossref: 1221] [Cited by in F6Publishing: 1096] [Article Influence: 152.6] [Reference Citation Analysis]
Number Citing Articles
1 Yu J, Liu D, Sun X, Yang K, Yao J, Cheng C, Wang C, Zheng J. CDX2 inhibits the proliferation and tumor formation of colon cancer cells by suppressing Wnt/β-catenin signaling via transactivation of GSK-3β and Axin2 expression. Cell Death Dis 2019;10:26. [PMID: 30631044 DOI: 10.1038/s41419-018-1263-9] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 13.5] [Reference Citation Analysis]
2 Muñoz-Galván S, Carnero A. Targeting Cancer Stem Cells to Overcome Therapy Resistance in Ovarian Cancer. Cells 2020;9:E1402. [PMID: 32512891 DOI: 10.3390/cells9061402] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 9.0] [Reference Citation Analysis]
3 Hu XY, Hou PF, Li TT, Quan HY, Li ML, Lin T, Liu JJ, Bai J, Zheng JN. The roles of Wnt/β-catenin signaling pathway related lncRNAs in cancer. Int J Biol Sci 2018;14:2003-11. [PMID: 30585264 DOI: 10.7150/ijbs.27977] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 8.0] [Reference Citation Analysis]
4 Shin HR, Islam R, Yoon WJ, Lee T, Cho YD, Bae HS, Kim BS, Woo KM, Baek JH, Ryoo HM. Pin1-mediated Modification Prolongs the Nuclear Retention of β-Catenin in Wnt3a-induced Osteoblast Differentiation. J Biol Chem 2016;291:5555-65. [PMID: 26740630 DOI: 10.1074/jbc.M115.698563] [Cited by in Crossref: 18] [Cited by in F6Publishing: 10] [Article Influence: 3.6] [Reference Citation Analysis]
5 Palechor-Ceron N, Krawczyk E, Dakic A, Simic V, Yuan H, Blancato J, Wang W, Hubbard F, Zheng YL, Dan H, Strome S, Cullen K, Davidson B, Deeken JF, Choudhury S, Ahn PH, Agarwal S, Zhou X, Schlegel R, Furth PA, Pan CX, Liu X. Conditional Reprogramming for Patient-Derived Cancer Models and Next-Generation Living Biobanks. Cells 2019;8:E1327. [PMID: 31717887 DOI: 10.3390/cells8111327] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 10.5] [Reference Citation Analysis]
6 Rajakulendran N, Rowland KJ, Selvadurai HJ, Ahmadi M, Park NI, Naumenko S, Dolma S, Ward RJ, So M, Lee L, MacLeod G, Pasiliao C, Brandon C, Clarke ID, Cusimano MD, Bernstein M, Batada N, Angers S, Dirks PB. Wnt and Notch signaling govern self-renewal and differentiation in a subset of human glioblastoma stem cells. Genes Dev 2019;33:498-510. [PMID: 30842215 DOI: 10.1101/gad.321968.118] [Cited by in Crossref: 39] [Cited by in F6Publishing: 25] [Article Influence: 19.5] [Reference Citation Analysis]
7 Wright C, Iyer AK, Wang L, Wu N, Yakisich JS, Rojanasakul Y, Azad N. Effects of titanium dioxide nanoparticles on human keratinocytes. Drug Chem Toxicol 2017;40:90-100. [PMID: 27310834 DOI: 10.1080/01480545.2016.1185111] [Cited by in Crossref: 18] [Cited by in F6Publishing: 7] [Article Influence: 3.6] [Reference Citation Analysis]
8 Chen X, Du P, She J, Cao L, Li Y, Xia H. Loss of ZG16 is regulated by miR-196a and contributes to stemness and progression of colorectal cancer. Oncotarget 2016;7:86695-703. [PMID: 27880730 DOI: 10.18632/oncotarget.13435] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 6.7] [Reference Citation Analysis]
9 Wang Z, Li Z, Ji H. Direct targeting of β-catenin in the Wnt signaling pathway: Current progress and perspectives. Med Res Rev 2021;41:2109-29. [PMID: 33475177 DOI: 10.1002/med.21787] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
10 Bognar MK, Vincendeau M, Erdmann T, Seeholzer T, Grau M, Linnemann JR, Ruland J, Scheel CH, Lenz P, Ott G, Lenz G, Hauck SM, Krappmann D. Oncogenic CARMA1 couples NF-κB and β-catenin signaling in diffuse large B-cell lymphomas. Oncogene 2016;35:4269-81. [PMID: 26776161 DOI: 10.1038/onc.2015.493] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 5.0] [Reference Citation Analysis]
11 Sun X, Liu S, Wang D, Zhang Y, Li W, Guo Y, Zhang H, Suo J. Colorectal cancer cells suppress CD4+ T cells immunity through canonical Wnt signaling. Oncotarget 2017;8:15168-81. [PMID: 28147310 DOI: 10.18632/oncotarget.14834] [Cited by in Crossref: 21] [Cited by in F6Publishing: 16] [Article Influence: 5.3] [Reference Citation Analysis]
12 Hu S, Zheng Q, Wu H, Wang C, Liu T, Zhou W. miR-532 promoted gastric cancer migration and invasion by targeting NKD1. Life Sciences 2017;177:15-9. [DOI: 10.1016/j.lfs.2017.03.019] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 5.0] [Reference Citation Analysis]
13 Cisternas P, Salazar P, Silva-Álvarez C, Barros LF, Inestrosa NC. Activation of Wnt Signaling in Cortical Neurons Enhances Glucose Utilization through Glycolysis. J Biol Chem 2016;291:25950-64. [PMID: 27703002 DOI: 10.1074/jbc.M116.735373] [Cited by in Crossref: 28] [Cited by in F6Publishing: 16] [Article Influence: 5.6] [Reference Citation Analysis]
14 Conboy CB, Vélez-Reyes GL, Rathe SK, Abrahante JE, Temiz NA, Burns MB, Harris RS, Starr TK, Largaespada DA. R-Spondins 2 and 3 Are Overexpressed in a Subset of Human Colon and Breast Cancers. DNA Cell Biol 2021;40:70-9. [PMID: 33320737 DOI: 10.1089/dna.2020.5585] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 Stella GM, Gentile A, Balderacchi A, Meloni F, Milan M, Benvenuti S. Ockham's razor for the MET-driven invasive growth linking idiopathic pulmonary fibrosis and cancer. J Transl Med 2016;14:256. [PMID: 27590450 DOI: 10.1186/s12967-016-1008-4] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
16 Paine HA, Nathubhai A, Woon EC, Sunderland PT, Wood PJ, Mahon MF, Lloyd MD, Thompson AS, Haikarainen T, Narwal M, Lehtiö L, Threadgill MD. Exploration of the nicotinamide-binding site of the tankyrases, identifying 3-arylisoquinolin-1-ones as potent and selective inhibitors in vitro. Bioorg Med Chem 2015;23:5891-908. [PMID: 26189030 DOI: 10.1016/j.bmc.2015.06.061] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 3.3] [Reference Citation Analysis]
17 Tang X, Zheng D, Hu P, Zeng Z, Li M, Tucker L, Monahan R, Resnick MB, Liu M, Ramratnam B. Glycogen synthase kinase 3 beta inhibits microRNA-183-96-182 cluster via the β-Catenin/TCF/LEF-1 pathway in gastric cancer cells. Nucleic Acids Res. 2014;42:2988-2998. [PMID: 24335145 DOI: 10.1093/nar/gkt1275] [Cited by in Crossref: 52] [Cited by in F6Publishing: 47] [Article Influence: 6.5] [Reference Citation Analysis]
18 Zhong Q, Zhao Y, Ye F, Xiao Z, Huang G, Xu M, Zhang Y, Zhan X, Sun K, Wang Z, Cheng S, Feng S, Zhao X, Zhang J, Lu P, Xu W, Zhou Q, Ma D. Cryo-EM structure of human Wntless in complex with Wnt3a. Nat Commun 2021;12:4541. [PMID: 34315898 DOI: 10.1038/s41467-021-24731-3] [Reference Citation Analysis]
19 Fiskus W, Sharma S, Saha S, Shah B, Devaraj SG, Sun B, Horrigan S, Leveque C, Zu Y, Iyer S, Bhalla KN. Pre-clinical efficacy of combined therapy with novel β-catenin antagonist BC2059 and histone deacetylase inhibitor against AML cells. Leukemia 2015;29:1267-78. [PMID: 25482131 DOI: 10.1038/leu.2014.340] [Cited by in Crossref: 49] [Cited by in F6Publishing: 43] [Article Influence: 7.0] [Reference Citation Analysis]
20 Ohishi K, Toume K, Arai MA, Koyano T, Kowithayakorn T, Mizoguchi T, Itoh M, Ishibashi M. 9-Hydroxycanthin-6-one, a β-Carboline Alkaloid from Eurycoma longifolia, Is the First Wnt Signal Inhibitor through Activation of Glycogen Synthase Kinase 3β without Depending on Casein Kinase 1α. J Nat Prod 2015;78:1139-46. [PMID: 25905468 DOI: 10.1021/acs.jnatprod.5b00153] [Cited by in Crossref: 29] [Cited by in F6Publishing: 20] [Article Influence: 4.8] [Reference Citation Analysis]
21 Yang D, Wang C, Luo Y, Li X, Song Q, Zhang J, Xin S. Activated E2F activity induces cell death in papillary thyroid carcinoma K1 cells with enhanced Wnt signaling. PLoS One 2017;12:e0178908. [PMID: 28570681 DOI: 10.1371/journal.pone.0178908] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
22 Inestrosa NC, Varela-Nallar L. Wnt signaling in the nervous system and in Alzheimer's disease. J Mol Cell Biol 2014;6:64-74. [PMID: 24549157 DOI: 10.1093/jmcb/mjt051] [Cited by in Crossref: 168] [Cited by in F6Publishing: 146] [Article Influence: 24.0] [Reference Citation Analysis]
23 Peng W, Zhang H, Tan S, Li Y, Zhou Y, Wang L, Liu C, Li Q, Cen X, Yang S, Zhao Y. Synergistic antitumor effect of 5-fluorouracil with the novel LSD1 inhibitor ZY0511 in colorectal cancer. Ther Adv Med Oncol 2020;12:1758835920937428. [PMID: 32754230 DOI: 10.1177/1758835920937428] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
24 Fu Y, Chen Y, Huang J, Cai Z, Wang Y. RYK, a receptor of noncanonical Wnt ligand Wnt5a, is positively correlated with gastric cancer tumorigenesis and potential of liver metastasis. Am J Physiol Gastrointest Liver Physiol 2020;318:G352-60. [PMID: 31869240 DOI: 10.1152/ajpgi.00228.2019] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
25 Kerdidani D, Chouvardas P, Arjo AR, Giopanou I, Ntaliarda G, Guo YA, Tsikitis M, Kazamias G, Potaris K, Stathopoulos GT, Zakynthinos S, Kalomenidis I, Soumelis V, Kollias G, Tsoumakidou M. Wnt1 silences chemokine genes in dendritic cells and induces adaptive immune resistance in lung adenocarcinoma. Nat Commun 2019;10:1405. [PMID: 30926812 DOI: 10.1038/s41467-019-09370-z] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 13.0] [Reference Citation Analysis]
26 Tan C, Scotting P. Expression of Kit and Etv1 in restricted brain regions supports a brain-cell progenitor as an origin for cranial germinomas. Cancer Genet 2015;208:55-61. [PMID: 25736805 DOI: 10.1016/j.cancergen.2014.12.007] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
27 Suryawanshi A, Tadagavadi RK, Swafford D, Manicassamy S. Modulation of Inflammatory Responses by Wnt/β-Catenin Signaling in Dendritic Cells: A Novel Immunotherapy Target for Autoimmunity and Cancer. Front Immunol 2016;7:460. [PMID: 27833613 DOI: 10.3389/fimmu.2016.00460] [Cited by in Crossref: 66] [Cited by in F6Publishing: 60] [Article Influence: 13.2] [Reference Citation Analysis]
28 Low JL, Du W, Gocha T, Oguz G, Zhang X, Chen MW, Masirevic S, Yim DGR, Tan IBH, Ramasamy A, Fan H, DasGupta R. Molecular docking-aided identification of small molecule inhibitors targeting β-catenin-TCF4 interaction. iScience 2021;24:102544. [PMID: 34142050 DOI: 10.1016/j.isci.2021.102544] [Reference Citation Analysis]
29 Mcquate A, Latorre-esteves E, Barria A. A Wnt/Calcium Signaling Cascade Regulates Neuronal Excitability and Trafficking of NMDARs. Cell Reports 2017;21:60-9. [DOI: 10.1016/j.celrep.2017.09.023] [Cited by in Crossref: 33] [Cited by in F6Publishing: 26] [Article Influence: 8.3] [Reference Citation Analysis]
30 Roy S, Pradhan D, Ernst WL, Mercurio S, Najjar Y, Parikh R, Parwani AV, Pai RK, Dhir R, Nikiforova MN. Next-generation sequencing-based molecular characterization of primary urinary bladder adenocarcinoma. Mod Pathol 2017;30:1133-43. [DOI: 10.1038/modpathol.2017.33] [Cited by in Crossref: 23] [Cited by in F6Publishing: 15] [Article Influence: 5.8] [Reference Citation Analysis]
31 Madan B, Walker MP, Young R, Quick L, Orgel KA, Ryan M, Gupta P, Henrich IC, Ferrer M, Marine S, Roberts BS, Arthur WT, Berndt JD, Oliveira AM, Moon RT, Virshup DM, Chou MM, Major MB. USP6 oncogene promotes Wnt signaling by deubiquitylating Frizzleds. Proc Natl Acad Sci U S A 2016;113:E2945-54. [PMID: 27162353 DOI: 10.1073/pnas.1605691113] [Cited by in Crossref: 55] [Cited by in F6Publishing: 43] [Article Influence: 11.0] [Reference Citation Analysis]
32 Wiese M, Walther N, Diederichs C, Schill F, Monecke S, Salinas G, Sturm D, Pfister SM, Dressel R, Johnsen SA, Kramm CM. The β-catenin/CBP-antagonist ICG-001 inhibits pediatric glioma tumorigenicity in a Wnt-independent manner. Oncotarget 2017;8:27300-13. [PMID: 28460484 DOI: 10.18632/oncotarget.15934] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 6.0] [Reference Citation Analysis]
33 Fu Y, Katsaros D, Biglia N, Wang Z, Pagano I, Tius M, Tiirikainen M, Rosser C, Yang H, Yu H. Vitamin D receptor upregulates lncRNA TOPORS-AS1 which inhibits the Wnt/β-catenin pathway and associates with favorable prognosis of ovarian cancer. Sci Rep 2021;11:7484. [PMID: 33820921 DOI: 10.1038/s41598-021-86923-7] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
34 Yu F, Liu Z, Tong Z, Zhao Z, Liang H. Soybean isoflavone treatment induces osteoblast differentiation and proliferation by regulating analysis of Wnt/β-catenin pathway. Gene 2015;573:273-7. [DOI: 10.1016/j.gene.2015.07.054] [Cited by in Crossref: 22] [Cited by in F6Publishing: 14] [Article Influence: 3.7] [Reference Citation Analysis]
35 Flores-Hernández E, Velázquez DM, Castañeda-Patlán MC, Fuentes-García G, Fonseca-Camarillo G, Yamamoto-Furusho JK, Romero-Avila MT, García-Sáinz JA, Robles-Flores M. Canonical and non-canonical Wnt signaling are simultaneously activated by Wnts in colon cancer cells. Cell Signal 2020;72:109636. [PMID: 32283254 DOI: 10.1016/j.cellsig.2020.109636] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 12.0] [Reference Citation Analysis]
36 Del Bello F, Farande A, Giannella M, Piergentili A, Quaglia W, Benicchi T, Cappelli F, Nencini A, Salerno M, Thomas RJ, Travagli M, Varrone M. Identification of 2-aminopyrimidine derivatives as inhibitors of the canonical Wnt signaling pathway. Bioorganic & Medicinal Chemistry 2015;23:5725-33. [DOI: 10.1016/j.bmc.2015.07.015] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
37 Li MM, Tang YQ, Gong YF, Cheng W, Li HL, Kong FE, Zhu WJ, Liu SS, Huang L, Guan XY, Ma NF, Liu M. Development of an oncogenic dedifferentiation SOX signature with prognostic significance in hepatocellular carcinoma. BMC Cancer 2019;19:851. [PMID: 31462277 DOI: 10.1186/s12885-019-6041-2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
38 Weidle UH, Birzele F, Nopora A. Pancreatic Ductal Adenocarcinoma: MicroRNAs Affecting Tumor Growth and Metastasis in Preclinical In Vivo Models. Cancer Genomics Proteomics 2019;16:451-64. [PMID: 31659100 DOI: 10.21873/cgp.20149] [Cited by in Crossref: 4] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
39 Rangel R, Lee SC, Hon-Kim Ban K, Guzman-Rojas L, Mann MB, Newberg JY, Kodama T, McNoe LA, Selvanesan L, Ward JM, Rust AG, Chin KY, Black MA, Jenkins NA, Copeland NG. Transposon mutagenesis identifies genes that cooperate with mutant Pten in breast cancer progression. Proc Natl Acad Sci U S A 2016;113:E7749-58. [PMID: 27849608 DOI: 10.1073/pnas.1613859113] [Cited by in Crossref: 39] [Cited by in F6Publishing: 30] [Article Influence: 7.8] [Reference Citation Analysis]
40 Li B, Orton D, Neitzel LR, Astudillo L, Shen C, Long J, Chen X, Kirkbride KC, Doundoulakis T, Guerra ML, Zaias J, Fei DL, Rodriguez-Blanco J, Thorne C, Wang Z, Jin K, Nguyen DM, Sands LR, Marchetti F, Abreu MT, Cobb MH, Capobianco AJ, Lee E, Robbins DJ. Differential abundance of CK1α provides selectivity for pharmacological CK1α activators to target WNT-dependent tumors. Sci Signal 2017;10:eaak9916. [PMID: 28655862 DOI: 10.1126/scisignal.aak9916] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 3.8] [Reference Citation Analysis]
41 Hino M, Kamo M, Saito D, Kyakumoto S, Shibata T, Mizuki H, Ishisaki A. Transforming growth factor-β1 induces invasion ability of HSC-4 human oral squamous cell carcinoma cells through the Slug/Wnt-5b/MMP-10 signalling axis. J Biochem 2016;159:631-40. [PMID: 26861993 DOI: 10.1093/jb/mvw007] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 2.8] [Reference Citation Analysis]
42 Konstorum A, Sprowl SA, Waterman ML, Lander AD, Lowengrub JS. Predicting mechanism of biphasic growth factor action on tumor growth using a multi-species model with feedback control. J Coupled Syst Multiscale Dyn 2013;1:459-67. [PMID: 25075381 DOI: 10.1166/jcsmd.2013.1028] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
43 Jeong WJ, Ro EJ, Choi KY. Interaction between Wnt/β-catenin and RAS-ERK pathways and an anti-cancer strategy via degradations of β-catenin and RAS by targeting the Wnt/β-catenin pathway. NPJ Precis Oncol 2018;2:5. [PMID: 29872723 DOI: 10.1038/s41698-018-0049-y] [Cited by in Crossref: 65] [Cited by in F6Publishing: 55] [Article Influence: 21.7] [Reference Citation Analysis]
44 Borgal L, Rinschen MM, Dafinger C, Hoff S, Reinert MJ, Lamkemeyer T, Lienkamp SS, Benzing T, Schermer B. Casein kinase 1 α phosphorylates the Wnt regulator Jade-1 and modulates its activity. J Biol Chem 2014;289:26344-56. [PMID: 25100726 DOI: 10.1074/jbc.M114.562165] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
45 Martianov I, Cler E, Duluc I, Vicaire S, Philipps M, Freund JN, Davidson I. TAF4 inactivation reveals the 3 dimensional growth promoting activities of collagen 6A3. PLoS One 2014;9:e87365. [PMID: 24498316 DOI: 10.1371/journal.pone.0087365] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
46 Stessman HA, Turner TN, Eichler EE. Molecular subtyping and improved treatment of neurodevelopmental disease. Genome Med 2016;8:22. [PMID: 26917491 DOI: 10.1186/s13073-016-0278-z] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 2.6] [Reference Citation Analysis]
47 Aiello NM, Stanger BZ. Echoes of the embryo: using the developmental biology toolkit to study cancer. Dis Model Mech 2016;9:105-14. [PMID: 26839398 DOI: 10.1242/dmm.023184] [Cited by in Crossref: 54] [Cited by in F6Publishing: 31] [Article Influence: 10.8] [Reference Citation Analysis]
48 Gruszka AM, Valli D, Alcalay M. Wnt Signalling in Acute Myeloid Leukaemia. Cells 2019;8:E1403. [PMID: 31703382 DOI: 10.3390/cells8111403] [Cited by in Crossref: 19] [Cited by in F6Publishing: 14] [Article Influence: 9.5] [Reference Citation Analysis]
49 Berger H, Wodarz A, Borchers A. PTK7 Faces the Wnt in Development and Disease. Front Cell Dev Biol 2017;5:31. [PMID: 28424771 DOI: 10.3389/fcell.2017.00031] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 6.8] [Reference Citation Analysis]
50 Zeng S, Seifert AM, Zhang JQ, Cavnar MJ, Kim TS, Balachandran VP, Santamaria-Barria JA, Cohen NA, Beckman MJ, Medina BD, Rossi F, Crawley MH, Loo JK, Maltbaek JH, Besmer P, Antonescu CR, DeMatteo RP. Wnt/β-catenin Signaling Contributes to Tumor Malignancy and Is Targetable in Gastrointestinal Stromal Tumor. Mol Cancer Ther 2017;16:1954-66. [PMID: 28611108 DOI: 10.1158/1535-7163.MCT-17-0139] [Cited by in Crossref: 24] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
51 Hong Y, Manoharan I, Suryawanshi A, Shanmugam A, Swafford D, Ahmad S, Chinnadurai R, Manicassamy B, He Y, Mellor AL, Thangaraju M, Munn DH, Manicassamy S. Deletion of LRP5 and LRP6 in dendritic cells enhances antitumor immunity. Oncoimmunology 2016;5:e1115941. [PMID: 27141399 DOI: 10.1080/2162402X.2015.1115941] [Cited by in Crossref: 38] [Cited by in F6Publishing: 24] [Article Influence: 6.3] [Reference Citation Analysis]
52 Chen Y, Wu N, Liu L, Dong H, Liu X. microRNA-128-3p overexpression inhibits breast cancer stem cell characteristics through suppression of Wnt signalling pathway by down-regulating NEK2. J Cell Mol Med 2020;24:7353-69. [PMID: 32558224 DOI: 10.1111/jcmm.15317] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 10.0] [Reference Citation Analysis]
53 Roy L, Cowden Dahl KD. Can Stemness and Chemoresistance Be Therapeutically Targeted via Signaling Pathways in Ovarian Cancer? Cancers (Basel). 2018;10:pii: E241. [PMID: 30042330 DOI: 10.3390/cancers10080241] [Cited by in Crossref: 31] [Cited by in F6Publishing: 29] [Article Influence: 10.3] [Reference Citation Analysis]
54 Chen N, Wang J. Wnt/β-Catenin Signaling and Obesity. Front Physiol 2018;9:792. [PMID: 30065654 DOI: 10.3389/fphys.2018.00792] [Cited by in Crossref: 41] [Cited by in F6Publishing: 31] [Article Influence: 13.7] [Reference Citation Analysis]
55 Liu MY, Zhang H, Hu YJ, Chen YW, Zhao XN. Identification of key genes associated with cervical cancer by comprehensive analysis of transcriptome microarray and methylation microarray. Oncol Lett 2016;12:473-8. [PMID: 27347167 DOI: 10.3892/ol.2016.4658] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 2.4] [Reference Citation Analysis]
56 Lu Y, Xie S, Zhang W, Zhang C, Gao C, Sun Q, Cai Y, Xu Z, Xiao M, Xu Y, Huang X, Wu X, Liu W, Wang F, Kang Y, Zhou T. Twa1/Gid8 is a β-catenin nuclear retention factor in Wnt signaling and colorectal tumorigenesis. Cell Res 2017;27:1422-40. [PMID: 28829046 DOI: 10.1038/cr.2017.107] [Cited by in Crossref: 24] [Cited by in F6Publishing: 14] [Article Influence: 6.0] [Reference Citation Analysis]
57 Choi H, Sheng J, Gao D, Li F, Durrans A, Ryu S, Lee SB, Narula N, Rafii S, Elemento O, Altorki NK, Wong ST, Mittal V. Transcriptome analysis of individual stromal cell populations identifies stroma-tumor crosstalk in mouse lung cancer model. Cell Rep 2015;10:1187-201. [PMID: 25704820 DOI: 10.1016/j.celrep.2015.01.040] [Cited by in Crossref: 62] [Cited by in F6Publishing: 47] [Article Influence: 10.3] [Reference Citation Analysis]
58 Tao Y, Xin M, Cheng H, Huang Z, Hu T, Zhang T, Wang J. TRIM37 promotes tumor cell proliferation and drug resistance in pediatric osteosarcoma. Oncol Lett 2017;14:6365-72. [PMID: 29163677 DOI: 10.3892/ol.2017.7059] [Cited by in Crossref: 6] [Cited by in F6Publishing: 11] [Article Influence: 1.5] [Reference Citation Analysis]
59 Tsai LH, Madabhushi R. Alzheimer's disease: A protective factor for the ageing brain. Nature 2014;507:439-40. [PMID: 24670758 DOI: 10.1038/nature13214] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 2.7] [Reference Citation Analysis]
60 Zhu W, Krishna S, Garcia C, Lin CJ, Mitchell BD, Scott KL, Mohila CA, Creighton CJ, Yoo SH, Lee HK, Deneen B. Daam2 driven degradation of VHL promotes gliomagenesis. Elife 2017;6:e31926. [PMID: 29053101 DOI: 10.7554/eLife.31926] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
61 Vastrad C, Vastrad B. Bioinformatics analysis of gene expression profiles to diagnose crucial and novel genes in glioblastoma multiform. Pathol Res Pract 2018;214:1395-461. [PMID: 30097214 DOI: 10.1016/j.prp.2018.07.015] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
62 Narayanan D, Rady PL, Tyring SK. Recent developments in trichodysplasia spinulosa disease. Transpl Infect Dis 2020;22:e13434. [PMID: 32748541 DOI: 10.1111/tid.13434] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
63 de Jaime-Soguero A, Abreu de Oliveira WA, Lluis F. The Pleiotropic Effects of the Canonical Wnt Pathway in Early Development and Pluripotency. Genes (Basel) 2018;9:E93. [PMID: 29443926 DOI: 10.3390/genes9020093] [Cited by in Crossref: 23] [Cited by in F6Publishing: 16] [Article Influence: 7.7] [Reference Citation Analysis]
64 Shono T, Ishikawa N, Toume K, Arai MA, Masu H, Koyano T, Kowithayakorn T, Ishibashi M. Cerasoidine, a Bis-aporphine Alkaloid Isolated from Polyalthia cerasoides during Screening for Wnt Signal Inhibitors. J Nat Prod 2016;79:2083-8. [DOI: 10.1021/acs.jnatprod.6b00409] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 2.2] [Reference Citation Analysis]
65 Elkhenany H, Shekshek A, Abdel-Daim M, El-Badri N. Stem Cell Therapy for Hepatocellular Carcinoma: Future Perspectives. Adv Exp Med Biol 2020;1237:97-119. [PMID: 31728916 DOI: 10.1007/5584_2019_441] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
66 Salazar VS, Zarkadis N, Huang L, Watkins M, Kading J, Bonar S, Norris J, Mbalaviele G, Civitelli R. Postnatal ablation of osteoblast Smad4 enhances proliferative responses to canonical Wnt signaling through interactions with β-catenin. J Cell Sci 2013;126:5598-609. [PMID: 24101723 DOI: 10.1242/jcs.132233] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
67 Yoo BH, Masson O, Li Y, Khan IA, Gowda PS, Rosen KV. Anoikis of colon carcinoma cells triggered by β-catenin loss can be enhanced by tumor necrosis factor receptor 1 antagonists. Oncogene 2015;34:4939-51. [PMID: 25531320 DOI: 10.1038/onc.2014.415] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
68 Ma S, Wang S, Li M, Zhang Y, Zhu P. The effects of pigment epithelium-derived factor on atherosclerosis: putative mechanisms of the process. Lipids Health Dis 2018;17:240. [PMID: 30326915 DOI: 10.1186/s12944-018-0889-z] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 3.3] [Reference Citation Analysis]
69 Chang S, Sun G, Zhang D, Li Q, Qian H. MiR-3622a-3p acts as a tumor suppressor in colorectal cancer by reducing stemness features and EMT through targeting spalt-like transcription factor 4. Cell Death Dis 2020;11:592. [PMID: 32719361 DOI: 10.1038/s41419-020-02789-z] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
70 Li D, Liu W, Wang X, Wu J, Quan W, Yao Y, Bals R, Ji S, Wu K, Guo J, Wan H. Cathelicidin, an antimicrobial peptide produced by macrophages, promotes colon cancer by activating the Wnt/β-catenin pathway. Oncotarget 2015;6:2939-50. [PMID: 25596747 DOI: 10.18632/oncotarget.2845] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.2] [Reference Citation Analysis]
71 Yao G, Tang J, Yang X, Zhao Y, Zhou R, Meng R, Zhang S, Dong X, Zhang T, Yang K, Wu G, Xu S. Cyclin K interacts with β-catenin to induce Cyclin D1 expression and facilitates tumorigenesis and radioresistance in lung cancer. Theranostics 2020;10:11144-58. [PMID: 33042275 DOI: 10.7150/thno.42578] [Reference Citation Analysis]
72 Barghout SH, Zepeda N, Xu Z, Steed H, Lee CH, Fu Y. Elevated β-catenin activity contributes to carboplatin resistance in A2780cp ovarian cancer cells. Biochem Biophys Res Commun 2015;468:173-8. [PMID: 26522223 DOI: 10.1016/j.bbrc.2015.10.138] [Cited by in Crossref: 22] [Cited by in F6Publishing: 17] [Article Influence: 3.7] [Reference Citation Analysis]
73 Raisch J, Côté-Biron A, Rivard N. A Role for the WNT Co-Receptor LRP6 in Pathogenesis and Therapy of Epithelial Cancers. Cancers (Basel) 2019;11:E1162. [PMID: 31412666 DOI: 10.3390/cancers11081162] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 7.5] [Reference Citation Analysis]
74 Dcona MM, Morris BL, Ellis KC, Grossman SR. CtBP- an emerging oncogene and novel small molecule drug target: Advances in the understanding of its oncogenic action and identification of therapeutic inhibitors. Cancer Biol Ther 2017;18:379-91. [PMID: 28532298 DOI: 10.1080/15384047.2017.1323586] [Cited by in Crossref: 37] [Cited by in F6Publishing: 33] [Article Influence: 9.3] [Reference Citation Analysis]
75 Ranganath R, Shah MA, Shah AR. Anaplastic thyroid cancer. Curr Opin Endocrinol Diabetes Obes 2015;22:387-91. [PMID: 26313900 DOI: 10.1097/MED.0000000000000189] [Cited by in Crossref: 29] [Cited by in F6Publishing: 14] [Article Influence: 5.8] [Reference Citation Analysis]
76 Nigjeh SE, Yeap SK, Nordin N, Kamalideghan B, Ky H, Rosli R. Citral induced apoptosis in MDA-MB-231 spheroid cells. BMC Complement Altern Med 2018;18:56. [PMID: 29433490 DOI: 10.1186/s12906-018-2115-y] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
77 Ren F, Shen J, Shi H, Hornicek FJ, Kan Q, Duan Z. Novel mechanisms and approaches to overcome multidrug resistance in the treatment of ovarian cancer. Biochim Biophys Acta 2016;1866:266-75. [PMID: 27717733 DOI: 10.1016/j.bbcan.2016.10.001] [Cited by in Crossref: 31] [Cited by in F6Publishing: 44] [Article Influence: 6.2] [Reference Citation Analysis]
78 Sherwood V. WNT signaling: an emerging mediator of cancer cell metabolism? Mol Cell Biol. 2015;35:2-10. [PMID: 25348713 DOI: 10.1128/mcb.00992-14] [Cited by in Crossref: 93] [Cited by in F6Publishing: 60] [Article Influence: 13.3] [Reference Citation Analysis]
79 Kwapisz O, Górka J, Korlatowicz A, Kotlinowski J, Waligórska A, Marona P, Pydyn N, Dobrucki JW, Jura J, Miekus K. Fatty Acids and a High-Fat Diet Induce Epithelial-Mesenchymal Transition by Activating TGFβ and β-Catenin in Liver Cells. Int J Mol Sci 2021;22:1272. [PMID: 33525359 DOI: 10.3390/ijms22031272] [Reference Citation Analysis]
80 Chen Y, Li Y, Xue J, Gong A, Yu G, Zhou A, Lin K, Zhang S, Zhang N, Gottardi CJ, Huang S. Wnt-induced deubiquitination FoxM1 ensures nucleus β-catenin transactivation. EMBO J 2016;35:668-84. [PMID: 26912724 DOI: 10.15252/embj.201592810] [Cited by in Crossref: 56] [Cited by in F6Publishing: 54] [Article Influence: 11.2] [Reference Citation Analysis]
81 Barker AR, Thomas R, Dawe HR. Meckel-Gruber syndrome and the role of primary cilia in kidney, skeleton, and central nervous system development. Organogenesis 2014;10:96-107. [PMID: 24322779 DOI: 10.4161/org.27375] [Cited by in Crossref: 57] [Cited by in F6Publishing: 35] [Article Influence: 7.1] [Reference Citation Analysis]
82 Stamatakou E, Salinas PC. Postsynaptic assembly: a role for Wnt signaling. Dev Neurobiol 2014;74:818-27. [PMID: 24105999 DOI: 10.1002/dneu.22138] [Cited by in Crossref: 7] [Cited by in F6Publishing: 14] [Article Influence: 0.9] [Reference Citation Analysis]
83 Gao H, Sun B, Fu H, Chi X, Wang F, Qi X, Hu J, Shao S. PDIA6 promotes the proliferation of HeLa cells through activating the Wnt/β-catenin signaling pathway. Oncotarget 2016;7:53289-98. [PMID: 27462866 DOI: 10.18632/oncotarget.10795] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 5.0] [Reference Citation Analysis]
84 Jiao S, Li C, Hao Q, Miao H, Zhang L, Li L, Zhou Z. VGLL4 targets a TCF4-TEAD4 complex to coregulate Wnt and Hippo signalling in colorectal cancer. Nat Commun 2017;8:14058. [PMID: 28051067 DOI: 10.1038/ncomms14058] [Cited by in Crossref: 65] [Cited by in F6Publishing: 56] [Article Influence: 16.3] [Reference Citation Analysis]
85 Lamba A, Parekh P, Dvorak CC, Karlitz J. Pedigree analysis supports a correlation between an AXIN2 variant and polyposis/colorectal cancer. WJMG 2018;8:1-4. [DOI: 10.5496/wjmg.v8.i1.1] [Reference Citation Analysis]
86 Poniah P, Mohd Zain S, Abdul Razack AH, Kuppusamy S, Karuppayah S, Sian Eng H, Mohamed Z. Genome-wide copy number analysis reveals candidate gene loci that confer susceptibility to high-grade prostate cancer. Urol Oncol 2017;35:545.e1-545.e11. [PMID: 28527622 DOI: 10.1016/j.urolonc.2017.04.017] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
87 Li M, Liu S, Huang W, Zhang J. Physiological and pathological functions of βB2-crystallins in multiple organs: a systematic review. Aging (Albany NY) 2021;13:15674-87. [PMID: 34118792 DOI: 10.18632/aging.203147] [Reference Citation Analysis]
88 Cattrini C, Zanardi E, Vallome G, Cavo A, Cerbone L, Di Meglio A, Fabbroni C, Latocca MM, Rizzo F, Messina C, Rubagotti A, Barboro P, Boccardo F. Targeting androgen-independent pathways: new chances for patients with prostate cancer? Crit Rev Oncol Hematol 2017;118:42-53. [PMID: 28917268 DOI: 10.1016/j.critrevonc.2017.08.009] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 4.5] [Reference Citation Analysis]
89 Kim TH, Chang JS, Park KS, Park J, Kim N, Lee JI, Kong ID. Effects of exercise training on circulating levels of Dickkpof-1 and secreted frizzled-related protein-1 in breast cancer survivors: A pilot single-blind randomized controlled trial. PLoS One 2017;12:e0171771. [PMID: 28178355 DOI: 10.1371/journal.pone.0171771] [Cited by in Crossref: 22] [Cited by in F6Publishing: 17] [Article Influence: 5.5] [Reference Citation Analysis]
90 Kang MH, Choi H, Oshima M, Cheong JH, Kim S, Lee JH, Park YS, Choi HS, Kweon MN, Pack CG, Lee JS, Mills GB, Myung SJ, Park YY. Estrogen-related receptor gamma functions as a tumor suppressor in gastric cancer. Nat Commun 2018;9:1920. [PMID: 29765046 DOI: 10.1038/s41467-018-04244-2] [Cited by in Crossref: 31] [Cited by in F6Publishing: 36] [Article Influence: 10.3] [Reference Citation Analysis]
91 Manz DH, Blanchette NL, Paul BT, Torti FM, Torti SV. Iron and cancer: recent insights. Ann N Y Acad Sci. 2016;1368:149-161. [PMID: 26890363 DOI: 10.1111/nyas.13008] [Cited by in Crossref: 150] [Cited by in F6Publishing: 129] [Article Influence: 30.0] [Reference Citation Analysis]
92 Gruber ES, Oberhuber G, Birner P, Schlederer M, Kenn M, Schreiner W, Jomrich G, Schoppmann SF, Gnant M, Tse W, Kenner L. The Oncogene AF1Q is Associated with WNT and STAT Signaling and Offers a Novel Independent Prognostic Marker in Patients with Resectable Esophageal Cancer. Cells 2019;8:E1357. [PMID: 31671695 DOI: 10.3390/cells8111357] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
93 Mahalingaiah PK, Singh KP. Chronic oxidative stress increases growth and tumorigenic potential of MCF-7 breast cancer cells. PLoS One 2014;9:e87371. [PMID: 24489904 DOI: 10.1371/journal.pone.0087371] [Cited by in Crossref: 72] [Cited by in F6Publishing: 62] [Article Influence: 10.3] [Reference Citation Analysis]
94 Yun SI, Kim HH, Yoon JH, Park WS, Hahn MJ, Kim HC, Chung CH, Kim KK. Ubiquitin specific protease 4 positively regulates the WNT/β-catenin signaling in colorectal cancer. Mol Oncol 2015;9:1834-51. [PMID: 26189775 DOI: 10.1016/j.molonc.2015.06.006] [Cited by in Crossref: 62] [Cited by in F6Publishing: 56] [Article Influence: 10.3] [Reference Citation Analysis]
95 Bansod S, Aslam Saifi M, Khurana A, Godugu C. Nimbolide abrogates cerulein-induced chronic pancreatitis by modulating β-catenin/Smad in a sirtuin-dependent way. Pharmacol Res 2020;156:104756. [PMID: 32194177 DOI: 10.1016/j.phrs.2020.104756] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 8.0] [Reference Citation Analysis]
96 Liu SG, Luo GP, Qu YB, Chen YF. Indirubin inhibits Wnt/β-catenin signal pathway via promoter demethylation of WIF-1. BMC Complement Med Ther 2020;20:250. [PMID: 32795328 DOI: 10.1186/s12906-020-03045-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
97 Liang Y, Li X, He X, Qiu X, Jin XL, Zhao XY, Xu RZ. Polyphyllin I induces cell cycle arrest and apoptosis in human myeloma cells via modulating β-catenin signaling pathway. Eur J Haematol 2016;97:371-8. [PMID: 26821882 DOI: 10.1111/ejh.12741] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.8] [Reference Citation Analysis]
98 Tian J, He H, Lei G. Wnt/β-catenin pathway in bone cancers. Tumour Biol 2014;35:9439-45. [PMID: 25117074 DOI: 10.1007/s13277-014-2433-8] [Cited by in Crossref: 54] [Cited by in F6Publishing: 47] [Article Influence: 7.7] [Reference Citation Analysis]
99 Palomo-Irigoyen M, Pérez-Andrés E, Iruarrizaga-Lejarreta M, Barreira-Manrique A, Tamayo-Caro M, Vila-Vecilla L, Moreno-Cugnon L, Beitia N, Medrano D, Fernández-Ramos D, Lozano JJ, Okawa S, Lavín JL, Martín-Martín N, Sutherland JD, de Juan VG, Gonzalez-Lopez M, Macías-Cámara N, Mosén-Ansorena D, Laraba L, Hanemann CO, Ercolano E, Parkinson DB, Schultz CW, Araúzo-Bravo MJ, Ascensión AM, Gerovska D, Iribar H, Izeta A, Pytel P, Krastel P, Provenzani A, Seneci P, Carrasco RD, Del Sol A, Martinez-Chantar ML, Barrio R, Serra E, Lazaro C, Flanagan AM, Gorospe M, Ratner N, Aransay AM, Carracedo A, Varela-Rey M, Woodhoo A. HuR/ELAVL1 drives malignant peripheral nerve sheath tumor growth and metastasis. J Clin Invest 2020;130:3848-64. [PMID: 32315290 DOI: 10.1172/JCI130379] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 6.0] [Reference Citation Analysis]
100 Voloshanenko O, Gmach P, Winter J, Kranz D, Boutros M. Mapping of Wnt-Frizzled interactions by multiplex CRISPR targeting of receptor gene families. FASEB J 2017;31:4832-44. [PMID: 28733458 DOI: 10.1096/fj.201700144R] [Cited by in Crossref: 53] [Cited by in F6Publishing: 31] [Article Influence: 13.3] [Reference Citation Analysis]
101 Liang J, Zhou H, Peng Y, Xie X, Li R, Liu Y, Xie Q, Lin Z. β-Catenin Expression Negatively Correlates with WIF1 and Predicts Poor Clinical Outcomes in Patients with Cervical Cancer. Biomed Res Int 2016;2016:4923903. [PMID: 27843945 DOI: 10.1155/2016/4923903] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
102 Sato T, Arai MA, Yixizhuoma, Hara Y, Koyano T, Kowithayakorn T, Ishibashi M. Cadinane sesquiterpenoids isolated from Santalum album using a screening program for Wnt signal inhibitory activity. J Nat Med 2020;74:476-81. [DOI: 10.1007/s11418-019-01380-x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
103 Azbazdar Y, Ozalp O, Sezgin E, Veerapathiran S, Duncan AL, Sansom MSP, Eggeling C, Wohland T, Karaca E, Ozhan G. More Favorable Palmitic Acid Over Palmitoleic Acid Modification of Wnt3 Ensures Its Localization and Activity in Plasma Membrane Domains. Front Cell Dev Biol 2019;7:281. [PMID: 31803740 DOI: 10.3389/fcell.2019.00281] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
104 Lüscher B, Bütepage M, Eckei L, Krieg S, Verheugd P, Shilton BH. ADP-Ribosylation, a Multifaceted Posttranslational Modification Involved in the Control of Cell Physiology in Health and Disease. Chem Rev 2018;118:1092-136. [PMID: 29172462 DOI: 10.1021/acs.chemrev.7b00122] [Cited by in Crossref: 93] [Cited by in F6Publishing: 78] [Article Influence: 23.3] [Reference Citation Analysis]
105 Li K, Xu X, He Y, Tian Y, Pan W, Xu L, Ma Y, Gao Y, Gao J, Qi Y, Wei L, Zhang J. P21-activated kinase 7 (PAK7) interacts with and activates Wnt/β-catenin signaling pathway in breast cancer. J Cancer 2018;9:1821-35. [PMID: 29805709 DOI: 10.7150/jca.24934] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 4.7] [Reference Citation Analysis]
106 Chandrasekaran B, Dahiya NR, Tyagi A, Kolluru V, Saran U, Baby BV, States JC, Haddad AQ, Ankem MK, Damodaran C. Chronic exposure to cadmium induces a malignant transformation of benign prostate epithelial cells. Oncogenesis 2020;9:23. [PMID: 32066655 DOI: 10.1038/s41389-020-0202-7] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 6.0] [Reference Citation Analysis]
107 Hsu LI, Briggs F, Shao X, Metayer C, Wiemels JL, Chokkalingam AP, Barcellos LF. Pathway Analysis of Genome-wide Association Study in Childhood Leukemia among Hispanics. Cancer Epidemiol Biomarkers Prev 2016;25:815-22. [PMID: 26941364 DOI: 10.1158/1055-9965.EPI-15-0528] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 1.2] [Reference Citation Analysis]
108 Li Y, Liu X, Lin X, Zhao M, Xiao Y, Liu C, Liang Z, Lin Z, Yi R, Tang Z, Liu J, Li X, Jiang Q, Li L, Xie Y, Liu Z, Fang W. Chemical compound cinobufotalin potently induces FOXO1-stimulated cisplatin sensitivity by antagonizing its binding partner MYH9. Signal Transduct Target Ther 2019;4:48. [PMID: 31754475 DOI: 10.1038/s41392-019-0084-3] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 7.0] [Reference Citation Analysis]
109 Russo M, Lamba S, Lorenzato A, Sogari A, Corti G, Rospo G, Mussolin B, Montone M, Lazzari L, Arena S, Oddo D, Linnebacher M, Sartore-Bianchi A, Pietrantonio F, Siena S, Di Nicolantonio F, Bardelli A. Reliance upon ancestral mutations is maintained in colorectal cancers that heterogeneously evolve during targeted therapies. Nat Commun 2018;9:2287. [PMID: 29895949 DOI: 10.1038/s41467-018-04506-z] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 3.7] [Reference Citation Analysis]
110 Qi J, Lee HJ, Saquet A, Cheng XN, Shao M, Zheng JJ, Shi DL. Autoinhibition of Dishevelled protein regulated by its extreme C terminus plays a distinct role in Wnt/β-catenin and Wnt/planar cell polarity (PCP) signaling pathways. J Biol Chem 2017;292:5898-908. [PMID: 28223363 DOI: 10.1074/jbc.M116.772509] [Cited by in Crossref: 15] [Cited by in F6Publishing: 8] [Article Influence: 3.8] [Reference Citation Analysis]
111 Yeh Y, Guo Q, Connelly Z, Cheng S, Yang S, Prieto-Dominguez N, Yu X. Wnt/Beta-Catenin Signaling and Prostate Cancer Therapy Resistance. Adv Exp Med Biol 2019;1210:351-78. [PMID: 31900917 DOI: 10.1007/978-3-030-32656-2_16] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 16.0] [Reference Citation Analysis]
112 Park E, Kim EK, Kim M, Ha JM, Kim YW, Jin SY, Shin HK, Ha HK, Lee JZ, Bae SS. Androgen Receptor-dependent Expression of Low-density Lipoprotein Receptor-related Protein 6 is Necessary for Prostate Cancer Cell Proliferation. Korean J Physiol Pharmacol 2015;19:235-40. [PMID: 25954128 DOI: 10.4196/kjpp.2015.19.3.235] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
113 Xu T, Zeng Y, Shi L, Yang Q, Chen Y, Wu G, Li G, Xu S. Targeting NEK2 impairs oncogenesis and radioresistance via inhibiting the Wnt1/β-catenin signaling pathway in cervical cancer. J Exp Clin Cancer Res 2020;39:183. [PMID: 32907622 DOI: 10.1186/s13046-020-01659-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
114 Zhang L, Liu H, Mu X, Cui J, Peng Z. Dysregulation of Fra1 expression by Wnt/β-catenin signalling promotes glioma aggressiveness through epithelial-mesenchymal transition. Biosci Rep 2017;37:BSR20160643. [PMID: 28232512 DOI: 10.1042/BSR20160643] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 4.3] [Reference Citation Analysis]
115 Yu C, Ding Z, Liang H, Zhang B, Chen X. The Roles of TIF1γ in Cancer. Front Oncol 2019;9:979. [PMID: 31632911 DOI: 10.3389/fonc.2019.00979] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 6.5] [Reference Citation Analysis]
116 Zhang KZ, Zhang QB, Zhang QB, Sun HC, Ao JY, Chai ZT, Zhu XD, Lu L, Zhang YY, Bu Y. Arsenic trioxide induces differentiation of CD133+ hepatocellular carcinoma cells and prolongs posthepatectomy survival by targeting GLI1 expression in a mouse model. J Hematol Oncol. 2014;7:28. [PMID: 24678763 DOI: 10.1186/1756-8722-7-28] [Cited by in Crossref: 27] [Cited by in F6Publishing: 30] [Article Influence: 3.9] [Reference Citation Analysis]
117 Bayerlová M, Klemm F, Kramer F, Pukrop T, Beißbarth T, Bleckmann A. Newly Constructed Network Models of Different WNT Signaling Cascades Applied to Breast Cancer Expression Data. PLoS One 2015;10:e0144014. [PMID: 26632845 DOI: 10.1371/journal.pone.0144014] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 2.5] [Reference Citation Analysis]
118 Caldwell C, Rottman JB, Paces W, Bueche E, Reitsma S, Gibb J, Adisetiyo V, Haas MS, Heath H, Newman W, Baum J, Gianani R, Kagey MH. Validation of a DKK1 RNAscope chromogenic in situ hybridization assay for gastric and gastroesophageal junction adenocarcinoma tumors. Sci Rep 2021;11:9920. [PMID: 33972574 DOI: 10.1038/s41598-021-89060-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
119 Rajan P, Sudbery IM, Villasevil ME, Mui E, Fleming J, Davis M, Ahmad I, Edwards J, Sansom OJ, Sims D, Ponting CP, Heger A, McMenemin RM, Pedley ID, Leung HY. Next-generation sequencing of advanced prostate cancer treated with androgen-deprivation therapy. Eur Urol 2014;66:32-9. [PMID: 24054872 DOI: 10.1016/j.eururo.2013.08.011] [Cited by in Crossref: 95] [Cited by in F6Publishing: 80] [Article Influence: 11.9] [Reference Citation Analysis]
120 You BH, Yoon JH, Kang H, Lee EK, Lee SK, Nam JW. HERES, a lncRNA that regulates canonical and noncanonical Wnt signaling pathways via interaction with EZH2. Proc Natl Acad Sci U S A 2019;116:24620-9. [PMID: 31732666 DOI: 10.1073/pnas.1912126116] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 8.5] [Reference Citation Analysis]
121 Sun X, Xu C, Tang SC, Wang J, Wang H, Wang P, Du N, Qin S, Li G, Xu S, Tao Z, Liu D, Ren H. Let-7c blocks estrogen-activated Wnt signaling in induction of self-renewal of breast cancer stem cells. Cancer Gene Ther 2016;23:83-9. [PMID: 26987290 DOI: 10.1038/cgt.2016.3] [Cited by in Crossref: 49] [Cited by in F6Publishing: 46] [Article Influence: 9.8] [Reference Citation Analysis]
122 Roy A, Ansari SA, Das K, Prasad R, Bhattacharya A, Mallik S, Mukherjee A, Sen P. Coagulation factor VIIa-mediated protease-activated receptor 2 activation leads to β-catenin accumulation via the AKT/GSK3β pathway and contributes to breast cancer progression. J Biol Chem 2017;292:13688-701. [PMID: 28522609 DOI: 10.1074/jbc.M116.764670] [Cited by in Crossref: 16] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
123 Regel I, Eichenmüller M, Mahajan UM, Hagl B, Benitz S, Häberle B, Vokuhl C, von Schweinitz D, Kappler R. Downregulation of SFRP1 is a protumorigenic event in hepatoblastoma and correlates with beta-catenin mutations. J Cancer Res Clin Oncol 2020;146:1153-67. [PMID: 32189106 DOI: 10.1007/s00432-020-03182-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
124 Gao Y, Teschendorff AE. Epigenetic and genetic deregulation in cancer target distinct signaling pathway domains. Nucleic Acids Res 2017;45:583-96. [PMID: 27899617 DOI: 10.1093/nar/gkw1100] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 2.2] [Reference Citation Analysis]
125 Wang W, Xiao X, Chen X, Huo Y, Xi W, Lin Z, Zhang D, Li Y, Yang F, Wen W, Yang A, Wang T. Tumor-suppressive miR-145 co-repressed by TCF4-β-catenin and PRC2 complexes forms double-negative regulation loops with its negative regulators in colorectal cancer: Reciprocally regulated Wnt/PRC2 and miR-145 in colorectal cancer. Int J Cancer 2018;142:308-21. [DOI: 10.1002/ijc.31056] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 5.0] [Reference Citation Analysis]
126 Jakobsson E, Argüello-Miranda O, Chiu SW, Fazal Z, Kruczek J, Nunez-Corrales S, Pandit S, Pritchet L. Towards a Unified Understanding of Lithium Action in Basic Biology and its Significance for Applied Biology. J Membr Biol 2017;250:587-604. [PMID: 29127487 DOI: 10.1007/s00232-017-9998-2] [Cited by in Crossref: 50] [Cited by in F6Publishing: 24] [Article Influence: 12.5] [Reference Citation Analysis]
127 Chen X, Duan N, Zhang C, Zhang W. Survivin and Tumorigenesis: Molecular Mechanisms and Therapeutic Strategies. J Cancer 2016;7:314-23. [PMID: 26918045 DOI: 10.7150/jca.13332] [Cited by in Crossref: 137] [Cited by in F6Publishing: 109] [Article Influence: 27.4] [Reference Citation Analysis]
128 Krausova M, Korinek V. Wnt signaling in adult intestinal stem cells and cancer. Cell Signal. 2014;26:570-579. [PMID: 24308963 DOI: 10.1016/j.cellsig.2013.11.032] [Cited by in Crossref: 229] [Cited by in F6Publishing: 195] [Article Influence: 28.6] [Reference Citation Analysis]
129 Lee J, Kee HJ, Min S, Park KC, Park S, Hwang TH, Ryu DH, Hwang GS, Cheong JH. Integrated omics-analysis reveals Wnt-mediated NAD+ metabolic reprogramming in cancer stem-like cells. Oncotarget 2016;7:48562-76. [PMID: 27391070 DOI: 10.18632/oncotarget.10432] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.7] [Reference Citation Analysis]
130 Teh C, Sun G, Shen H, Korzh V, Wohland T. Modulating the expression level of secreted Wnt3 influences cerebellum development in zebrafish transgenics. Development 2015;142:3721-33. [PMID: 26395493 DOI: 10.1242/dev.127589] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]
131 Spaan I, Raymakers RA, van de Stolpe A, Peperzak V. Wnt signaling in multiple myeloma: a central player in disease with therapeutic potential. J Hematol Oncol 2018;11:67. [PMID: 29776381 DOI: 10.1186/s13045-018-0615-3] [Cited by in Crossref: 33] [Cited by in F6Publishing: 29] [Article Influence: 11.0] [Reference Citation Analysis]
132 Hubaux R, Vandermeers F, Cosse JP, Crisanti C, Kapoor V, Albelda SM, Mascaux C, Delvenne P, Hubert P, Willems L. Valproic acid improves second-line regimen of small cell lung carcinoma in preclinical models. ERJ Open Res 2015;1:00028-2015. [PMID: 27730151 DOI: 10.1183/23120541.00028-2015] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
133 Huang P, Yan R, Zhang X, Wang L, Ke X, Qu Y. Activating Wnt/β-catenin signaling pathway for disease therapy: Challenges and opportunities. Pharmacol Ther 2019;196:79-90. [PMID: 30468742 DOI: 10.1016/j.pharmthera.2018.11.008] [Cited by in Crossref: 51] [Cited by in F6Publishing: 39] [Article Influence: 17.0] [Reference Citation Analysis]
134 Flanagan DJ, Vincan E, Phesse TJ. Winding back Wnt signalling: potential therapeutic targets for treating gastric cancers. Br J Pharmacol 2017;174:4666-83. [PMID: 28568899 DOI: 10.1111/bph.13890] [Cited by in Crossref: 20] [Cited by in F6Publishing: 14] [Article Influence: 5.0] [Reference Citation Analysis]
135 Llado V, Nakanishi Y, Duran A, Reina-Campos M, Shelton PM, Linares JF, Yajima T, Campos A, Aza-Blanc P, Leitges M, Diaz-Meco MT, Moscat J. Repression of Intestinal Stem Cell Function and Tumorigenesis through Direct Phosphorylation of β-Catenin and Yap by PKCζ. Cell Rep 2015;10:740-54. [PMID: 25660024 DOI: 10.1016/j.celrep.2015.01.007] [Cited by in Crossref: 44] [Cited by in F6Publishing: 45] [Article Influence: 7.3] [Reference Citation Analysis]
136 Stylianidis V, Hermans KCM, Blankesteijn WM. Wnt Signaling in Cardiac Remodeling and Heart Failure. In: Bauersachs J, Butler J, Sandner P, editors. Heart Failure. Cham: Springer International Publishing; 2017. pp. 371-93. [DOI: 10.1007/164_2016_56] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 2.2] [Reference Citation Analysis]
137 Priestley RS, Cheung J, Murphy EJ, Ehebauer MT, Davis JB, Di Daniel E. A novel high-content imaging-based technique for measuring binding of Dickkopf-1 to low-density lipoprotein receptor-related protein 6. Journal of Pharmacological and Toxicological Methods 2019;95:47-55. [DOI: 10.1016/j.vascn.2018.11.003] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
138 Shimono Y, Mukohyama J, Nakamura S, Minami H. MicroRNA Regulation of Human Breast Cancer Stem Cells. J Clin Med. 2015;5. [PMID: 26712794 DOI: 10.3390/jcm5010002] [Cited by in Crossref: 47] [Cited by in F6Publishing: 45] [Article Influence: 7.8] [Reference Citation Analysis]
139 Kerekes K, Bányai L, Patthy L. Wnts grasp the WIF domain of Wnt Inhibitory Factor 1 at two distinct binding sites. FEBS Lett 2015;589:3044-51. [PMID: 26342861 DOI: 10.1016/j.febslet.2015.08.031] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
140 Vadde R, Radhakrishnan S, Eranda Karunathilake Kurundu H, Reddivari L, Vanamala JK. Indian gooseberry (Emblica officinalis Gaertn.) suppresses cell proliferation and induces apoptosis in human colon cancer stem cells independent of p53 status via suppression of c-Myc and cyclin D1. Journal of Functional Foods 2016;25:267-78. [DOI: 10.1016/j.jff.2016.06.007] [Cited by in Crossref: 16] [Cited by in F6Publishing: 8] [Article Influence: 3.2] [Reference Citation Analysis]
141 Johannes JW, Almeida L, Barlaam B, Boriack-Sjodin PA, Casella R, Croft RA, Dishington AP, Gingipalli L, Gu C, Hawkins JL, Holmes JL, Howard T, Huang J, Ioannidis S, Kazmirski S, Lamb ML, McGuire TM, Moore JE, Ogg D, Patel A, Pike KG, Pontz T, Robb GR, Su N, Wang H, Wu X, Zhang HJ, Zhang Y, Zheng X, Wang T. Pyrimidinone nicotinamide mimetics as selective tankyrase and wnt pathway inhibitors suitable for in vivo pharmacology. ACS Med Chem Lett 2015;6:254-9. [PMID: 25815142 DOI: 10.1021/ml5003663] [Cited by in Crossref: 35] [Cited by in F6Publishing: 26] [Article Influence: 5.8] [Reference Citation Analysis]
142 McCubrey JA, Steelman LS, Bertrand FE, Davis NM, Abrams SL, Montalto G, D'Assoro AB, Libra M, Nicoletti F, Maestro R, Basecke J, Cocco L, Cervello M, Martelli AM. Multifaceted roles of GSK-3 and Wnt/β-catenin in hematopoiesis and leukemogenesis: opportunities for therapeutic intervention. Leukemia 2014;28:15-33. [PMID: 23778311 DOI: 10.1038/leu.2013.184] [Cited by in Crossref: 149] [Cited by in F6Publishing: 127] [Article Influence: 18.6] [Reference Citation Analysis]
143 Stepicheva N, Nigam PA, Siddam AD, Peng CF, Song JL. microRNAs regulate β-catenin of the Wnt signaling pathway in early sea urchin development. Dev Biol 2015;402:127-41. [PMID: 25614238 DOI: 10.1016/j.ydbio.2015.01.008] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.7] [Reference Citation Analysis]
144 Liu Y, Song Y, Ye M, Hu X, Wang ZP, Zhu X. The emerging role of WISP proteins in tumorigenesis and cancer therapy. J Transl Med 2019;17:28. [PMID: 30651114 DOI: 10.1186/s12967-019-1769-7] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 4.5] [Reference Citation Analysis]
145 Astudillo P. A Non-canonical Wnt Signature Correlates With Lower Survival in Gastric Cancer. Front Cell Dev Biol 2021;9:633675. [PMID: 33869179 DOI: 10.3389/fcell.2021.633675] [Reference Citation Analysis]
146 Zhu Y, Du Y, Zhang Y. DHX33 promotes colon cancer development downstream of Wnt signaling. Gene 2020;735:144402. [PMID: 32004669 DOI: 10.1016/j.gene.2020.144402] [Reference Citation Analysis]
147 Choi JC, Worman HJ. Nuclear Envelope Regulation of Signaling Cascades. In: Schirmer EC, de las Heras JI, editors. Cancer Biology and the Nuclear Envelope. New York: Springer; 2014. pp. 187-206. [DOI: 10.1007/978-1-4899-8032-8_9] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 2.1] [Reference Citation Analysis]
148 Sherwood V, Chaurasiya SK, Ekström EJ, Guilmain W, Liu Q, Koeck T, Brown K, Hansson K, Agnarsdóttir M, Bergqvist M, Jirström K, Ponten F, James P, Andersson T. WNT5A-mediated β-catenin-independent signalling is a novel regulator of cancer cell metabolism. Carcinogenesis 2014;35:784-94. [PMID: 24293407 DOI: 10.1093/carcin/bgt390] [Cited by in Crossref: 35] [Cited by in F6Publishing: 35] [Article Influence: 4.4] [Reference Citation Analysis]
149 Chu T, Teng J, Jiang L, Zhong H, Han B. Lung cancer-derived Dickkopf1 is associated with bone metastasis and the mechanism involves the inhibition of osteoblast differentiation. Biochem Biophys Res Commun 2014;443:962-8. [PMID: 24361889 DOI: 10.1016/j.bbrc.2013.12.076] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 1.9] [Reference Citation Analysis]
150 Nelson A, Karageorgis G. Natural product-informed exploration of chemical space to enable bioactive molecular discovery. RSC Med Chem 2021;12:353-62. [PMID: 34046620 DOI: 10.1039/d0md00376j] [Reference Citation Analysis]
151 Voloshanenko O, Schwartz U, Kranz D, Rauscher B, Linnebacher M, Augustin I, Boutros M. β-catenin-independent regulation of Wnt target genes by RoR2 and ATF2/ATF4 in colon cancer cells. Sci Rep 2018;8:3178. [PMID: 29453334 DOI: 10.1038/s41598-018-20641-5] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 6.7] [Reference Citation Analysis]
152 Pandey MK, Gupta SC, Nabavizadeh A, Aggarwal BB. Regulation of cell signaling pathways by dietary agents for cancer prevention and treatment. Semin Cancer Biol 2017;46:158-81. [PMID: 28823533 DOI: 10.1016/j.semcancer.2017.07.002] [Cited by in Crossref: 29] [Cited by in F6Publishing: 24] [Article Influence: 7.3] [Reference Citation Analysis]
153 Zhu S, Han Z, Luo Y, Chen Y, Zeng Q, Wu X, Yuan W. Molecular mechanisms of heart failure: insights from Drosophila. Heart Fail Rev 2017;22:91-8. [PMID: 27904993 DOI: 10.1007/s10741-016-9590-3] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 3.3] [Reference Citation Analysis]
154 Zhang E, Ma X. Regularized Multi-View Subspace Clustering for Common Modules Across Cancer Stages. Molecules 2018;23:E1016. [PMID: 29701681 DOI: 10.3390/molecules23051016] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 2.3] [Reference Citation Analysis]
155 Onyido EK, Sweeney E, Nateri AS. Wnt-signalling pathways and microRNAs network in carcinogenesis: experimental and bioinformatics approaches. Mol Cancer 2016;15:56. [PMID: 27590724 DOI: 10.1186/s12943-016-0541-3] [Cited by in Crossref: 34] [Cited by in F6Publishing: 30] [Article Influence: 6.8] [Reference Citation Analysis]
156 Wang Q, Pan F, Li S, Huang R, Wang X, Wang S, Liao X, Li D, Zhang L. The prognostic value of the proteasome activator subunit gene family in skin cutaneous melanoma. J Cancer 2019;10:2205-19. [PMID: 31258724 DOI: 10.7150/jca.30612] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 4.5] [Reference Citation Analysis]
157 Carels N, Spinassé LB, Tilli TM, Tuszynski JA. Toward precision medicine of breast cancer. Theor Biol Med Model 2016;13:7. [PMID: 26925829 DOI: 10.1186/s12976-016-0035-4] [Cited by in Crossref: 29] [Cited by in F6Publishing: 22] [Article Influence: 5.8] [Reference Citation Analysis]
158 Bui T, Schade B, Cardiff RD, Aina OH, Sanguin-Gendreau V, Muller WJ. β-Catenin haploinsufficiency promotes mammary tumorigenesis in an ErbB2-positive basal breast cancer model. Proc Natl Acad Sci U S A 2017;114:E707-16. [PMID: 28096336 DOI: 10.1073/pnas.1610383114] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 5.0] [Reference Citation Analysis]
159 Shi X, Banerjee S, Chen L, Hilakivi-Clarke L, Clarke R, Xuan J. CyNetSVM: A Cytoscape App for Cancer Biomarker Identification Using Network Constrained Support Vector Machines. PLoS One 2017;12:e0170482. [PMID: 28122019 DOI: 10.1371/journal.pone.0170482] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
160 Pez F, Lopez A, Kim M, Wands JR, Caron de Fromentel C, Merle P. Wnt signaling and hepatocarcinogenesis: molecular targets for the development of innovative anticancer drugs. J Hepatol 2013;59:1107-17. [PMID: 23835194 DOI: 10.1016/j.jhep.2013.07.001] [Cited by in Crossref: 172] [Cited by in F6Publishing: 145] [Article Influence: 21.5] [Reference Citation Analysis]
161 Jandova J, Xu W, Nfonsam V. Sporadic early-onset colon cancer expresses unique molecular features. J Surg Res. 2016;204:251-260. [PMID: 27451894 DOI: 10.1016/j.jss.2016.04.068] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
162 Guo J, Yu W, Su H, Pang X. Genomic landscape of gastric cancer: molecular classification and potential targets. Sci China Life Sci. 2017;60:126-137. [PMID: 27460193 DOI: 10.1007/s11427-016-0034-1] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
163 Jearawuttanakul K, Khumkhrong P, Suksen K, Reabroi S, Munyoo B, Tuchinda P, Borwornpinyo S, Boonmuen N, Chairoungdua A. Cleistanthin A induces apoptosis and suppresses motility of colorectal cancer cells. Eur J Pharmacol 2020;889:173604. [PMID: 32980346 DOI: 10.1016/j.ejphar.2020.173604] [Reference Citation Analysis]
164 Norton L, Chen X, Fourcaudot M, Acharya NK, DeFronzo RA, Heikkinen S. The mechanisms of genome-wide target gene regulation by TCF7L2 in liver cells. Nucleic Acids Res 2014;42:13646-61. [PMID: 25414334 DOI: 10.1093/nar/gku1225] [Cited by in Crossref: 31] [Cited by in F6Publishing: 28] [Article Influence: 4.4] [Reference Citation Analysis]
165 Kowalczyk R, Harris PWR, Williams GM, Yang SH, Brimble MA. Peptide Lipidation - A Synthetic Strategy to Afford Peptide Based Therapeutics. Adv Exp Med Biol 2017;1030:185-227. [PMID: 29081055 DOI: 10.1007/978-3-319-66095-0_9] [Cited by in Crossref: 15] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
166 Viscarra T, Buchegger K, Jofre I, Riquelme I, Zanella L, Abanto M, Parker AC, Piccolo SR, Roa JC, Ili C, Brebi P. Functional and transcriptomic characterization of carboplatin-resistant A2780 ovarian cancer cell line. Biol Res 2019;52:13. [PMID: 30894224 DOI: 10.1186/s40659-019-0220-0] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
167 Poli V, Fagnocchi L, Fasciani A, Cherubini A, Mazzoleni S, Ferrillo S, Miluzio A, Gaudioso G, Vaira V, Turdo A, Gaggianesi M, Chinnici A, Lipari E, Bicciato S, Bosari S, Todaro M, Zippo A. MYC-driven epigenetic reprogramming favors the onset of tumorigenesis by inducing a stem cell-like state. Nat Commun. 2018;9:1024. [PMID: 29523784 DOI: 10.1038/s41467-018-03264-2] [Cited by in Crossref: 62] [Cited by in F6Publishing: 52] [Article Influence: 20.7] [Reference Citation Analysis]
168 McCubrey JA, Davis NM, Abrams SL, Montalto G, Cervello M, Basecke J, Libra M, Nicoletti F, Cocco L, Martelli AM. Diverse roles of GSK-3: tumor promoter-tumor suppressor, target in cancer therapy. Adv Biol Regul. 2014;54:176-196. [PMID: 24169510 DOI: 10.1016/j.jbior.2013.09.013] [Cited by in Crossref: 57] [Cited by in F6Publishing: 54] [Article Influence: 7.1] [Reference Citation Analysis]
169 Sun Y, Zhu D, Chen F, Qian M, Wei H, Chen W, Xu J. SFRP2 augments WNT16B signaling to promote therapeutic resistance in the damaged tumor microenvironment. Oncogene 2016;35:4321-34. [PMID: 26751775 DOI: 10.1038/onc.2015.494] [Cited by in Crossref: 63] [Cited by in F6Publishing: 59] [Article Influence: 12.6] [Reference Citation Analysis]
170 Han Q, Wang X, Liao X, Han C, Yu T, Yang C, Li G, Han B, Huang K, Zhu G, Liu Z, Zhou X, Su H, Shang L, Gong Y, Song X, Peng T, Ye X. Diagnostic and prognostic value of WNT family gene expression in hepatitis B virus‑related hepatocellular carcinoma. Oncol Rep 2019;42:895-910. [PMID: 31322232 DOI: 10.3892/or.2019.7224] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
171 Schneider AJ, Branam AM, Peterson RE. Intersection of AHR and Wnt signaling in development, health, and disease. Int J Mol Sci 2014;15:17852-85. [PMID: 25286307 DOI: 10.3390/ijms151017852] [Cited by in Crossref: 57] [Cited by in F6Publishing: 51] [Article Influence: 8.1] [Reference Citation Analysis]
172 Meier-Abt F, Bentires-Alj M. How pregnancy at early age protects against breast cancer. Trends Mol Med 2014;20:143-53. [PMID: 24355762 DOI: 10.1016/j.molmed.2013.11.002] [Cited by in Crossref: 38] [Cited by in F6Publishing: 25] [Article Influence: 4.8] [Reference Citation Analysis]
173 Gore AJ, Deitz SL, Palam LR, Craven KE, Korc M. Pancreatic cancer-associated retinoblastoma 1 dysfunction enables TGF-β to promote proliferation. J Clin Invest 2014;124:338-52. [PMID: 24334458 DOI: 10.1172/JCI71526] [Cited by in Crossref: 46] [Cited by in F6Publishing: 27] [Article Influence: 5.8] [Reference Citation Analysis]
174 Qin HD, Liao XY, Chen YB, Huang SY, Xue WQ, Li FF, Ge XS, Liu DQ, Cai Q, Long J, Li XZ, Hu YZ, Zhang SD, Zhang LJ, Lehrman B, Scott AF, Lin D, Zeng YX, Shugart YY, Jia WH. Genomic Characterization of Esophageal Squamous Cell Carcinoma Reveals Critical Genes Underlying Tumorigenesis and Poor Prognosis. Am J Hum Genet. 2016;98:709-727. [PMID: 27058444 DOI: 10.1016/j.ajhg.2016.02.021] [Cited by in Crossref: 76] [Cited by in F6Publishing: 76] [Article Influence: 15.2] [Reference Citation Analysis]
175 Benoit YD, Mitchell RR, Risueño RM, Orlando L, Tanasijevic B, Boyd AL, Aslostovar L, Salci KR, Shapovalova Z, Russell J, Eguchi M, Golubeva D, Graham M, Xenocostas A, Trus MR, Foley R, Leber B, Collins TJ, Bhatia M. Sam68 Allows Selective Targeting of Human Cancer Stem Cells. Cell Chem Biol 2017;24:833-844.e9. [PMID: 28648376 DOI: 10.1016/j.chembiol.2017.05.026] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 4.5] [Reference Citation Analysis]
176 Ho SY, Keller TH. The use of porcupine inhibitors to target Wnt-driven cancers. Bioorg Med Chem Lett 2015;25:5472-6. [PMID: 26522946 DOI: 10.1016/j.bmcl.2015.10.032] [Cited by in Crossref: 35] [Cited by in F6Publishing: 29] [Article Influence: 5.8] [Reference Citation Analysis]
177 Valenta T, Degirmenci B, Moor AE, Herr P, Zimmerli D, Moor MB, Hausmann G, Cantù C, Aguet M, Basler K. Wnt Ligands Secreted by Subepithelial Mesenchymal Cells Are Essential for the Survival of Intestinal Stem Cells and Gut Homeostasis. Cell Rep 2016;15:911-8. [PMID: 27117411 DOI: 10.1016/j.celrep.2016.03.088] [Cited by in Crossref: 138] [Cited by in F6Publishing: 111] [Article Influence: 27.6] [Reference Citation Analysis]
178 Wisniewski JA, Yin J, Teuscher KB, Zhang M, Ji H. Structure-Based Design of 1,4-Dibenzoylpiperazines as β-Catenin/B-Cell Lymphoma 9 Protein-Protein Interaction Inhibitors. ACS Med Chem Lett 2016;7:508-13. [PMID: 27190602 DOI: 10.1021/acsmedchemlett.5b00284] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 4.4] [Reference Citation Analysis]
179 Tai D, Wells K, Arcaroli J, Vanderbilt C, Aisner DL, Messersmith WA, Lieu CH. Targeting the WNT Signaling Pathway in Cancer Therapeutics. Oncologist 2015;20:1189-98. [PMID: 26306903 DOI: 10.1634/theoncologist.2015-0057] [Cited by in Crossref: 71] [Cited by in F6Publishing: 71] [Article Influence: 11.8] [Reference Citation Analysis]
180 Ali H, Braga L, Giacca M. Cardiac regeneration and remodelling of the cardiomyocyte cytoarchitecture. FEBS J 2020;287:417-38. [PMID: 31743572 DOI: 10.1111/febs.15146] [Cited by in Crossref: 13] [Cited by in F6Publishing: 7] [Article Influence: 6.5] [Reference Citation Analysis]
181 Duan H, Yan Z, Chen W, Wu Y, Han J, Guo H, Qiao J. TET1 inhibits EMT of ovarian cancer cells through activating Wnt/β-catenin signaling inhibitors DKK1 and SFRP2. Gynecol Oncol 2017;147:408-17. [PMID: 28851501 DOI: 10.1016/j.ygyno.2017.08.010] [Cited by in Crossref: 34] [Cited by in F6Publishing: 31] [Article Influence: 8.5] [Reference Citation Analysis]
182 Dagg RA, Zonderland G, Lombardi EP, Rossetti GG, Groelly FJ, Barroso S, Tacconi EMC, Wright B, Lockstone H, Aguilera A, Halazonetis TD, Tarsounas M. A transcription-based mechanism for oncogenic β-catenin-induced lethality in BRCA1/2-deficient cells. Nat Commun 2021;12:4919. [PMID: 34389725 DOI: 10.1038/s41467-021-25215-0] [Reference Citation Analysis]
183 VanderVorst K, Hatakeyama J, Berg A, Lee H, Carraway KL 3rd. Cellular and molecular mechanisms underlying planar cell polarity pathway contributions to cancer malignancy. Semin Cell Dev Biol 2018;81:78-87. [PMID: 29107170 DOI: 10.1016/j.semcdb.2017.09.026] [Cited by in Crossref: 23] [Cited by in F6Publishing: 14] [Article Influence: 5.8] [Reference Citation Analysis]
184 Guo H, Nagy T, Pierce M. Post-translational glycoprotein modifications regulate colon cancer stem cells and colon adenoma progression in Apc(min/+) mice through altered Wnt receptor signaling. J Biol Chem. 2014;289:31534-31549. [PMID: 25274627 DOI: 10.1074/jbc.m114.602680] [Cited by in Crossref: 39] [Cited by in F6Publishing: 23] [Article Influence: 5.6] [Reference Citation Analysis]
185 Sun Z, Yang Z, Wang M, Huang C, Ren Y, Zhang W, Gao F, Cao L, Li L, Nie S. Paraquat induces pulmonary fibrosis through Wnt/β-catenin signaling pathway and myofibroblast differentiation. Toxicol Lett 2020;333:170-83. [PMID: 32795487 DOI: 10.1016/j.toxlet.2020.08.004] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
186 Cui Y, Wu X, Lin C, Zhang X, Ye L, Ren L, Chen M, Yang M, Li Y, Li M, Li J, Guan J, Song L. AKIP1 promotes early recurrence of hepatocellular carcinoma through activating the Wnt/β-catenin/CBP signaling pathway. Oncogene 2019;38:5516-29. [PMID: 30936461 DOI: 10.1038/s41388-019-0807-5] [Cited by in Crossref: 17] [Cited by in F6Publishing: 11] [Article Influence: 8.5] [Reference Citation Analysis]
187 Meng Z, Moroishi T, Guan KL. Mechanisms of Hippo pathway regulation. Genes Dev. 2016;30:1-17. [PMID: 26728553 DOI: 10.1101/gad.274027.115] [Cited by in Crossref: 696] [Cited by in F6Publishing: 590] [Article Influence: 139.2] [Reference Citation Analysis]
188 Kraus S, Vay C, Baldus S, Knoefel WT, Stoecklein NH, Vallbohmer D. Expression of wingless-type mouse mammary tumor virus integration site family pathway effectors in lymphatic and hepatic metastases of patients with colorectal cancer: Associations with the primary tumor. Oncol Lett. 2015;10:863-868. [PMID: 26622584 DOI: 10.3892/ol.2015.3291] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
189 Vallée A, Lecarpentier Y, Guillevin R, Vallée JN. Demyelination in Multiple Sclerosis: Reprogramming Energy Metabolism and Potential PPARγ Agonist Treatment Approaches. Int J Mol Sci 2018;19:E1212. [PMID: 29659554 DOI: 10.3390/ijms19041212] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 6.7] [Reference Citation Analysis]
190 Chen X, Yan H, Chen Y, Li G, Bin Y, Zhou X. Moderate oxidative stress promotes epithelial-mesenchymal transition in the lens epithelial cells via the TGF-β/Smad and Wnt/β-catenin pathways. Mol Cell Biochem 2021;476:1631-42. [PMID: 33417163 DOI: 10.1007/s11010-020-04034-9] [Reference Citation Analysis]
191 Nakano K, Chihara Y, Kobayashi S, Iwanaga M, Utsunomiya A, Watanabe T, Uchimaru K. Overexpression of aberrant Wnt5a and its effect on acquisition of malignant phenotypes in adult T-cell leukemia/lymphoma (ATL) cells. Sci Rep 2021;11:4114. [PMID: 33603066 DOI: 10.1038/s41598-021-83613-2] [Reference Citation Analysis]
192 Wang JB, Wang ZW, Li Y, Huang CQ, Zheng CH, Li P, Xie JW, Lin JX, Lu J, Chen QY. CDK5RAP3 acts as a tumor suppressor in gastric cancer through inhibition of β-catenin signaling. Cancer Lett. 2017;385:188-197. [PMID: 27793695 DOI: 10.1016/j.canlet.2016.10.024] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 4.0] [Reference Citation Analysis]
193 Xu K, Liu B, Ma Y. The tumor suppressive roles of ARHGAP25 in lung cancer cells. Onco Targets Ther 2019;12:6699-710. [PMID: 31692494 DOI: 10.2147/OTT.S207540] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
194 Sweeney K, Cameron ER, Blyth K. Complex Interplay between the RUNX Transcription Factors and Wnt/β-Catenin Pathway in Cancer: A Tango in the Night. Mol Cells 2020;43:188-97. [PMID: 32041394 DOI: 10.14348/molcells.2019.0310] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
195 Domingues MJ, Martinez-Sanz J, Papon L, Larue L, Mouawad L, Bonaventure J. Structure-based mutational analysis of ICAT residues mediating negative regulation of β-catenin co-transcriptional activity. PLoS One 2017;12:e0172603. [PMID: 28273108 DOI: 10.1371/journal.pone.0172603] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
196 Rismani E, Fazeli MS, Mahmoodzadeh H, Movassagh A, Azami S, Karimipoor M, Teimoori-Toolabi L. Pattern of LRP6 gene expression in tumoral tissues of colorectal cancer. Cancer Biomark 2017;19:151-9. [PMID: 28387660 DOI: 10.3233/CBM-160175] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 3.3] [Reference Citation Analysis]
197 Pisano C, Tucci M, Di Stefano RF, Turco F, Scagliotti GV, Di Maio M, Buttigliero C. Interactions between androgen receptor signaling and other molecular pathways in prostate cancer progression: Current and future clinical implications. Crit Rev Oncol Hematol 2021;157:103185. [PMID: 33341506 DOI: 10.1016/j.critrevonc.2020.103185] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
198 Bowman BM, Sebolt KA, Hoff BA, Boes JL, Daniels DL, Heist KA, Galbán CJ, Patel RM, Zhang J, Beer DG, Ross BD, Rehemtulla A, Galbán S. Phosphorylation of FADD by the kinase CK1α promotes KRASG12D-induced lung cancer. Sci Signal 2015;8:ra9. [PMID: 25628462 DOI: 10.1126/scisignal.2005607] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 3.3] [Reference Citation Analysis]
199 Tan Z, Zheng H, Liu X, Zhang W, Zhu J, Wu G, Cao L, Song J, Wu S, Song L, Li J. MicroRNA-1229 overexpression promotes cell proliferation and tumorigenicity and activates Wnt/β-catenin signaling in breast cancer. Oncotarget 2016;7:24076-87. [PMID: 26992223 DOI: 10.18632/oncotarget.8119] [Cited by in Crossref: 29] [Cited by in F6Publishing: 29] [Article Influence: 9.7] [Reference Citation Analysis]
200 Karakas D, Cevatemre B, Aztopal N, Ari F, Yilmaz VT, Ulukaya E. Addition of niclosamide to palladium(II) saccharinate complex of terpyridine results in enhanced cytotoxic activity inducing apoptosis on cancer stem cells of breast cancer. Bioorganic & Medicinal Chemistry 2015;23:5580-6. [DOI: 10.1016/j.bmc.2015.07.026] [Cited by in Crossref: 22] [Cited by in F6Publishing: 17] [Article Influence: 3.7] [Reference Citation Analysis]
201 Rangel MC, Bertolette D, Castro NP, Klauzinska M, Cuttitta F, Salomon DS. Developmental signaling pathways regulating mammary stem cells and contributing to the etiology of triple-negative breast cancer. Breast Cancer Res Treat 2016;156:211-26. [PMID: 26968398 DOI: 10.1007/s10549-016-3746-7] [Cited by in Crossref: 55] [Cited by in F6Publishing: 50] [Article Influence: 11.0] [Reference Citation Analysis]
202 Slomovitz BM, Jiang Y, Yates MS, Soliman PT, Johnston T, Nowakowski M, Levenback C, Zhang Q, Ring K, Munsell MF, Gershenson DM, Lu KH, Coleman RL. Phase II study of everolimus and letrozole in patients with recurrent endometrial carcinoma. J Clin Oncol 2015;33:930-6. [PMID: 25624430 DOI: 10.1200/JCO.2014.58.3401] [Cited by in Crossref: 138] [Cited by in F6Publishing: 43] [Article Influence: 23.0] [Reference Citation Analysis]
203 Siriboonpiputtana T, Zeisig BB, Zarowiecki M, Fung TK, Mallardo M, Tsai CT, Lau PNI, Hoang QC, Veiga P, Barnes J, Lynn C, Wilson A, Lenhard B, So CWE. Transcriptional memory of cells of origin overrides β-catenin requirement of MLL cancer stem cells. EMBO J 2017;36:3139-55. [PMID: 28978671 DOI: 10.15252/embj.201797994] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
204 Li G, Su Q, Liu H, Wang D, Zhang W, Lu Z, Chen Y, Huang X, Li W, Zhang C, He Y, Fu L, Bi J. Frizzled7 Promotes Epithelial-to-mesenchymal Transition and Stemness Via Activating Canonical Wnt/β-catenin Pathway in Gastric Cancer. Int J Biol Sci 2018;14:280-93. [PMID: 29559846 DOI: 10.7150/ijbs.23756] [Cited by in Crossref: 46] [Cited by in F6Publishing: 39] [Article Influence: 15.3] [Reference Citation Analysis]
205 Liu L, Zhu H, Liao Y, Wu W, Liu L, Liu L, Wu Y, Sun F, Lin HW. Inhibition of Wnt/β-catenin pathway reverses multi-drug resistance and EMT in Oct4+/Nanog+ NSCLC cells. Biomed Pharmacother 2020;127:110225. [PMID: 32428834 DOI: 10.1016/j.biopha.2020.110225] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 14.0] [Reference Citation Analysis]
206 Chen Z, Sui J, Zhang F, Zhang C. Cullin family proteins and tumorigenesis: genetic association and molecular mechanisms. J Cancer 2015;6:233-42. [PMID: 25663940 DOI: 10.7150/jca.11076] [Cited by in Crossref: 29] [Cited by in F6Publishing: 27] [Article Influence: 4.8] [Reference Citation Analysis]
207 Bae SM, Hong JY. The Wnt Signaling Pathway and Related Therapeutic Drugs in Autism Spectrum Disorder. Clin Psychopharmacol Neurosci 2018;16:129-35. [PMID: 29739125 DOI: 10.9758/cpn.2018.16.2.129] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 5.3] [Reference Citation Analysis]
208 Dabrowska M, Skoneczny M, Zielinski Z, Rode W. Wnt signaling in regulation of biological functions of the nurse cell harboring Trichinella spp. Parasit Vectors 2016;9:483. [PMID: 27589866 DOI: 10.1186/s13071-016-1770-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
209 Schmid SC, Sathe A, Guerth F, Seitz AK, Heck MM, Maurer T, Schwarzenböck SM, Krause BJ, Schulz WA, Stoehr R, Gschwend JE, Retz M, Nawroth R; German Bladder Cancer Network. Wntless promotes bladder cancer growth and acts synergistically as a molecular target in combination with cisplatin. Urol Oncol 2017;35:544.e1-544.e10. [PMID: 28501564 DOI: 10.1016/j.urolonc.2017.04.015] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
210 Barbayianni E, Kaffe E, Aidinis V, Kokotos G. Autotaxin, a secreted lysophospholipase D, as a promising therapeutic target in chronic inflammation and cancer. Progress in Lipid Research 2015;58:76-96. [DOI: 10.1016/j.plipres.2015.02.001] [Cited by in Crossref: 71] [Cited by in F6Publishing: 56] [Article Influence: 11.8] [Reference Citation Analysis]
211 Gao H, He F, Lin X, Wu Y. Drosophila VAMP7 regulates Wingless intracellular trafficking. PLoS One 2017;12:e0186938. [PMID: 29065163 DOI: 10.1371/journal.pone.0186938] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
212 Rong X, Zhou Y, Liu Y, Zhao B, Wang B, Wang C, Gong X, Tang P, Lu L, Li Y, Zhao C, Zhou J. Glutathione peroxidase 4 inhibits Wnt/β-catenin signaling and regulates dorsal organizer formation in zebrafish embryos. Development 2017;144:1687-97. [PMID: 28302747 DOI: 10.1242/dev.144261] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
213 Zhang Y, Dun Y, Zhou S, Huang XH. LncRNA HOXD-AS1 promotes epithelial ovarian cancer cells proliferation and invasion by targeting miR-133a-3p and activating Wnt/β-catenin signaling pathway. Biomed Pharmacother 2017;96:1216-21. [PMID: 29239819 DOI: 10.1016/j.biopha.2017.11.096] [Cited by in Crossref: 44] [Cited by in F6Publishing: 49] [Article Influence: 11.0] [Reference Citation Analysis]
214 Arai MA, Ishikawa N, Tanaka M, Uemura K, Sugimitsu N, Suganami A, Tamura Y, Koyano T, Kowithayakorn T, Ishibashi M. Hes1 inhibitor isolated by target protein oriented natural products isolation (TPO-NAPI) of differentiation activators of neural stem cells. Chem Sci 2016;7:1514-20. [PMID: 29899896 DOI: 10.1039/c5sc03540f] [Cited by in Crossref: 21] [Cited by in F6Publishing: 2] [Article Influence: 3.5] [Reference Citation Analysis]
215 Ma B, Hottiger MO. Crosstalk between Wnt/β-Catenin and NF-κB Signaling Pathway during Inflammation. Front Immunol 2016;7:378. [PMID: 27713747 DOI: 10.3389/fimmu.2016.00378] [Cited by in Crossref: 187] [Cited by in F6Publishing: 187] [Article Influence: 37.4] [Reference Citation Analysis]
216 Labbé P, Thorin E. Therapeutic Targeting of LRP6 in Cardiovascular Diseases: Challenging But Not Wnt-Possible! Canadian Journal of Cardiology 2019;35:1567-75. [DOI: 10.1016/j.cjca.2019.06.030] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
217 Zhao C, Zhang J, Ma L, Wu H, Zhang H, Su J, Geng B, Yao Q, Zheng J. GOLPH3 Promotes Angiogenesis of Lung Adenocarcinoma by Regulating the Wnt/β-Catenin Signaling Pathway. Onco Targets Ther 2020;13:6265-77. [PMID: 32636646 DOI: 10.2147/OTT.S249994] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
218 Murphy M, Chatterjee SS, Jain S, Katari M, DasGupta R. TCF7L1 Modulates Colorectal Cancer Growth by Inhibiting Expression of the Tumor-Suppressor Gene EPHB3. Sci Rep 2016;6:28299. [PMID: 27333864 DOI: 10.1038/srep28299] [Cited by in Crossref: 22] [Cited by in F6Publishing: 15] [Article Influence: 4.4] [Reference Citation Analysis]
219 Yu Z, Jiang X, Qin L, Deng H, Wang J, Ren W, Li H, Zhao L, Liu H, Yan H, Shi W, Wang Q, Luo C, Long B, Zhou H, Sun H, Jiao Z. A novel UBE2T inhibitor suppresses Wnt/β-catenin signaling hyperactivation and gastric cancer progression by blocking RACK1 ubiquitination. Oncogene 2021;40:1027-42. [PMID: 33323973 DOI: 10.1038/s41388-020-01572-w] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
220 Chinison J, Aguilar JS, Avalos A, Huang Y, Wang Z, Cameron DJ, Hao J. Triptonide Effectively Inhibits Wnt/β-Catenin Signaling via C-terminal Transactivation Domain of β-catenin. Sci Rep 2016;6:32779. [PMID: 27596363 DOI: 10.1038/srep32779] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 4.8] [Reference Citation Analysis]
221 Lee Y, Lee JK, Ahn SH, Lee J, Nam DH. WNT signaling in glioblastoma and therapeutic opportunities. Lab Invest 2016;96:137-50. [PMID: 26641068 DOI: 10.1038/labinvest.2015.140] [Cited by in Crossref: 117] [Cited by in F6Publishing: 104] [Article Influence: 19.5] [Reference Citation Analysis]
222 Xia P, Gu R, Zhang W, Shao L, Li F, Wu C, Sun Y. MicroRNA-377 exerts a potent suppressive role in osteosarcoma through the involvement of the histone acetyltransferase 1-mediated Wnt axis. J Cell Physiol 2019;234:22787-98. [PMID: 31152456 DOI: 10.1002/jcp.28843] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 7.0] [Reference Citation Analysis]
223 Röhrig F, Schulze A. The multifaceted roles of fatty acid synthesis in cancer. Nat Rev Cancer 2016;16:732-49. [PMID: 27658529 DOI: 10.1038/nrc.2016.89] [Cited by in Crossref: 455] [Cited by in F6Publishing: 370] [Article Influence: 91.0] [Reference Citation Analysis]
224 Wu D, Fan Y, Liu S, Woollam MD, Sun X, Murao E, Zha R, Prakash R, Park C, Siegel AP, Liu J, Agarwal M, Li BY, Yokota H. Loading-induced antitumor capability of murine and human urine. FASEB J 2020;34:7578-92. [PMID: 32293076 DOI: 10.1096/fj.202000096R] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
225 Li X, Cai H, Zheng W, Tong M, Li H, Ao L, Li J, Hong G, Li M, Guan Q, Yang S, Yang D, Lin X, Guo Z. An individualized prognostic signature for gastric cancer patients treated with 5-Fluorouracil-based chemotherapy and distinct multi-omics characteristics of prognostic groups. Oncotarget. 2016;7:8743-8755. [PMID: 26840027 DOI: 10.18632/oncotarget.7087] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 5.8] [Reference Citation Analysis]
226 Beard JA, Tenga A, Chen T. The interplay of NR4A receptors and the oncogene-tumor suppressor networks in cancer. Cell Signal 2015;27:257-66. [PMID: 25446259 DOI: 10.1016/j.cellsig.2014.11.009] [Cited by in Crossref: 53] [Cited by in F6Publishing: 43] [Article Influence: 7.6] [Reference Citation Analysis]
227 Suebsoonthron J, Jaroonwitchawan T, Yamabhai M, Noisa P. Inhibition of WNT signaling reduces differentiation and induces sensitivity to doxorubicin in human malignant neuroblastoma SH-SY5Y cells. Anticancer Drugs 2017;28:469-79. [PMID: 28240680 DOI: 10.1097/CAD.0000000000000478] [Cited by in Crossref: 14] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
228 Zhang S, Guo X, Chen C, Chen Y, Li J, Sun Y, Wu C, Yang Y, Jiang C, Li W, Xue L. dFoxO promotes Wingless signaling in Drosophila. Sci Rep 2016;6:22348. [PMID: 26936649 DOI: 10.1038/srep22348] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
229 Degirmenci B, Hausmann G, Valenta T, Basler K. Wnt Ligands as a Part of the Stem Cell Niche in the Intestine and the Liver. WNT Signaling in Health and Disease. Elsevier; 2018. pp. 1-19. [DOI: 10.1016/bs.pmbts.2017.11.011] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
230 Wei W, Lewis MT. Identifying and targeting tumor-initiating cells in the treatment of breast cancer. Endocr Relat Cancer. 2015;22:R135-R155. [PMID: 25876646 DOI: 10.1530/erc-14-0447] [Cited by in Crossref: 34] [Cited by in F6Publishing: 24] [Article Influence: 5.7] [Reference Citation Analysis]
231 Ahadova A, von Knebel Doeberitz M, Bläker H, Kloor M. CTNNB1-mutant colorectal carcinomas with immediate invasive growth: a model of interval cancers in Lynch syndrome. Familial Cancer 2016;15:579-86. [DOI: 10.1007/s10689-016-9899-z] [Cited by in Crossref: 45] [Cited by in F6Publishing: 37] [Article Influence: 9.0] [Reference Citation Analysis]
232 Gonzalez-Meljem JM, Martinez-Barbera JP. Adamantinomatous craniopharyngioma as a model to understand paracrine and senescence-induced tumourigenesis. Cell Mol Life Sci 2021;78:4521-44. [PMID: 34019103 DOI: 10.1007/s00018-021-03798-7] [Reference Citation Analysis]
233 Ghoshal A, Goswami U, Raza A, Chattopadhyay A, Ghosh SS. Recombinant sFRP4 bound chitosan–alginate composite nanoparticles embedded with silver nanoclusters for Wnt/β-catenin targeting in cancer theranostics. RSC Adv 2016;6:85763-72. [DOI: 10.1039/c6ra16066b] [Cited by in Crossref: 9] [Article Influence: 1.8] [Reference Citation Analysis]
234 Liu H, Zhang S, Zhao L, Zhang Y, Li Q, Chai X, Zhang Y. Resveratrol Enhances Cardiomyocyte Differentiation of Human Induced Pluripotent Stem Cells through Inhibiting Canonical WNT Signal Pathway and Enhancing Serum Response Factor-miR-1 Axis. Stem Cells Int 2016;2016:2524092. [PMID: 26798354 DOI: 10.1155/2016/2524092] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.3] [Reference Citation Analysis]
235 Sferrazza G, Corti M, Brusotti G, Pierimarchi P, Temporini C, Serafino A, Calleri E. Nature-derived compounds modulating Wnt/ β -catenin pathway: a preventive and therapeutic opportunity in neoplastic diseases. Acta Pharm Sin B 2020;10:1814-34. [PMID: 33163337 DOI: 10.1016/j.apsb.2019.12.019] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 13.0] [Reference Citation Analysis]
236 Ashmawy AM, Elgeshy KM, Abdel Salam ET, Ghareeb M, Kobaisi MH, Amin HAA, Sharawy SK, Abdel Wahab AHA. Crosstalk between liver-related microRNAs and Wnt/β-catenin pathway in hepatocellular carcinoma patients. Arab J Gastroenterol 2017;18:144-50. [PMID: 28958640 DOI: 10.1016/j.ajg.2017.09.001] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 4.3] [Reference Citation Analysis]
237 Lee E, Ha S, Logan SK. Divergent Androgen Receptor and Beta-Catenin Signaling in Prostate Cancer Cells. PLoS One 2015;10:e0141589. [PMID: 26509262 DOI: 10.1371/journal.pone.0141589] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 4.0] [Reference Citation Analysis]
238 Delaunay S, Rapino F, Tharun L, Zhou Z, Heukamp L, Termathe M, Shostak K, Klevernic I, Florin A, Desmecht H, Desmet CJ, Nguyen L, Leidel SA, Willis AE, Büttner R, Chariot A, Close P. Elp3 links tRNA modification to IRES-dependent translation of LEF1 to sustain metastasis in breast cancer. J Exp Med 2016;213:2503-23. [PMID: 27811057 DOI: 10.1084/jem.20160397] [Cited by in Crossref: 77] [Cited by in F6Publishing: 66] [Article Influence: 15.4] [Reference Citation Analysis]
239 Zhang S, Guo X, Wu H, Sun Y, Ma X, Li J, Xu Q, Wu C, Li Q, Jiang C, Li W, Ho MS, Lv Z, Xue L. Wingless modulates activator protein-1-mediated tumor invasion. Oncogene 2019;38:3871-85. [PMID: 30683884 DOI: 10.1038/s41388-018-0629-x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 6.0] [Reference Citation Analysis]
240 Li B, Guo X, Li N, Chen Q, Shen J, Huang X, Huang G, Wang F. WNT1, a target of miR-34a, promotes cervical squamous cell carcinoma proliferation and invasion by induction of an E-P cadherin switch via the WNT/β-catenin pathway. Cell Oncol (Dordr) 2020;43:489-503. [PMID: 32301035 DOI: 10.1007/s13402-020-00506-8] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
241 Sharma M, Jamieson C, Lui C, Henderson BR. Distinct hydrophobic “patches” in the N- and C-tails of beta-catenin contribute to nuclear transport. Experimental Cell Research 2016;348:132-45. [DOI: 10.1016/j.yexcr.2016.09.009] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
242 Li H, Li J, Han R, Deng X, Shi J, Huang H, Hamad N, McCaughley A, Liu J, Wang C, Chen K, Wei D, Qiang J, Thatcher S, Wu Y, Liu C, Thibault O, Wei X, Chen S, Qian H, Zhou BP, Xu P, Yang XH. Deletion of tetraspanin CD151 alters the Wnt oncogene-induced mammary tumorigenesis: A cell type-linked function and signaling. Neoplasia 2019;21:1151-63. [PMID: 31783316 DOI: 10.1016/j.neo.2019.08.005] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
243 Dunn SJ, Osborne JM, Appleton PL, Näthke I. Combined changes in Wnt signaling response and contact inhibition induce altered proliferation in radiation-treated intestinal crypts. Mol Biol Cell 2016;27:1863-74. [PMID: 27053661 DOI: 10.1091/mbc.E15-12-0854] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 2.8] [Reference Citation Analysis]
244 Nie X, Wei X, Ma H, Fan L, Chen WD. The complex role of Wnt ligands in type 2 diabetes mellitus and related complications. J Cell Mol Med 2021;25:6479-95. [PMID: 34042263 DOI: 10.1111/jcmm.16663] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
245 Zhu X, Wen L, Sheng S, Wang W, Xiao Q, Qu M, Hu Y, Liu C, He K. Porcine Circovirus-Like Virus P1 Inhibits Wnt Signaling Pathway in Vivo and in Vitro. Front Microbiol 2018;9:390. [PMID: 29593670 DOI: 10.3389/fmicb.2018.00390] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
246 Chen Z, Zhang J, Yuan A, Han J, Tan L, Zhou Z, Zhao H, Su R, Huang B, Wang B, Sun B, Fan X, Yang Q. R-spondin3 promotes the tumor growth of choriocarcinoma JEG-3 cells. Am J Physiol Cell Physiol 2020;318:C664-74. [PMID: 31851527 DOI: 10.1152/ajpcell.00295.2019] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
247 Ganguly SS, Li X, Miranti CK. The host microenvironment influences prostate cancer invasion, systemic spread, bone colonization, and osteoblastic metastasis. Front Oncol 2014;4:364. [PMID: 25566502 DOI: 10.3389/fonc.2014.00364] [Cited by in Crossref: 31] [Cited by in F6Publishing: 31] [Article Influence: 4.4] [Reference Citation Analysis]
248 Yoshida GJ. Emerging role of epithelial-mesenchymal transition in hepatic cancer. J Exp Clin Cancer Res 2016;35:141. [PMID: 27619936 DOI: 10.1186/s13046-016-0419-7] [Cited by in Crossref: 30] [Cited by in F6Publishing: 27] [Article Influence: 6.0] [Reference Citation Analysis]
249 Xu H, Xia H, Zhou S, Tang Q, Bi F. Cholesterol activates the Wnt/PCP-YAP signaling in SOAT1-targeted treatment of colon cancer. Cell Death Discov 2021;7:38. [PMID: 33637695 DOI: 10.1038/s41420-021-00421-3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
250 Wang Z, Sheng YY, Gao XM, Wang CQ, Wang XY, Lu XU, Wei JW, Zhang KL, Dong QZ, Qin LX. β-catenin mutation is correlated with a favorable prognosis in patients with hepatocellular carcinoma. Mol Clin Oncol 2015;3:936-40. [PMID: 26171210 DOI: 10.3892/mco.2015.569] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
251 Shin S, Im HJ, Kwon YJ, Ye DJ, Baek HS, Kim D, Choi HK, Chun YJ. Human steroid sulfatase induces Wnt/β-catenin signaling and epithelial-mesenchymal transition by upregulating Twist1 and HIF-1α in human prostate and cervical cancer cells. Oncotarget 2017;8:61604-17. [PMID: 28977889 DOI: 10.18632/oncotarget.18645] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 5.5] [Reference Citation Analysis]
252 Martinez-Font E, Pérez-Capó M, Ramos R, Felipe I, Garcías C, Luna P, Terrasa J, Martín-Broto J, Vögler O, Alemany R, Obrador-Hevia A. Impact of Wnt/β-Catenin Inhibition on Cell Proliferation through CDC25A Downregulation in Soft Tissue Sarcomas. Cancers (Basel) 2020;12:E2556. [PMID: 32911761 DOI: 10.3390/cancers12092556] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
253 Abou-elhamd A, Alrefaei AF, Mok GF, Garcia-morales C, Abu-elmagd M, Wheeler GN, Münsterberg AE. Klhl31 attenuates β-catenin dependent Wnt signaling and regulates embryo myogenesis. Developmental Biology 2015;402:61-71. [DOI: 10.1016/j.ydbio.2015.02.024] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
254 Friese A, Kapoor S, Schneidewind T, Vidadala SR, Sardana J, Brause A, Förster T, Bischoff M, Wagner J, Janning P, Ziegler S, Waldmann H. Chemical Genetics Reveals a Role of dCTP Pyrophosphatase 1 in Wnt Signaling. Angew Chem Int Ed 2019;58:13009-13. [DOI: 10.1002/anie.201905977] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
255 Reyes M, Flores T, Betancur D, Peña-Oyarzún D, Torres VA. Wnt/β-Catenin Signaling in Oral Carcinogenesis. Int J Mol Sci 2020;21:E4682. [PMID: 32630122 DOI: 10.3390/ijms21134682] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
256 Náger M, Santacana M, Bhardwaj D, Valls J, Ferrer I, Nogués P, Cantí C, Herreros J. Nuclear phosphorylated Y142 β-catenin accumulates in astrocytomas and glioblastomas and regulates cell invasion. Cell Cycle 2015;14:3644-55. [PMID: 26654598 DOI: 10.1080/15384101.2015.1104443] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 2.6] [Reference Citation Analysis]
257 Wu Y, Wang A, Zhu B, Huang J, Lu E, Xu H, Xia W, Dong G, Jiang F, Xu L. KIF18B promotes tumor progression through activating the Wnt/β-catenin pathway in cervical cancer. Onco Targets Ther 2018;11:1707-20. [PMID: 29636620 DOI: 10.2147/OTT.S157440] [Cited by in Crossref: 24] [Cited by in F6Publishing: 19] [Article Influence: 8.0] [Reference Citation Analysis]
258 Brown L, Wan H. Desmoglein 3: a help or a hindrance in cancer progression? Cancers (Basel) 2015;7:266-86. [PMID: 25629808 DOI: 10.3390/cancers7010266] [Cited by in Crossref: 22] [Cited by in F6Publishing: 16] [Article Influence: 3.7] [Reference Citation Analysis]
259 Xu Y, Shen D, Liu J, Xu X, Tu J, Qin L, Jiang L, Qian H, Guo F. Long non-coding RNAs as targets for immunosuppressive drug teriflunomide in anti-cancer potential for hepatocellular carcinoma. J Mol Histol 2020;51:659-73. [PMID: 33034797 DOI: 10.1007/s10735-020-09912-6] [Reference Citation Analysis]
260 Pak S, Park S, Kim Y, Park JH, Park CH, Lee KJ, Kim CS, Ahn H. The small molecule WNT/β-catenin inhibitor CWP232291 blocks the growth of castration-resistant prostate cancer by activating the endoplasmic reticulum stress pathway. J Exp Clin Cancer Res 2019;38:342. [PMID: 31387608 DOI: 10.1186/s13046-019-1342-5] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 7.5] [Reference Citation Analysis]
261 Alexander CM. The Wnt Signaling Landscape of Mammary Stem Cells and Breast Tumors. WNT Signaling in Health and Disease. Elsevier; 2018. pp. 271-98. [DOI: 10.1016/bs.pmbts.2017.11.020] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
262 Liu C, Zhang Y, Li J, Wang Y, Ren F, Zhou Y, Wu Y, Feng Y, Zhou Y, Su F. p15RS/RPRD1A (p15INK4b-related sequence/regulation of nuclear pre-mRNA domain-containing protein 1A) interacts with HDAC2 in inhibition of the Wnt/β-catenin signaling pathway. J Biol Chem. 2015;290:9701-9713. [PMID: 25697359 DOI: 10.1074/jbc.m114.620872] [Cited by in Crossref: 22] [Cited by in F6Publishing: 17] [Article Influence: 3.7] [Reference Citation Analysis]
263 Cong LH, Du SY, Wu YN, Liu Y, Li T, Wang H, Li G, Duan J. Upregulation of Klotho potentially inhibits pulmonary vascular remodeling by blocking the activation of the Wnt signaling pathway in rats with PM2.5-induced pulmonary arterial hypertension. J Cell Biochem 2018;119:5581-97. [PMID: 29380911 DOI: 10.1002/jcb.26729] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
264 Hara Y, Arai MA, Toume K, Masu H, Sato T, Komatsu K, Yaguchi T, Ishibashi M. Coculture of a Pathogenic Actinomycete and Animal Cells To Produce Nocarjamide, a Cyclic Nonapeptide with Wnt Signal-Activating Effect. Org Lett 2018;20:5831-4. [DOI: 10.1021/acs.orglett.8b02522] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 2.3] [Reference Citation Analysis]
265 Hatakeyama J, Wald JH, Printsev I, Ho HY, Carraway KL. Vangl1 and Vangl2: planar cell polarity components with a developing role in cancer. Endocr Relat Cancer. 2014;21:R345-R356. [PMID: 24981109 DOI: 10.1530/erc-14-0141] [Cited by in Crossref: 38] [Cited by in F6Publishing: 25] [Article Influence: 5.4] [Reference Citation Analysis]
266 Gao X, Mi Y, Ma Y, Jin W. LEF1 regulates glioblastoma cell proliferation, migration, invasion, and cancer stem-like cell self-renewal. Tumour Biol 2014;35:11505-11. [PMID: 25128061 DOI: 10.1007/s13277-014-2466-z] [Cited by in Crossref: 27] [Cited by in F6Publishing: 23] [Article Influence: 3.9] [Reference Citation Analysis]
267 Zhang Y, Liu C, Duan X, Ren F, Li S, Jin Z, Wang Y, Feng Y, Liu Z, Chang Z. CREPT/RPRD1B, a recently identified novel protein highly expressed in tumors, enhances the β-catenin·TCF4 transcriptional activity in response to Wnt signaling. J Biol Chem 2014;289:22589-99. [PMID: 24982424 DOI: 10.1074/jbc.M114.560979] [Cited by in Crossref: 27] [Cited by in F6Publishing: 20] [Article Influence: 3.9] [Reference Citation Analysis]
268 Wald JH, Hatakeyama J, Printsev I, Cuevas A, Fry WHD, Saldana MJ, VanderVorst K, Rowson-Hodel A, Angelastro JM, Sweeney C, Carraway KL Rd. Suppression of planar cell polarity signaling and migration in glioblastoma by Nrdp1-mediated Dvl polyubiquitination. Oncogene 2017;36:5158-67. [PMID: 28481871 DOI: 10.1038/onc.2017.126] [Cited by in Crossref: 23] [Cited by in F6Publishing: 18] [Article Influence: 5.8] [Reference Citation Analysis]
269 Zhang H, Rong X, Wang C, Liu Y, Lu L, Li Y, Zhao C, Zhou J. VBP1 modulates Wnt/β-catenin signaling by mediating the stability of the transcription factors TCF/LEFs. J Biol Chem 2020;295:16826-39. [PMID: 32989053 DOI: 10.1074/jbc.RA120.015282] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
270 Hirashima T, Karasawa H, Aizawa T, Suzuki T, Yamamura A, Suzuki H, Kajiwara T, Musha H, Funayama R, Shirota M, Ohnuma S, Nakayama K, Unno M. Wnt5a in cancer-associated fibroblasts promotes colorectal cancer progression. Biochem Biophys Res Commun 2021;568:37-42. [PMID: 34175688 DOI: 10.1016/j.bbrc.2021.06.062] [Reference Citation Analysis]
271 Bhavanasi D, Speer KF, Klein PS. CKAP4 is identified as a receptor for Dickkopf in cancer cells. J Clin Invest 2016;126:2419-21. [PMID: 27322056 DOI: 10.1172/JCI88620] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
272 Javed Z, Muhammad Farooq H, Ullah M, Zaheer Iqbal M, Raza Q, Sadia H, Pezzani R, Salehi B, Sharifi-Rad J, Cho WC. Wnt Signaling: A Potential Therapeutic Target in Head and Neck Squamous Cell Carcinoma. Asian Pac J Cancer Prev 2019;20:995-1003. [PMID: 31030466 DOI: 10.31557/APJCP.2019.20.4.995] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 4.5] [Reference Citation Analysis]
273 Anastasakis D, Skeparnias I, Shaukat AN, Grafanaki K, Kanellou A, Taraviras S, Papachristou DJ, Papakyriakou A, Stathopoulos C. Mammalian PNLDC1 is a novel poly(A) specific exonuclease with discrete expression during early development. Nucleic Acids Res 2016;44:8908-20. [PMID: 27515512 DOI: 10.1093/nar/gkw709] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 2.6] [Reference Citation Analysis]
274 Souza WFD, Araújo WMD, de-Freitas-Junior JCM, Morgado-díaz JA. Sinalização celular em câncer. Cienc Cult 2014;66:30-3. [DOI: 10.21800/s0009-67252014000100013] [Cited by in Crossref: 2] [Article Influence: 0.3] [Reference Citation Analysis]
275 Wu X, Yu N, Zhang Y, Ye Y, Sun W, Ye L, Wu H, Yang Z, Wu L, Wang F. Radix Tetrastigma hemsleyani flavone exhibits antitumor activity in colorectal cancer via Wnt/β-catenin signaling pathway. Onco Targets Ther 2018;11:6437-46. [PMID: 30323621 DOI: 10.2147/OTT.S172048] [Cited by in Crossref: 9] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
276 Lee HJ, Bao J, Miller A, Zhang C, Wu J, Baday YC, Guibao C, Li L, Wu D, Zheng JJ. Structure-based Discovery of Novel Small Molecule Wnt Signaling Inhibitors by Targeting the Cysteine-rich Domain of Frizzled. J Biol Chem 2015;290:30596-606. [PMID: 26504084 DOI: 10.1074/jbc.M115.673202] [Cited by in Crossref: 28] [Cited by in F6Publishing: 17] [Article Influence: 4.7] [Reference Citation Analysis]
277 Chen YC, Statt S, Wu R, Chang HT, Liao JW, Wang CN, Shyu WC, Lee CC. High mobility group box 1-induced epithelial mesenchymal transition in human airway epithelial cells. Sci Rep 2016;6:18815. [PMID: 26739898 DOI: 10.1038/srep18815] [Cited by in Crossref: 36] [Cited by in F6Publishing: 36] [Article Influence: 7.2] [Reference Citation Analysis]
278 Nair J, Jain P, Chandola U, Palve V, Vardhan NR, Reddy RB, Kekatpure VD, Suresh A, Kuriakose MA, Panda B. Gene and miRNA expression changes in squamous cell carcinoma of larynx and hypopharynx. Genes Cancer 2015;6:328-40. [PMID: 26413216 DOI: 10.18632/genesandcancer.69] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 3.0] [Reference Citation Analysis]
279 Ding Y, Wu H, Warden C, Steele L, Liu X, Iterson MV, Wu X, Nelson R, Liu Z, Yuan YC, Neuhausen SL. Gene Expression Differences in Prostate Cancers between Young and Old Men. PLoS Genet 2016;12:e1006477. [PMID: 28027300 DOI: 10.1371/journal.pgen.1006477] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 3.2] [Reference Citation Analysis]
280 Kong W, Zhang J, Mou X, Yang Y. Integrating gene expression and protein interaction data for signaling pathway prediction of Alzheimer's disease. Comput Math Methods Med 2014;2014:340758. [PMID: 24812571 DOI: 10.1155/2014/340758] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
281 Hiraga T. Targeted Agents in Preclinical and Early Clinical Development for the Treatment of Cancer Bone Metastases. Expert Opinion on Investigational Drugs 2016;25:319-34. [DOI: 10.1517/13543784.2016.1142972] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 2.6] [Reference Citation Analysis]
282 Horne GA, Copland M. Approaches for targeting self-renewal pathways in cancer stem cells: implications for hematological treatments. Expert Opinion on Drug Discovery 2017;12:465-74. [DOI: 10.1080/17460441.2017.1303477] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
283 Liu K, Fan J, Wu J. Forkhead Box Protein J1 (FOXJ1) is Overexpressed in Colorectal Cancer and Promotes Nuclear Translocation of β-Catenin in SW620 Cells. Med Sci Monit 2017;23:856-66. [PMID: 28209947 DOI: 10.12659/msm.902906] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
284 Wang W, Xu L, Liu P, Jairam K, Yin Y, Chen K, Sprengers D, Peppelenbosch MP, Pan Q, Smits R. Blocking Wnt Secretion Reduces Growth of Hepatocellular Carcinoma Cell Lines Mostly Independent of β-Catenin Signaling. Neoplasia 2016;18:711-23. [PMID: 27851986 DOI: 10.1016/j.neo.2016.10.004] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 4.8] [Reference Citation Analysis]
285 Fasihi A, M. Soltani B, Atashi A, Nasiri S. Introduction of hsa‐miR‐103a and hsa‐miR‐1827 and hsa‐miR‐137 as new regulators of Wnt signaling pathway and their relation to colorectal carcinoma. J Cell Biochem 2018;119:5104-17. [DOI: 10.1002/jcb.26357] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 7.0] [Reference Citation Analysis]
286 Jin PY, Zheng ZH, Lu HJ, Yan J, Zheng GH, Zheng YL, Wu DM, Lu J. Roles of β-catenin, TCF-4, and survivin in nasopharyngeal carcinoma: correlation with clinicopathological features and prognostic significance. Cancer Cell Int 2019;19:48. [PMID: 30867651 DOI: 10.1186/s12935-019-0764-7] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 4.5] [Reference Citation Analysis]
287 Wang Z, Liu CH, Huang S, Chen J. Wnt Signaling in vascular eye diseases. Prog Retin Eye Res 2019;70:110-33. [PMID: 30513356 DOI: 10.1016/j.preteyeres.2018.11.008] [Cited by in Crossref: 33] [Cited by in F6Publishing: 20] [Article Influence: 11.0] [Reference Citation Analysis]
288 Li K, Yuan C. MicroRNA‑103 modulates tumor progression by targeting KLF7 in non‑small cell lung cancer. Int J Mol Med 2020;46:1013-28. [PMID: 32582959 DOI: 10.3892/ijmm.2020.4649] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
289 Malgulwar PB, Nambirajan A, Pathak P, Faruq M, Suri V, Sarkar C, Jagdevan A, Sharma BS, Sharma MC. Study of β-catenin and BRAF alterations in adamantinomatous and papillary craniopharyngiomas: mutation analysis with immunohistochemical correlation in 54 cases. J Neurooncol 2017;133:487-95. [DOI: 10.1007/s11060-017-2465-1] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
290 Yan C, Wang J, Wu FX. DWNN-RLS: regularized least squares method for predicting circRNA-disease associations. BMC Bioinformatics 2018;19:520. [PMID: 30598076 DOI: 10.1186/s12859-018-2522-6] [Cited by in Crossref: 41] [Cited by in F6Publishing: 27] [Article Influence: 13.7] [Reference Citation Analysis]
291 Toume K, Tsukahara K, Ito H, Arai MA, Ishibashi M. Chromomycins A2 and A3 from marine actinomycetes with TRAIL resistance-overcoming and Wnt signal inhibitory activities. Mar Drugs 2014;12:3466-76. [PMID: 24905484 DOI: 10.3390/md12063466] [Cited by in Crossref: 20] [Cited by in F6Publishing: 12] [Article Influence: 2.9] [Reference Citation Analysis]
292 Becker J, Wilting J. WNT Signaling in Neuroblastoma. Cancers (Basel). 2019;11. [PMID: 31331081 DOI: 10.3390/cancers11071013] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
293 Peglion F, Etienne-Manneville S. p120catenin alteration in cancer and its role in tumour invasion. Philos Trans R Soc Lond B Biol Sci 2013;368:20130015. [PMID: 24062585 DOI: 10.1098/rstb.2013.0015] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.5] [Reference Citation Analysis]
294 Madan B, McDonald MJ, Foxa GE, Diegel CR, Williams BO, Virshup DM. Bone loss from Wnt inhibition mitigated by concurrent alendronate therapy. Bone Res 2018;6:17. [PMID: 29844946 DOI: 10.1038/s41413-018-0017-8] [Cited by in Crossref: 33] [Cited by in F6Publishing: 21] [Article Influence: 11.0] [Reference Citation Analysis]
295 Kim M, Kim S, Lee SH, Kim W, Sohn MJ, Kim HS, Kim J, Jho EH. Merlin inhibits Wnt/β-catenin signaling by blocking LRP6 phosphorylation. Cell Death Differ 2016;23:1638-47. [PMID: 27285107 DOI: 10.1038/cdd.2016.54] [Cited by in Crossref: 18] [Cited by in F6Publishing: 12] [Article Influence: 3.6] [Reference Citation Analysis]
296 Wang Y, Freedman JA, Liu H, Moorman PG, Hyslop T, George DJ, Lee NH, Patierno SR, Wei Q. Associations between RNA splicing regulatory variants of stemness-related genes and racial disparities in susceptibility to prostate cancer. Int J Cancer 2017;141:731-43. [PMID: 28510291 DOI: 10.1002/ijc.30787] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 3.5] [Reference Citation Analysis]
297 Lim S, Kaldis P. Cdks, cyclins and CKIs: roles beyond cell cycle regulation. Development. 2013;140:3079-3093. [PMID: 23861057 DOI: 10.1242/dev.091744] [Cited by in Crossref: 785] [Cited by in F6Publishing: 612] [Article Influence: 98.1] [Reference Citation Analysis]
298 Kim H, Rodriguez-Navas C, Kollipara RK, Kapur P, Pedrosa I, Brugarolas J, Kittler R, Ye J. Unsaturated Fatty Acids Stimulate Tumor Growth through Stabilization of β-Catenin. Cell Rep 2015;13:495-503. [PMID: 26456834 DOI: 10.1016/j.celrep.2015.09.010] [Cited by in Crossref: 30] [Cited by in F6Publishing: 31] [Article Influence: 5.0] [Reference Citation Analysis]
299 Mirhosseini SA, Sarfi M, Samavarchi Tehrani S, Mirazakhani M, Maniati M, Amani J. Modulation of cancer cell signaling by long noncoding RNAs. J Cell Biochem 2019;120:12224-46. [PMID: 31069841 DOI: 10.1002/jcb.28847] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 6.5] [Reference Citation Analysis]
300 Weng YC, Ma J, Zhang J, Wang JC. Long non-coding RNA LINC01133 silencing exerts antioncogenic effect in pancreatic cancer through the methylation of DKK1 promoter and the activation of Wnt signaling pathway. Cancer Biol Ther 2019;20:368-80. [PMID: 30580676 DOI: 10.1080/15384047.2018.1529110] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
301 Duan X, Zhang T, Kong Z, Mai X, Lan C, Chen D, Liu Y, Zeng Z, Cai C, Deng T, Wu W, Zeng G. β-arrestin1 promotes epithelial-mesenchymal transition via modulating GSK-3β/β-catenin pathway in prostate cancer cells. Biochemical and Biophysical Research Communications 2016;479:204-10. [DOI: 10.1016/j.bbrc.2016.09.039] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 3.4] [Reference Citation Analysis]
302 Zhao Z, Lu P, Zhang H, Xu H, Gao N, Li M, Liu C. Nestin positively regulates the Wnt/β-catenin pathway and the proliferation, survival and invasiveness of breast cancer stem cells. Breast Cancer Res 2014;16:408. [PMID: 25056574 DOI: 10.1186/s13058-014-0408-8] [Cited by in Crossref: 97] [Cited by in F6Publishing: 81] [Article Influence: 13.9] [Reference Citation Analysis]
303 Ahmadzadeh A, Norozi F, Shahrabi S, Shahjahani M, Saki N. Wnt/β-catenin signaling in bone marrow niche. Cell Tissue Res 2016;363:321-35. [PMID: 26475718 DOI: 10.1007/s00441-015-2300-y] [Cited by in Crossref: 43] [Cited by in F6Publishing: 36] [Article Influence: 7.2] [Reference Citation Analysis]
304 Mir R, Sharma A, Pradhan SJ, Galande S. Regulation of Transcription Factor SP1 by the β-Catenin Destruction Complex Modulates Wnt Response. Mol Cell Biol 2018;38:e00188-18. [PMID: 30181396 DOI: 10.1128/MCB.00188-18] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 3.7] [Reference Citation Analysis]
305 Gillis WQ, Kirmizitas A, Iwasaki Y, Ki DH, Wyrick JM, Thomsen GH. Gtpbp2 is a positive regulator of Wnt signaling and maintains low levels of the Wnt negative regulator Axin. Cell Commun Signal 2016;14:15. [PMID: 27484226 DOI: 10.1186/s12964-016-0138-x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 1.2] [Reference Citation Analysis]
306 Ben-Hamo R, Jacob Berger A, Gavert N, Miller M, Pines G, Oren R, Pikarsky E, Benes CH, Neuman T, Zwang Y, Efroni S, Getz G, Straussman R. Predicting and affecting response to cancer therapy based on pathway-level biomarkers. Nat Commun 2020;11:3296. [PMID: 32620799 DOI: 10.1038/s41467-020-17090-y] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 10.0] [Reference Citation Analysis]
307 Ohishi K, Toume K, Arai MA, Sadhu SK, Ahmed F, Ishibashi M. Coronaridine, an iboga type alkaloid from Tabernaemontana divaricata, inhibits the Wnt signaling pathway by decreasing β-catenin mRNA expression. Bioorganic & Medicinal Chemistry Letters 2015;25:3937-40. [DOI: 10.1016/j.bmcl.2015.07.036] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
308 Roos J, Grösch S, Werz O, Schröder P, Ziegler S, Fulda S, Paulus P, Urbschat A, Kühn B, Maucher I, Fettel J, Vorup-jensen T, Piesche M, Matrone C, Steinhilber D, Parnham MJ, Maier TJ. Regulation of tumorigenic Wnt signaling by cyclooxygenase-2, 5-lipoxygenase and their pharmacological inhibitors: A basis for novel drugs targeting cancer cells? Pharmacology & Therapeutics 2016;157:43-64. [DOI: 10.1016/j.pharmthera.2015.11.001] [Cited by in Crossref: 23] [Cited by in F6Publishing: 18] [Article Influence: 4.6] [Reference Citation Analysis]
309 Zheng L, Liang X, Li S, Li T, Shang W, Ma L, Jia X, Shao W, Sun P, Chen C, Jia J. CHAF1A interacts with TCF4 to promote gastric carcinogenesis via upregulation of c-MYC and CCND1 expression. EBioMedicine 2018;38:69-78. [PMID: 30449701 DOI: 10.1016/j.ebiom.2018.11.009] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 4.7] [Reference Citation Analysis]
310 Li Q, Sun M, Wang M, Feng M, Yang F, Li L, Zhao J, Chang C, Dong H, Xie T, Chen J. Dysregulation of Wnt/β-catenin signaling by protein kinases in hepatocellular carcinoma and its therapeutic application. Cancer Sci 2021;112:1695-706. [PMID: 33605517 DOI: 10.1111/cas.14861] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
311 Xi Y, Chen Y. Wnt signaling pathway: implications for therapy in lung cancer and bone metastasis. Cancer Lett 2014;353:8-16. [PMID: 25042867 DOI: 10.1016/j.canlet.2014.07.010] [Cited by in Crossref: 28] [Cited by in F6Publishing: 27] [Article Influence: 4.0] [Reference Citation Analysis]
312 Kim GW, Won JH, Lee OK, Lee SS, Han JH, Tsogtbaatar O, Nam S, Kim Y, Cho KO. Sol narae (Sona) is a Drosophila ADAMTS involved in Wg signaling. Sci Rep 2016;6:31863. [PMID: 27535473 DOI: 10.1038/srep31863] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
313 Lu J, Qian Y, Jin W, Tian R, Zhu Y, Wang J, Meng X, Wang R. Hypoxia-inducible factor-1α regulates epithelial-to-mesenchymal transition in paraquat-induced pulmonary fibrosis by activating lysyl oxidase. Exp Ther Med 2018;15:2287-94. [PMID: 29467842 DOI: 10.3892/etm.2017.5677] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
314 Lee JH, Cho HS, Lee JJ, Jun SY, Ahn JH, Min JS, Yoon JY, Choi MH, Jeon SJ, Lim JH, Jung CR, Kim DS, Kim HT, Factor VM, Lee YH, Thorgeirsson SS, Kim CH, Kim NS. Plasma glutamate carboxypeptidase is a negative regulator in liver cancer metastasis. Oncotarget. 2016;7:79774-79786. [PMID: 27806330 DOI: 10.18632/oncotarget.12967] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
315 Wang Z, Luo J, Xu L, Zhou H, Zhang W. Harnessing low-density lipoprotein receptor protein 6 (LRP6) genetic variation and Wnt signaling for innovative diagnostics in complex diseases. Pharmacogenomics J 2018;18:351-8. [DOI: 10.1038/tpj.2017.28] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
316 Thomas PD, Kahn M. Kat3 coactivators in somatic stem cells and cancer stem cells: biological roles, evolution, and pharmacologic manipulation. Cell Biol Toxicol 2016;32:61-81. [PMID: 27008332 DOI: 10.1007/s10565-016-9318-0] [Cited by in Crossref: 26] [Cited by in F6Publishing: 22] [Article Influence: 5.2] [Reference Citation Analysis]
317 Li B, Lee C, Cadete M, Zhu H, Koike Y, Hock A, Wu RY, Botts SR, Minich A, Alganabi M, Chi L, Zani-Ruttenstock E, Miyake H, Chen Y, Mutanen A, Ngan B, Johnson-Henry KC, De Coppi P, Eaton S, Määttänen P, Delgado-Olguin P, Sherman PM, Zani A, Pierro A. Impaired Wnt/β-catenin pathway leads to dysfunction of intestinal regeneration during necrotizing enterocolitis. Cell Death Dis 2019;10:743. [PMID: 31582728 DOI: 10.1038/s41419-019-1987-1] [Cited by in Crossref: 28] [Cited by in F6Publishing: 23] [Article Influence: 14.0] [Reference Citation Analysis]
318 Li C, Zheng X, Han Y, Lv Y, Lan F, Zhao J. XAV939 inhibits the proliferation and migration of lung adenocarcinoma A549 cells through the WNT pathway. Oncol Lett 2018;15:8973-82. [PMID: 29805633 DOI: 10.3892/ol.2018.8491] [Cited by in Crossref: 14] [Cited by in F6Publishing: 17] [Article Influence: 4.7] [Reference Citation Analysis]
319 El-Shayeb AF, El-Habachi NM, Mansour AR, Zaghloul MS. Serum midkine is a more sensitive predictor for hepatocellular carcinoma than Dickkopf-1 and alpha-L-fucosidase in cirrhotic HCV patients. Medicine (Baltimore) 2021;100:e25112. [PMID: 33907088 DOI: 10.1097/MD.0000000000025112] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
320 Zhi X, Tao J, Xie K, Zhu Y, Li Z, Tang J, Wang W, Xu H, Zhang J, Xu Z. MUC4-induced nuclear translocation of β-catenin: a novel mechanism for growth, metastasis and angiogenesis in pancreatic cancer. Cancer Lett 2014;346:104-13. [PMID: 24374017 DOI: 10.1016/j.canlet.2013.12.021] [Cited by in Crossref: 37] [Cited by in F6Publishing: 33] [Article Influence: 4.6] [Reference Citation Analysis]
321 Yoshimoto K, Hatae R, Suzuki SO, Hata N, Kuga D, Akagi Y, Amemiya T, Sangatsuda Y, Mukae N, Mizoguchi M, Iwaki T, Iihara K. High-resolution melting and immunohistochemical analysis efficiently detects mutually exclusive genetic alterations of adamantinomatous and papillary craniopharyngiomas. Neuropathology 2018;38:3-10. [PMID: 28840946 DOI: 10.1111/neup.12408] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 3.3] [Reference Citation Analysis]
322 Alok A, Lei Z, Jagannathan NS, Kaur S, Harmston N, Rozen SG, Tucker-Kellogg L, Virshup DM. Wnt proteins synergize to activate β-catenin signaling. J Cell Sci 2017;130:1532-44. [PMID: 28289266 DOI: 10.1242/jcs.198093] [Cited by in Crossref: 32] [Cited by in F6Publishing: 24] [Article Influence: 8.0] [Reference Citation Analysis]
323 Wang Y, Guo D, He J, Song L, Chen H, Zhang Z, Tan N. Inhibition of fatty acid synthesis arrests colorectal neoplasm growth and metastasis: Anti-cancer therapeutical effects of natural cyclopeptide RA-XII. Biochem Biophys Res Commun 2019;512:819-24. [PMID: 30928092 DOI: 10.1016/j.bbrc.2019.03.088] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
324 Niwa Y, Suzuki T, Dohmae N, Simizu S. Identification of DPY19L3 as the C-mannosyltransferase of R-spondin1 in human cells. Mol Biol Cell 2016;27:744-56. [PMID: 26764097 DOI: 10.1091/mbc.E15-06-0373] [Cited by in Crossref: 33] [Cited by in F6Publishing: 8] [Article Influence: 6.6] [Reference Citation Analysis]
325 Thapar R, Denmon AP. Signaling pathways that control mRNA turnover. Cell Signal 2013;25:1699-710. [PMID: 23602935 DOI: 10.1016/j.cellsig.2013.03.026] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 2.5] [Reference Citation Analysis]
326 Lu W, Li Y. Salinomycin suppresses LRP6 expression and inhibits both Wnt/β-catenin and mTORC1 signaling in breast and prostate cancer cells. J Cell Biochem. 2014;115:1799-1807. [PMID: 24905570 DOI: 10.1002/jcb.24850] [Cited by in Crossref: 59] [Cited by in F6Publishing: 52] [Article Influence: 9.8] [Reference Citation Analysis]
327 Zhang QY, Wang L, Song ZY, Qu XJ. Knockdown of type I insulin-like growth factor receptor inhibits human colorectal cancer cell growth and downstream PI3K/Akt, WNT/β-catenin signal pathways. Biomed Pharmacother 2015;73:12-8. [PMID: 26211576 DOI: 10.1016/j.biopha.2015.05.004] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
328 Carreira-Barbosa F, Nunes SC. Wnt Signaling: Paths for Cancer Progression. Adv Exp Med Biol. 2020;1219:189-202. [PMID: 32130700 DOI: 10.1007/978-3-030-34025-4_10] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
329 Lee JS. The mutational landscape of hepatocellular carcinoma. Clin Mol Hepatol 2015;21:220-9. [PMID: 26523267 DOI: 10.3350/cmh.2015.21.3.220] [Cited by in Crossref: 63] [Cited by in F6Publishing: 49] [Article Influence: 10.5] [Reference Citation Analysis]
330 Berger BS, Acebron SP, Herbst J, Koch S, Niehrs C. Parkinson's disease-associated receptor GPR37 is an ER chaperone for LRP6. EMBO Rep 2017;18:712-25. [PMID: 28341812 DOI: 10.15252/embr.201643585] [Cited by in Crossref: 26] [Cited by in F6Publishing: 18] [Article Influence: 6.5] [Reference Citation Analysis]
331 Maubant S, Tahtouh T, Brisson A, Maire V, Némati F, Tesson B, Ye M, Rigaill G, Noizet M, Dumont A, Gentien D, Marty-Prouvost B, de Koning L, Mahmood SF, Decaudin D, Cruzalegui F, Tucker GC, Roman-Roman S, Dubois T. LRP5 regulates the expression of STK40, a new potential target in triple-negative breast cancers. Oncotarget 2018;9:22586-604. [PMID: 29854300 DOI: 10.18632/oncotarget.25187] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
332 Armignacco R, Cantini G, Canu L, Poli G, Ercolino T, Mannelli M, Luconi M. Adrenocortical carcinoma: the dawn of a new era of genomic and molecular biology analysis. J Endocrinol Invest 2018;41:499-507. [DOI: 10.1007/s40618-017-0775-y] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.8] [Reference Citation Analysis]
333 Liang LJ, Yang Y, Wei WF, Wu XG, Yan RM, Zhou CF, Chen XJ, Wu S, Wang W, Fan LS. Tumor-secreted exosomal Wnt2B activates fibroblasts to promote cervical cancer progression. Oncogenesis 2021;10:30. [PMID: 33731705 DOI: 10.1038/s41389-021-00319-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
334 Zhang W, Zhang H, Wang N, Zhao C, Zhang H, Deng F, Wu N, He Y, Chen X, Zhang J, Wen S, Liao Z, Zhang Q, Zhang Z, Liu W, Yan Z, Luu HH, Haydon RC, Zhou L, He TC. Modulation of β-catenin signaling by the inhibitors of MAP kinase, tyrosine kinase, and PI3-kinase pathways. Int J Med Sci 2013;10:1888-98. [PMID: 24324366 DOI: 10.7150/ijms.6019] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
335 Zhao SG, Shilkrut M, Speers C, Liu M, Wilder-Romans K, Lawrence TS, Pierce LJ, Feng FY. Development and validation of a novel platform-independent metastasis signature in human breast cancer. PLoS One 2015;10:e0126631. [PMID: 25974184 DOI: 10.1371/journal.pone.0126631] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
336 Ruiduo C, Ying D, Qiwei W. CXCL9 promotes the progression of diffuse large B-cell lymphoma through up-regulating β-catenin. Biomedicine & Pharmacotherapy 2018;107:689-95. [DOI: 10.1016/j.biopha.2018.07.171] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 3.3] [Reference Citation Analysis]
337 Rosa R, D'Amato V, De Placido S, Bianco R. Approaches for targeting cancer stem cells drug resistance. Expert Opin Drug Discov 2016;11:1201-12. [PMID: 27700193 DOI: 10.1080/17460441.2016.1243525] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 3.2] [Reference Citation Analysis]
338 Szaryńska M, Olejniczak A, Kobiela J, Spychalski P, Kmieć Z. Therapeutic strategies against cancer stem cells in human colorectal cancer. Oncol Lett 2017;14:7653-68. [PMID: 29250169 DOI: 10.3892/ol.2017.7261] [Cited by in Crossref: 9] [Cited by in F6Publishing: 13] [Article Influence: 2.3] [Reference Citation Analysis]
339 Kim DK, Kim YN, Kim YE, Lee SY, Shin MJ, Do EK, Choi KU, Kim SC, Kim KH, Suh DS, Song P, Kim JH. TRIB2 Stimulates Cancer Stem-Like Properties through Activating the AKT-GSK3β-β-Catenin Signaling Axis. Mol Cells 2021;44:481-92. [PMID: 34326276 DOI: 10.14348/molcells.2021.0030] [Reference Citation Analysis]
340 Zhuang S, Yu X, Lu M, Li Y, Ding N, Ding Y. High mobility group box 3 promotes cervical cancer proliferation by regulating Wnt/β-catenin pathway. J Gynecol Oncol 2020;31:e91. [PMID: 33078596 DOI: 10.3802/jgo.2020.31.e91] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
341 Hu Q, Li L, Zou X, Xu L, Yi P. Berberine Attenuated Proliferation, Invasion and Migration by Targeting the AMPK/HNF4α/WNT5A Pathway in Gastric Carcinoma. Front Pharmacol 2018;9:1150. [PMID: 30405404 DOI: 10.3389/fphar.2018.01150] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 8.3] [Reference Citation Analysis]
342 Arai MA, Kofuji Y, Tanaka Y, Yanase N, Yamaku K, Fuentes RG, Karmakar UK, Ishibashi M. Synthesis of rocaglamide derivatives and evaluation of their Wnt signal inhibitory activities. Org Biomol Chem 2016;14:3061-8. [DOI: 10.1039/c5ob02537k] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 1.8] [Reference Citation Analysis]
343 Jiang X, Hao HX, Growney JD, Woolfenden S, Bottiglio C, Ng N, Lu B, Hsieh MH, Bagdasarian L, Meyer R. Inactivating mutations of RNF43 confer Wnt dependency in pancreatic ductal adenocarcinoma. Proc Natl Acad Sci USA. 2013;110:12649-12654. [PMID: 23847203 DOI: 10.1073/pnas.1307218110] [Cited by in Crossref: 232] [Cited by in F6Publishing: 206] [Article Influence: 29.0] [Reference Citation Analysis]
344 Tsai MC, Huang CC, Wei YC, Liu TT, Lin MT, Yi LN, Lin PR, Wang CC, Chu TH, Hsiao CC, Hu TH, Tai MH. Combined Chibby and β-Catenin Predicts Clinical Outcomes in Patients with Hepatocellular Carcinoma. Int J Mol Sci 2020;21:E2060. [PMID: 32192213 DOI: 10.3390/ijms21062060] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
345 Xie Q, Chen L, Shan X, Tang J, Zhou F, Chen Q, Quan H, Nie D, Zhang W, Huang AL, Tang N. Epigenetic silencing of SFRP1 and SFRP5 by hepatitis B virus X protein enhances hepatoma cell tumorigenicity through Wnt signaling pathway. Int J Cancer. 2014;135:635-646. [PMID: 24374650 DOI: 10.1002/ijc.28697] [Cited by in Crossref: 53] [Cited by in F6Publishing: 49] [Article Influence: 7.6] [Reference Citation Analysis]
346 He X, Zhang W, Yan C, Nie F, Li C, Liu X, Fei C, Li S, Song X, Jia Y, Zeng R, Wu D, Pan W, Hao X, Li L. Chemical biology reveals CARF as a positive regulator of canonical Wnt signaling by promoting TCF/β-catenin transcriptional activity. Cell Discov 2017;3:17003. [PMID: 28417011 DOI: 10.1038/celldisc.2017.3] [Cited by in Crossref: 17] [Cited by in F6Publishing: 10] [Article Influence: 4.3] [Reference Citation Analysis]
347 Chua CEL, Chan SN, Tang BL. Non-Cell Autonomous or Secretory Tumor Suppression: NON-CELL AUTONOMOUS TUMOR SUPPRESSION. J Cell Physiol 2014;229:1346-52. [DOI: 10.1002/jcp.24574] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
348 Dema A, Schröter MF, Perets E, Skroblin P, Moutty MC, Deàk VA, Birchmeier W, Klussmann E. The A-Kinase Anchoring Protein (AKAP) Glycogen Synthase Kinase 3β Interaction Protein (GSKIP) Regulates β-Catenin through Its Interactions with Both Protein Kinase A (PKA) and GSK3β. J Biol Chem 2016;291:19618-30. [PMID: 27484798 DOI: 10.1074/jbc.M116.738047] [Cited by in Crossref: 21] [Cited by in F6Publishing: 13] [Article Influence: 4.2] [Reference Citation Analysis]
349 Seo J, Kee HJ, Choi HJ, Lee JE, Park SY, Lee SH, Jeong MH, Guk G, Lee S, Choi KC, Choi YY, Kim H, Noh SH, Yoon HG, Cheong JH. Inhibition of Wntless/GPR177 suppresses gastric tumorigenesis. BMB Rep 2018;51:255-60. [PMID: 29555015 DOI: 10.5483/bmbrep.2018.51.5.046] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
350 Shi Y, Zhu N, Liu C, Wu H, Gui Y, Liao D, Qin L. Wnt5a and its signaling pathway in angiogenesis. Clinica Chimica Acta 2017;471:263-9. [DOI: 10.1016/j.cca.2017.06.017] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 6.3] [Reference Citation Analysis]
351 Lađinović D, Pinkas D, Šopin T, Raška O, Liška F, Raška I, Vacík T. Alternative isoforms of KDM2A and KDM2B lysine demethylases negatively regulate canonical Wnt signaling. PLoS One 2020;15:e0236612. [PMID: 33104714 DOI: 10.1371/journal.pone.0236612] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
352 Bravi L, Rudini N, Cuttano R, Giampietro C, Maddaluno L, Ferrarini L, Adams RH, Corada M, Boulday G, Tournier-Lasserve E, Dejana E, Lampugnani MG. Sulindac metabolites decrease cerebrovascular malformations in CCM3-knockout mice. Proc Natl Acad Sci U S A 2015;112:8421-6. [PMID: 26109568 DOI: 10.1073/pnas.1501352112] [Cited by in Crossref: 75] [Cited by in F6Publishing: 56] [Article Influence: 12.5] [Reference Citation Analysis]
353 Watanabe K, Biesinger J, Salmans ML, Roberts BS, Arthur WT, Cleary M, Andersen B, Xie X, Dai X. Integrative ChIP-seq/microarray analysis identifies a CTNNB1 target signature enriched in intestinal stem cells and colon cancer. PLoS One 2014;9:e92317. [PMID: 24651522 DOI: 10.1371/journal.pone.0092317] [Cited by in Crossref: 32] [Cited by in F6Publishing: 28] [Article Influence: 4.6] [Reference Citation Analysis]
354 Azmi AS, Bao B, Sarkar FH. Exosomes in cancer development, metastasis, and drug resistance: a comprehensive review. Cancer Metastasis Rev. 2013;32:623-642. [PMID: 23709120 DOI: 10.1007/s10555-013-9441-9] [Cited by in Crossref: 643] [Cited by in F6Publishing: 604] [Article Influence: 91.9] [Reference Citation Analysis]
355 Wang Q, Zou Y, Nowotschin S, Kim SY, Li QV, Soh CL, Su J, Zhang C, Shu W, Xi Q, Huangfu D, Hadjantonakis AK, Massagué J. The p53 Family Coordinates Wnt and Nodal Inputs in Mesendodermal Differentiation of Embryonic Stem Cells. Cell Stem Cell 2017;20:70-86. [PMID: 27889317 DOI: 10.1016/j.stem.2016.10.002] [Cited by in Crossref: 73] [Cited by in F6Publishing: 56] [Article Influence: 14.6] [Reference Citation Analysis]
356 Vogt N, Dai B, Erdmann T, Berdel WE, Lenz G. The molecular pathogenesis of mantle cell lymphoma. Leuk Lymphoma 2017;58:1530-7. [PMID: 27894215 DOI: 10.1080/10428194.2016.1248965] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 4.6] [Reference Citation Analysis]
357 Zhang L, Shay JW. Multiple Roles of APC and its Therapeutic Implications in Colorectal Cancer. J Natl Cancer Inst. 2017;109. [PMID: 28423402 DOI: 10.1093/jnci/djw332] [Cited by in Crossref: 104] [Cited by in F6Publishing: 94] [Article Influence: 26.0] [Reference Citation Analysis]
358 Dzobo K, Thomford NE, Senthebane DA. Targeting the Versatile Wnt/β-Catenin Pathway in Cancer Biology and Therapeutics: From Concept to Actionable Strategy. OMICS 2019;23:517-38. [PMID: 31613700 DOI: 10.1089/omi.2019.0147] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
359 Zang Y, Gu L, Zhang Y, Wang Y, Xue F. Identification of key genes and pathways in uterine leiomyosarcoma through bioinformatics analysis. Oncol Lett 2018;15:9361-8. [PMID: 29844831 DOI: 10.3892/ol.2018.8503] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
360 Enzo MV, Rastrelli M, Rossi CR, Hladnik U, Segat D. The Wnt/β-catenin pathway in human fibrotic-like diseases and its eligibility as a therapeutic target. Mol Cell Ther 2015;3:1. [PMID: 26056602 DOI: 10.1186/s40591-015-0038-2] [Cited by in Crossref: 33] [Cited by in F6Publishing: 27] [Article Influence: 5.5] [Reference Citation Analysis]
361 Chang TH, Hsieh FL, Zebisch M, Harlos K, Elegheert J, Jones EY. Structure and functional properties of Norrin mimic Wnt for signalling with Frizzled4, Lrp5/6, and proteoglycan. Elife 2015;4. [PMID: 26158506 DOI: 10.7554/eLife.06554] [Cited by in Crossref: 53] [Cited by in F6Publishing: 34] [Article Influence: 8.8] [Reference Citation Analysis]
362 Liu X, Cheng Y, Abraham JM, Wang Z, Wang Z, Ke X, Yan R, Shin EJ, Ngamruengphong S, Khashab MA, Zhang G, McNamara G, Ewald AJ, Lin D, Liu Z, Meltzer SJ. Modeling Wnt signaling by CRISPR-Cas9 genome editing recapitulates neoplasia in human Barrett epithelial organoids. Cancer Lett 2018;436:109-18. [PMID: 30144514 DOI: 10.1016/j.canlet.2018.08.017] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 4.3] [Reference Citation Analysis]
363 Shao J, Shi CJ, Li Y, Zhang FW, Pan FF, Fu WM, Zhang JF. LincROR Mediates the Suppressive Effects of Curcumin on Hepatocellular Carcinoma Through Inactivating Wnt/β-Catenin Signaling. Front Pharmacol 2020;11:847. [PMID: 32714183 DOI: 10.3389/fphar.2020.00847] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 6.0] [Reference Citation Analysis]
364 Gonzalez-Fernandez C, Arevalo-Martin A, Paniagua-Torija B, Ferrer I, Rodriguez FJ, Garcia-Ovejero D. Wnts Are Expressed in the Ependymal Region of the Adult Spinal Cord. Mol Neurobiol 2017;54:6342-55. [PMID: 27722925 DOI: 10.1007/s12035-016-0132-8] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 2.2] [Reference Citation Analysis]
365 Li J, Jiang S, Chen Y, Ma R, Chen J, Qian S, Shi Y, Han Y, Zhang S, Yu K. Benzene metabolite hydroquinone induces apoptosis of bone marrow mononuclear cells through inhibition of β-catenin signaling. Toxicology in Vitro 2018;46:361-9. [DOI: 10.1016/j.tiv.2017.08.018] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 3.7] [Reference Citation Analysis]
366 Li Q, Yu D, Yu Z, Gao Q, Chen R, Zhou L, Wang R, Li Y, Qian Y, Zhao J, Rosell R, Tao M, Xie Y, Xu C. TIPE3 promotes non-small cell lung cancer progression via the protein kinase B/extracellular signal-regulated kinase 1/2-glycogen synthase kinase 3β-β-catenin/Snail axis. Transl Lung Cancer Res 2021;10:936-54. [PMID: 33718034 DOI: 10.21037/tlcr-21-147] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
367 Sandieson L, Hwang JT, Kelly GM. Redox regulation of canonical Wnt signaling affects extraembryonic endoderm formation. Stem Cells Dev 2014;23:1037-49. [PMID: 24471440 DOI: 10.1089/scd.2014.0010] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 2.3] [Reference Citation Analysis]
368 Zhang M, Du H, Wang L, Yue Y, Zhang P, Huang Z, Lv W, Ma J, Shao Q, Ma M, Liang X, Yang T, Wang W, Zeng J, Chen G, Wang X, Fan J. Thymoquinone suppresses invasion and metastasis in bladder cancer cells by reversing EMT through the Wnt/β-catenin signaling pathway. Chemico-Biological Interactions 2020;320:109022. [DOI: 10.1016/j.cbi.2020.109022] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 14.0] [Reference Citation Analysis]
369 Li SY, Huang PH, Tarng DC, Lin TP, Yang WC, Chang YH, Yang AH, Lin CC, Yang MH, Chen JW, Schmid-Schönbein GW, Chien S, Chu PH, Lin SJ. Four-and-a-Half LIM Domains Protein 2 Is a Coactivator of Wnt Signaling in Diabetic Kidney Disease. J Am Soc Nephrol 2015;26:3072-84. [PMID: 25855776 DOI: 10.1681/ASN.2014100989] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 3.2] [Reference Citation Analysis]
370 Han Q, Lv L, Wei J, Lei X, Lin H, Li G, Cao J, Xie J, Yang W, Wu S, You J, Lu J, Liu P, Min J. Vps4A mediates the localization and exosome release of β-catenin to inhibit epithelial-mesenchymal transition in hepatocellular carcinoma. Cancer Lett 2019;457:47-59. [PMID: 31059752 DOI: 10.1016/j.canlet.2019.04.035] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
371 Geng Y, Zheng X, Hu W, Wang Q, Xu Y, He W, Wu C, Zhu D, Wu C, Jiang J. Hsa_circ_0009361 acts as the sponge of miR-582 to suppress colorectal cancer progression by regulating APC2 expression. Clin Sci (Lond) 2019;133:1197-213. [PMID: 31109967 DOI: 10.1042/CS20190286] [Cited by in Crossref: 47] [Cited by in F6Publishing: 28] [Article Influence: 23.5] [Reference Citation Analysis]
372 Fatima I, Barman S, Rai R, Thiel KWW, Chandra V. Targeting Wnt Signaling in Endometrial Cancer. Cancers (Basel) 2021;13:2351. [PMID: 34068065 DOI: 10.3390/cancers13102351] [Reference Citation Analysis]
373 Bastakoty D, Saraswati S, Joshi P, Atkinson J, Feoktistov I, Liu J, Harris JL, Young PP. Temporary, Systemic Inhibition of the WNT/β-Catenin Pathway promotes Regenerative Cardiac Repair following Myocardial Infarct. Cell Stem Cells Regen Med 2016;2. [PMID: 28042617 DOI: 10.16966/2472-6990.111] [Cited by in Crossref: 29] [Cited by in F6Publishing: 27] [Article Influence: 5.8] [Reference Citation Analysis]
374 Han L, Dai S, Li Z, Zhang C, Wei S, Zhao R, Zhang H, Zhao L, Shan B. Combination of the natural compound Periplocin and TRAIL induce esophageal squamous cell carcinoma apoptosis in vitro and in vivo: Implication in anticancer therapy. J Exp Clin Cancer Res 2019;38:501. [PMID: 31864387 DOI: 10.1186/s13046-019-1498-z] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
375 Lenz HJ, Kahn M. Safely targeting cancer stem cells via selective catenin coactivator antagonism. Cancer Sci. 2014;105:1087-1092. [PMID: 24975284 DOI: 10.1111/cas.12471] [Cited by in Crossref: 113] [Cited by in F6Publishing: 103] [Article Influence: 16.1] [Reference Citation Analysis]
376 Wang L, Yan X, You ZH, Zhou X, Li HY, Huang YA. SGANRDA: semi-supervised generative adversarial networks for predicting circRNA-disease associations. Brief Bioinform 2021:bbab028. [PMID: 33734296 DOI: 10.1093/bib/bbab028] [Reference Citation Analysis]
377 Xavier CP, Melikova M, Chuman Y, Üren A, Baljinnyam B, Rubin JS. Secreted Frizzled-related protein potentiation versus inhibition of Wnt3a/β-catenin signaling. Cell Signal. 2014;26:94-101. [PMID: 24080158 DOI: 10.1016/j.cellsig.2013.09.016] [Cited by in Crossref: 58] [Cited by in F6Publishing: 47] [Article Influence: 7.3] [Reference Citation Analysis]
378 Shetti D, Zhang B, Fan C, Mo C, Lee BH, Wei K. Low Dose of Paclitaxel Combined with XAV939 Attenuates Metastasis, Angiogenesis and Growth in Breast Cancer by Suppressing Wnt Signaling. Cells 2019;8:E892. [PMID: 31416135 DOI: 10.3390/cells8080892] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 11.5] [Reference Citation Analysis]
379 Esposito M, Ganesan S, Kang Y. Emerging strategies for treating metastasis. Nat Cancer 2021;2:258-70. [PMID: 33899000 DOI: 10.1038/s43018-021-00181-0] [Cited by in Crossref: 3] [Article Influence: 3.0] [Reference Citation Analysis]
380 Abraham KJ, Zhang X, Vidal R, Paré GC, Feilotter HE, Tron VA. Roles for miR-375 in Neuroendocrine Differentiation and Tumor Suppression via Notch Pathway Suppression in Merkel Cell Carcinoma. Am J Pathol 2016;186:1025-35. [PMID: 26877261 DOI: 10.1016/j.ajpath.2015.11.020] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 4.8] [Reference Citation Analysis]
381 Tocci JM, Felcher CM, García Solá ME, Kordon EC. R-spondin-mediated WNT signaling potentiation in mammary and breast cancer development. IUBMB Life 2020;72:1546-59. [PMID: 32233118 DOI: 10.1002/iub.2278] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
382 Yang D, Zhao D, Chen X. MiR-133b inhibits proliferation and invasion of gastric cancer cells by up-regulating FBN1 expression. Cancer Biomark 2017;19:425-36. [PMID: 28582847 DOI: 10.3233/CBM-160421] [Cited by in Crossref: 16] [Cited by in F6Publishing: 10] [Article Influence: 5.3] [Reference Citation Analysis]
383 Zhang D, Jiang F, Wang X, Li G. Knockdown of SALL4 Inhibits Proliferation, Migration, and Invasion in Osteosarcoma Cells. Oncol Res 2017;25:763-71. [PMID: 27983924 DOI: 10.3727/096504016X14772402056137] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 1.2] [Reference Citation Analysis]
384 More S, Yang X, Zhu Z, Bamunuarachchi G, Guo Y, Huang C, Bailey K, Metcalf JP, Liu L. Regulation of influenza virus replication by Wnt/β-catenin signaling. PLoS One 2018;13:e0191010. [PMID: 29324866 DOI: 10.1371/journal.pone.0191010] [Cited by in Crossref: 21] [Cited by in F6Publishing: 13] [Article Influence: 7.0] [Reference Citation Analysis]
385 Jiang S, Zhang M, Zhang Y, Zhou W, Zhu T, Ruan Q, Chen H, Fang J, Zhou F, Sun J, Yang X. WNT5B governs the phenotype of basal-like breast cancer by activating WNT signaling. Cell Commun Signal 2019;17:109. [PMID: 31462314 DOI: 10.1186/s12964-019-0419-2] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 8.5] [Reference Citation Analysis]
386 Zhou Y, Hua Z, Zhu Y, Wang L, Chen F, Shan T, Zhou Y, Dai T. Upregulation of ARHGAP30 attenuates pancreatic cancer progression by inactivating the β-catenin pathway. Cancer Cell Int 2020;20:225. [PMID: 32536813 DOI: 10.1186/s12935-020-01288-7] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 6.0] [Reference Citation Analysis]
387 Chiarini F, Paganelli F, Martelli AM, Evangelisti C. The Role Played by Wnt/β-Catenin Signaling Pathway in Acute Lymphoblastic Leukemia. Int J Mol Sci 2020;21:E1098. [PMID: 32046053 DOI: 10.3390/ijms21031098] [Cited by in Crossref: 13] [Cited by in F6Publishing: 6] [Article Influence: 13.0] [Reference Citation Analysis]
388 Teng YC, Shen ZQ, Kao CH, Tsai TF. Hepatocellular carcinoma mouse models: Hepatitis B virus-associated hepatocarcinogenesis and haploinsufficient tumor suppressor genes. World J Gastroenterol 2016;22:300-25. [PMID: 26755878 DOI: 10.3748/wjg.v22.i1.300] [Cited by in CrossRef: 14] [Cited by in F6Publishing: 14] [Article Influence: 3.5] [Reference Citation Analysis]
389 Han J, Shen X, Zhang Y, Wang S, Zhou L. Astragaloside IV suppresses transforming growth factor-β1-induced epithelial-mesenchymal transition through inhibition of Wnt/β-catenin pathway in glioma U251 cells. Biosci Biotechnol Biochem 2020;84:1345-52. [PMID: 32154763 DOI: 10.1080/09168451.2020.1737502] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
390 Ghosh RD, Ghuwalewala S, Das P, Mandloi S, Alam SK, Chakraborty J, Sarkar S, Chakrabarti S, Panda CK, Roychoudhury S. MicroRNA profiling of cisplatin-resistant oral squamous cell carcinoma cell lines enriched with cancer-stem-cell-like and epithelial-mesenchymal transition-type features. Sci Rep 2016;6:23932. [PMID: 27045798 DOI: 10.1038/srep23932] [Cited by in Crossref: 31] [Cited by in F6Publishing: 29] [Article Influence: 6.2] [Reference Citation Analysis]
391 Wang HS, Nie X, Wu RB, Yuan HW, Ma YH, Liu XL, Zhang JY, Deng XL, Na Q, Jin HY, Bian YC, Gao YM, Wang YD, Chen WD. Downregulation of human Wnt3 in gastric cancer suppresses cell proliferation and induces apoptosis. Onco Targets Ther 2016;9:3849-60. [PMID: 27390525 DOI: 10.2147/OTT.S101782] [Cited by in Crossref: 18] [Cited by in F6Publishing: 11] [Article Influence: 3.6] [Reference Citation Analysis]
392 Xu H, Yang Y, Fan L, Deng L, Fan J, Li D, Li H, Zhao RC. Lnc13728 facilitates human mesenchymal stem cell adipogenic differentiation via positive regulation of ZBED3 and downregulation of the WNT/β-catenin pathway. Stem Cell Res Ther 2021;12:176. [PMID: 33712067 DOI: 10.1186/s13287-021-02250-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
393 Zhan T, Rindtorff N, Boutros M. Wnt signaling in cancer. Oncogene. 2017;36:1461-1473. [PMID: 27617575 DOI: 10.1038/onc.2016.304] [Cited by in Crossref: 939] [Cited by in F6Publishing: 761] [Article Influence: 187.8] [Reference Citation Analysis]
394 Acebron S, Karaulanov E, Berger B, Huang Y, Niehrs C. Mitotic Wnt Signaling Promotes Protein Stabilization and Regulates Cell Size. Molecular Cell 2014;54:663-74. [DOI: 10.1016/j.molcel.2014.04.014] [Cited by in Crossref: 114] [Cited by in F6Publishing: 89] [Article Influence: 16.3] [Reference Citation Analysis]
395 Bhattacharya M, Sharma AR, Sharma G, Patra BC, Lee SS, Chakraborty C. Interaction between miRNAs and signaling cascades of Wnt pathway in chronic lymphocytic leukemia. J Cell Biochem 2020;121:4654-66. [PMID: 32100920 DOI: 10.1002/jcb.29683] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
396 Sánchez-Tilló E, Fanlo L, Siles L, Montes-Moreno S, Moros A, Chiva-Blanch G, Estruch R, Martinez A, Colomer D, Győrffy B, Roué G, Postigo A. The EMT activator ZEB1 promotes tumor growth and determines differential response to chemotherapy in mantle cell lymphoma. Cell Death Differ 2014;21:247-57. [PMID: 24013721 DOI: 10.1038/cdd.2013.123] [Cited by in Crossref: 65] [Cited by in F6Publishing: 64] [Article Influence: 8.1] [Reference Citation Analysis]
397 Heerma van Voss MR, Vesuna F, Trumpi K, Brilliant J, Berlinicke C, de Leng W, Kranenburg O, Offerhaus GJ, Bürger H, van der Wall E, van Diest PJ, Raman V. Identification of the DEAD box RNA helicase DDX3 as a therapeutic target in colorectal cancer. Oncotarget 2015;6:28312-26. [PMID: 26311743 DOI: 10.18632/oncotarget.4873] [Cited by in Crossref: 47] [Cited by in F6Publishing: 49] [Article Influence: 9.4] [Reference Citation Analysis]
398 Lai KP, Li JW, Cheung A, Li R, Billah MB, Chan TF, Wong CKC. Transcriptome sequencing reveals prenatal PFOS exposure on liver disorders. Environmental Pollution 2017;223:416-25. [DOI: 10.1016/j.envpol.2017.01.041] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
399 Moti N, Yu J, Boncompain G, Perez F, Virshup DM. Wnt traffic from endoplasmic reticulum to filopodia. PLoS One 2019;14:e0212711. [PMID: 30794657 DOI: 10.1371/journal.pone.0212711] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 5.5] [Reference Citation Analysis]
400 Zou H, Yue W, Yu WK, Liu D, Fong CC, Zhao J, Yang M. Microfluidic Platform for Studying Chemotaxis of Adhesive Cells Revealed a Gradient-Dependent Migration and Acceleration of Cancer Stem Cells. Anal Chem 2015;87:7098-108. [PMID: 26087892 DOI: 10.1021/acs.analchem.5b00873] [Cited by in Crossref: 26] [Cited by in F6Publishing: 18] [Article Influence: 4.3] [Reference Citation Analysis]
401 Liu DJ, Xie YX, Liu XX, Huo YM, Yang MW, Fu XL, Liu W, Yang JY, Li J, Hua R, Liu PF, Sun YW, Zhang JF. The role of Dickkopf-1 as a potential prognostic marker in pancreatic ductal adenocarcinoma. Cell Cycle 2017;16:1622-9. [PMID: 28749252 DOI: 10.1080/15384101.2017.1356510] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
402 Grady WM, Pritchard CC. Molecular alterations and biomarkers in colorectal cancer. Toxicol Pathol 2014;42:124-39. [PMID: 24178577 DOI: 10.1177/0192623313505155] [Cited by in Crossref: 53] [Cited by in F6Publishing: 40] [Article Influence: 6.6] [Reference Citation Analysis]
403 Zeng B, Li Y, Feng Y, Lu M, Yuan H, Yi Z, Wu Y, Xiang T, Li H, Ren G. Downregulated miR-1247-5p associates with poor prognosis and facilitates tumor cell growth via DVL1/Wnt/β-catenin signaling in breast cancer. Biochemical and Biophysical Research Communications 2018;505:302-8. [DOI: 10.1016/j.bbrc.2018.09.103] [Cited by in Crossref: 21] [Cited by in F6Publishing: 16] [Article Influence: 7.0] [Reference Citation Analysis]
404 Zhang L, Xiong W, Xiong Y, Liu H, Liu Y. 17 β-Estradiol promotes vascular endothelial growth factor expression via the Wnt/β-catenin pathway during the pathogenesis of endometriosis. Mol Hum Reprod 2016;22:526-35. [DOI: 10.1093/molehr/gaw025] [Cited by in Crossref: 33] [Cited by in F6Publishing: 29] [Article Influence: 6.6] [Reference Citation Analysis]
405 Lund CM, Dyhl-Polk A, Nielsen DL, Riis LB. Wnt5a expression and prognosis in stage II-III colon cancer. Transl Oncol 2021;14:100892. [PMID: 33045677 DOI: 10.1016/j.tranon.2020.100892] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
406 Schomberg J. Identification of Targetable Pathways in Oral Cancer Patients via Random Forest and Chemical Informatics. Cancer Inform 2019;18:1176935119889911. [PMID: 31819345 DOI: 10.1177/1176935119889911] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
407 Xu Z, Li J, Wu Y, Sun Z, Luo L, Hu Z, He S, Zheng J, Zhang H, Zhang X. Design, synthesis, and evaluation of potent Wnt signaling inhibitors featuring a fused 3-ring system. European Journal of Medicinal Chemistry 2016;108:154-65. [DOI: 10.1016/j.ejmech.2015.11.026] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
408 Liu M, Xu A, Yuan X, Zhang Q, Fang T, Wang W, Li C. Downregulation of microRNA-409-3p promotes aggressiveness and metastasis in colorectal cancer: an indication for personalized medicine. J Transl Med 2015;13:195. [PMID: 26084278 DOI: 10.1186/s12967-015-0533-x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 2.7] [Reference Citation Analysis]
409 Pinto N, Black M, Patel K, Yoo J, Mymryk JS, Barrett JW, Nichols AC. Genomically driven precision medicine to improve outcomes in anaplastic thyroid cancer. J Oncol 2014;2014:936285. [PMID: 25276134 DOI: 10.1155/2014/936285] [Cited by in Crossref: 15] [Cited by in F6Publishing: 9] [Article Influence: 2.1] [Reference Citation Analysis]
410 Langton PF, Kakugawa S, Vincent JP. Making, Exporting, and Modulating Wnts. Trends Cell Biol 2016;26:756-65. [PMID: 27325141 DOI: 10.1016/j.tcb.2016.05.011] [Cited by in Crossref: 58] [Cited by in F6Publishing: 46] [Article Influence: 11.6] [Reference Citation Analysis]
411 Yang MH, Ha IJ, Lee SG, Lee J, Um JY, Ahn KS. Ginkgolide C promotes apoptosis and abrogates metastasis of colorectal carcinoma cells by targeting Wnt/β-catenin signaling pathway. IUBMB Life 2021. [PMID: 34273236 DOI: 10.1002/iub.2532] [Reference Citation Analysis]
412 Gao W, Liu Y, Qin R, Liu D, Feng Q. Silence of fibronectin 1 increases cisplatin sensitivity of non-small cell lung cancer cell line. Biochemical and Biophysical Research Communications 2016;476:35-41. [DOI: 10.1016/j.bbrc.2016.05.081] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 4.8] [Reference Citation Analysis]
413 Zhou S, Zhang M, Zhou C, Wang W, Yang H, Ye W. The role of epithelial-mesenchymal transition in regulating radioresistance. Crit Rev Oncol Hematol 2020;150:102961. [PMID: 32361589 DOI: 10.1016/j.critrevonc.2020.102961] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 7.0] [Reference Citation Analysis]
414 Ford CE, Henry C, Llamosas E, Djordjevic A, Hacker N. Wnt signalling in gynaecological cancers: A future target for personalised medicine? Gynecol Oncol 2016;140:345-51. [PMID: 26432042 DOI: 10.1016/j.ygyno.2015.09.085] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 3.0] [Reference Citation Analysis]
415 Wu K, Ning Z, Zeng J, Fan J, Zhou J, Zhang T, Zhang L, Chen Y, Gao Y, Wang B, Guo P, Li L, Wang X, He D. Silibinin inhibits β-catenin/ZEB1 signaling and suppresses bladder cancer metastasis via dual-blocking epithelial-mesenchymal transition and stemness. Cell Signal 2013;25:2625-33. [PMID: 24012496 DOI: 10.1016/j.cellsig.2013.08.028] [Cited by in Crossref: 64] [Cited by in F6Publishing: 64] [Article Influence: 8.0] [Reference Citation Analysis]
416 Lin J, Ding S, Xie C, Yi R, Wu Z, Luo J, Huang T, Zeng Y, Wang X, Xu A, Xiao J, Song Y, Zhang X. MicroRNA-4476 promotes glioma progression through a miR-4476/APC/β-catenin/c-Jun positive feedback loop. Cell Death Dis 2020;11:269. [PMID: 32327666 DOI: 10.1038/s41419-020-2474-4] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
417 Sajadimajd S, Momtaz S, Haratipour P, El-senduny FF, Panah AI, Navabi J, Soheilikhah Z, Farzaei MH, Rahimi R. Molecular Mechanisms Underlying Cancer Preventive and Therapeutic Potential of Algal Polysaccharides. CPD 2019;25:1210-35. [DOI: 10.2174/1381612825666190425155126] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
418 Chen H, Sun X, Ge W, Qian Y, Bai R, Zheng S. A seven-gene signature predicts overall survival of patients with colorectal cancer. Oncotarget 2017;8:95054-65. [PMID: 29221110 DOI: 10.18632/oncotarget.10982] [Cited by in Crossref: 29] [Cited by in F6Publishing: 24] [Article Influence: 5.8] [Reference Citation Analysis]
419 Li D, Tian B, Jin X. [ARTICLE WITHDRAWN] miR-630 Inhibits Epithelial-to-Mesenchymal Transition (EMT) by Regulating the Wnt/β-Catenin Pathway in Gastric Cancer Cells. Oncol Res 2018;27:9-17. [PMID: 29422112 DOI: 10.3727/096504018X15178732625479] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
420 Kolluri A, Ho M. The Role of Glypican-3 in Regulating Wnt, YAP, and Hedgehog in Liver Cancer. Front Oncol 2019;9:708. [PMID: 31428581 DOI: 10.3389/fonc.2019.00708] [Cited by in Crossref: 24] [Cited by in F6Publishing: 18] [Article Influence: 12.0] [Reference Citation Analysis]
421 Regua AT, Arrigo A, Doheny D, Wong GL, Lo HW. Transgenic mouse models of breast cancer. Cancer Lett 2021;516:73-83. [PMID: 34090924 DOI: 10.1016/j.canlet.2021.05.027] [Reference Citation Analysis]
422 Ozbey U, Attar R, Romero MA, Alhewairini SS, Afshar B, Sabitaliyevich UY, Hanna-Wakim L, Ozcelik B, Farooqi AA. Apigenin as an effective anticancer natural product: Spotlight on TRAIL, WNT/β-catenin, JAK-STAT pathways, and microRNAs. J Cell Biochem 2018. [PMID: 30278099 DOI: 10.1002/jcb.27575] [Cited by in Crossref: 23] [Cited by in F6Publishing: 25] [Article Influence: 7.7] [Reference Citation Analysis]
423 Ikeda H, Shikata Y, Watanapokasin R, Tashiro E, Imoto M. Metacycloprodigiosin induced cell death selectively in β-catenin-mutated tumor cells. J Antibiot (Tokyo) 2017;70:109-12. [PMID: 27328865 DOI: 10.1038/ja.2016.75] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 1.2] [Reference Citation Analysis]
424 Wang JJ, Li ZF, Li XJ, Han Z, Zhang L, Liu ZJ. Effects of microRNA-136 on melanoma cell proliferation, apoptosis, and epithelial-mesenchymal transition by targetting PMEL through the Wnt signaling pathway. Biosci Rep 2017;37:BSR20170743. [PMID: 28724603 DOI: 10.1042/BSR20170743] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 3.8] [Reference Citation Analysis]
425 Fernandez CJ, George AS, Subrahmanyan NA, Pappachan JM. Epidemiological link between obesity, type 2 diabetes mellitus and cancer. World J Methodol 2021;11:23-45. [PMID: 34026577 DOI: 10.5662/wjm.v11.i3.23] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
426 Phesse T, Flanagan D, Vincan E. Frizzled7: A Promising Achilles' Heel for Targeting the Wnt Receptor Complex to Treat Cancer. Cancers (Basel) 2016;8:E50. [PMID: 27196929 DOI: 10.3390/cancers8050050] [Cited by in Crossref: 47] [Cited by in F6Publishing: 40] [Article Influence: 9.4] [Reference Citation Analysis]
427 Liu S, Wu D, Sun X, Fan Y, Zha R, Jalali A, Feng Y, Li K, Sano T, Vike N, Li F, Rispoli J, Sudo A, Liu J, Robling A, Nakshatri H, Li BY, Yokota H. Overexpression of Lrp5 enhanced the anti-breast cancer effects of osteocytes in bone. Bone Res 2021;9:32. [PMID: 34230453 DOI: 10.1038/s41413-021-00152-2] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
428 Oh S, Gwak J, Park S, Yang CS. Green tea polyphenol EGCG suppresses Wnt/β-catenin signaling by promoting GSK-3β- and PP2A-independent β-catenin phosphorylation/degradation. Biofactors 2014;40:586-95. [PMID: 25352148 DOI: 10.1002/biof.1185] [Cited by in Crossref: 55] [Cited by in F6Publishing: 51] [Article Influence: 7.9] [Reference Citation Analysis]
429 Huang Y, Gu F, Dombkowski A, Wang L, Stoner GD. Black raspberries demethylate Sfrp4, a WNT pathway antagonist, in rat esophageal squamous cell papilloma: BRBs DEMETHYLATE Sfrp4 IN RAT ESOPHAGEAL PAPILLOMA. Mol Carcinog 2016;55:1867-75. [DOI: 10.1002/mc.22435] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
430 Hao HX, Jiang X, Cong F. Control of Wnt Receptor Turnover by R-spondin-ZNRF3/RNF43 Signaling Module and Its Dysregulation in Cancer. Cancers (Basel) 2016;8:E54. [PMID: 27338477 DOI: 10.3390/cancers8060054] [Cited by in Crossref: 66] [Cited by in F6Publishing: 52] [Article Influence: 13.2] [Reference Citation Analysis]
431 Dabrowska M, Uram L, Dabrowski M, Sikora E. Antigen presentation capability and AP-1 activation accompany methotrexate-induced colon cancer cell senescence in the context of aberrant β-catenin signaling. Mech Ageing Dev 2021;197:111517. [PMID: 34139213 DOI: 10.1016/j.mad.2021.111517] [Reference Citation Analysis]
432 Tompa M, Kalovits F, Nagy A, Kalman B. Contribution of the Wnt Pathway to Defining Biology of Glioblastoma. Neuromolecular Med 2018;20:437-51. [PMID: 30259273 DOI: 10.1007/s12017-018-8514-x] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 6.0] [Reference Citation Analysis]
433 Xie J, Huang L, Lu YG, Zheng DL. Roles of the Wnt Signaling Pathway in Head and Neck Squamous Cell Carcinoma. Front Mol Biosci 2020;7:590912. [PMID: 33469547 DOI: 10.3389/fmolb.2020.590912] [Reference Citation Analysis]
434 Shin SH, Lim DY, Reddy K, Malakhova M, Liu F, Wang T, Song M, Chen H, Bae KB, Ryu J, Liu K, Lee MH, Bode AM, Dong Z. A Small Molecule Inhibitor of the β-Catenin-TCF4 Interaction Suppresses Colorectal Cancer Growth In Vitro and In Vivo. EBioMedicine 2017;25:22-31. [PMID: 29033371 DOI: 10.1016/j.ebiom.2017.09.029] [Cited by in Crossref: 28] [Cited by in F6Publishing: 23] [Article Influence: 7.0] [Reference Citation Analysis]
435 McCubrey JA, Rakus D, Gizak A, Steelman LS, Abrams SL, Lertpiriyapong K, Fitzgerald TL, Yang LV, Montalto G, Cervello M, Libra M, Nicoletti F, Scalisi A, Torino F, Fenga C, Neri LM, Marmiroli S, Cocco L, Martelli AM. Effects of mutations in Wnt/β-catenin, hedgehog, Notch and PI3K pathways on GSK-3 activity-Diverse effects on cell growth, metabolism and cancer. Biochim Biophys Acta 2016;1863:2942-76. [PMID: 27612668 DOI: 10.1016/j.bbamcr.2016.09.004] [Cited by in Crossref: 85] [Cited by in F6Publishing: 75] [Article Influence: 17.0] [Reference Citation Analysis]
436 Nie X, Xia F, Liu Y, Zhou Y, Ye W, Hean P, Meng J, Liu H, Liu L, Wen J, Ren X, Chen WD, Wang YD. Downregulation of Wnt3 Suppresses Colorectal Cancer Development Through Inhibiting Cell Proliferation and Migration. Front Pharmacol 2019;10:1110. [PMID: 31632267 DOI: 10.3389/fphar.2019.01110] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
437 Wang T, Wu H, Liu S, Lei Z, Qin Z, Wen L, Liu K, Wang X, Guo Y, Liu Q, Liu L, Wang J, Lin L, Mao C, Zhu X, Xiao H, Bian X, Chen D, Xu C, Wang B. SMYD3 controls a Wnt-responsive epigenetic switch for ASCL2 activation and cancer stem cell maintenance. Cancer Letters 2018;430:11-24. [DOI: 10.1016/j.canlet.2018.05.003] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 6.7] [Reference Citation Analysis]
438 Korkmaz G, Horozoglu C, Arıkan S, Gural Z, Sağlam EK, Turan S, Özkan NE, Kahraman OT, Yenilmez EN, Düzköylü Y, Doğan MB, Zeybek U, Ergen A, Yaylım İ. LGALS3 and AXIN1 gene variants playing role in the Wnt/ β-catenin signaling pathway are associated with mucinous component and tumor size in colorectal cancer. Bosn J Basic Med Sci 2016;16:108-13. [PMID: 26894286 DOI: 10.17305/bjbms.2016.721] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
439 Huang Z, Li Q, Luo K, Zhang Q, Geng J, Zhou X, Xu Y, Qian M, Zhang JA, Ji L, Wu J. miR-340-FHL2 axis inhibits cell growth and metastasis in ovarian cancer. Cell Death Dis 2019;10:372. [PMID: 31068580 DOI: 10.1038/s41419-019-1604-3] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 8.5] [Reference Citation Analysis]
440 Esposito M, Mondal N, Greco TM, Wei Y, Spadazzi C, Lin SC, Zheng H, Cheung C, Magnani JL, Lin SH, Cristea IM, Sackstein R, Kang Y. Bone vascular niche E-selectin induces mesenchymal-epithelial transition and Wnt activation in cancer cells to promote bone metastasis. Nat Cell Biol 2019;21:627-39. [PMID: 30988423 DOI: 10.1038/s41556-019-0309-2] [Cited by in Crossref: 88] [Cited by in F6Publishing: 76] [Article Influence: 44.0] [Reference Citation Analysis]
441 Lu L, Gao Y, Zhang Z, Cao Q, Zhang X, Zou J, Cao Y. Kdm2a/b Lysine Demethylases Regulate Canonical Wnt Signaling by Modulating the Stability of Nuclear β-Catenin. Dev Cell 2015;33:660-74. [PMID: 26004508 DOI: 10.1016/j.devcel.2015.04.006] [Cited by in Crossref: 44] [Cited by in F6Publishing: 35] [Article Influence: 7.3] [Reference Citation Analysis]
442 Aminuddin A, Ng PY. Promising Druggable Target in Head and Neck Squamous Cell Carcinoma: Wnt Signaling. Front Pharmacol 2016;7:244. [PMID: 27570510 DOI: 10.3389/fphar.2016.00244] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 4.0] [Reference Citation Analysis]
443 Zucman-rossi J, Villanueva A, Nault J, Llovet JM. Genetic Landscape and Biomarkers of Hepatocellular Carcinoma. Gastroenterology 2015;149:1226-1239.e4. [DOI: 10.1053/j.gastro.2015.05.061] [Cited by in Crossref: 531] [Cited by in F6Publishing: 463] [Article Influence: 88.5] [Reference Citation Analysis]
444 Zhang Y, Zhao Y, Li Q, Wang Y. Macrophages, as a Promising Strategy to Targeted Treatment for Colorectal Cancer Metastasis in Tumor Immune Microenvironment. Front Immunol 2021;12:685978. [PMID: 34326840 DOI: 10.3389/fimmu.2021.685978] [Reference Citation Analysis]
445 Zhang X, Dong S, Xu F. Structural and Druggability Landscape of Frizzled G Protein-Coupled Receptors. Trends in Biochemical Sciences 2018;43:1033-46. [DOI: 10.1016/j.tibs.2018.09.002] [Cited by in Crossref: 18] [Cited by in F6Publishing: 11] [Article Influence: 6.0] [Reference Citation Analysis]
446 Wang Y, Chen Q, Liu Z, Guo X, Du Y, Yuan Z, Guo M, Kang L, Sun Y, Jiang Y. Transcriptome Analysis on Single Small Yellow Follicles Reveals That Wnt4 Is Involved in Chicken Follicle Selection. Front Endocrinol (Lausanne) 2017;8:317. [PMID: 29187833 DOI: 10.3389/fendo.2017.00317] [Cited by in Crossref: 19] [Cited by in F6Publishing: 13] [Article Influence: 4.8] [Reference Citation Analysis]
447 Lee M, Kim YS, Lee K, Kang M, Shin H, Oh JW, Koo H, Kim D, Kim Y, Kong DS, Nam DH, Lee HW. Novel Semi-Replicative Retroviral Vector Mediated Double Suicide Gene Transfer Enhances Antitumor Effects in Patient-Derived Glioblastoma Models. Cancers (Basel) 2019;11:E1090. [PMID: 31370279 DOI: 10.3390/cancers11081090] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 2.5] [Reference Citation Analysis]
448 Monteverde T, Muthalagu N, Port J, Murphy DJ. Evidence of cancer-promoting roles for AMPK and related kinases. FEBS J 2015;282:4658-71. [PMID: 26426570 DOI: 10.1111/febs.13534] [Cited by in Crossref: 45] [Cited by in F6Publishing: 43] [Article Influence: 7.5] [Reference Citation Analysis]
449 Liu L, Jiang H, Zhao J, Wen H. MiRNA-16 inhibited oral squamous carcinoma tumor growth in vitro and in vivo via suppressing Wnt/β-catenin signaling pathway. Onco Targets Ther 2018;11:5111-9. [PMID: 30197522 DOI: 10.2147/OTT.S153888] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 2.3] [Reference Citation Analysis]
450 Bi Y, Li H, Yi D, Bai Y, Zhong S, Liu Q, Chen Y, Zhao G. β-catenin contributes to cordycepin-induced MGMT inhibition and reduction of temozolomide resistance in glioma cells by increasing intracellular reactive oxygen species. Cancer Lett 2018;435:66-79. [PMID: 30081068 DOI: 10.1016/j.canlet.2018.07.040] [Cited by in Crossref: 15] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
451 Ríos JA, Cisternas P, Arrese M, Barja S, Inestrosa NC. Is Alzheimer's disease related to metabolic syndrome? A Wnt signaling conundrum. Prog Neurobiol 2014;121:125-46. [PMID: 25084549 DOI: 10.1016/j.pneurobio.2014.07.004] [Cited by in Crossref: 69] [Cited by in F6Publishing: 58] [Article Influence: 9.9] [Reference Citation Analysis]
452 Fan W, Du F, Liu X. TRIM66 confers tumorigenicity of hepatocellular carcinoma cells by regulating GSK-3β-dependent Wnt/β-catenin signaling. Eur J Pharmacol 2019;850:109-17. [PMID: 30710548 DOI: 10.1016/j.ejphar.2019.01.054] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
453 Emons G, Spitzner M, Reineke S, Möller J, Auslander N, Kramer F, Hu Y, Beissbarth T, Wolff HA, Rave-Fränk M, Heßmann E, Gaedcke J, Ghadimi BM, Johnsen SA, Ried T, Grade M. Chemoradiotherapy Resistance in Colorectal Cancer Cells is Mediated by Wnt/β-catenin Signaling. Mol Cancer Res 2017;15:1481-90. [PMID: 28811361 DOI: 10.1158/1541-7786.MCR-17-0205] [Cited by in Crossref: 53] [Cited by in F6Publishing: 27] [Article Influence: 13.3] [Reference Citation Analysis]
454 Yang K, Wang X, Zhang H, Wang Z, Nan G, Li Y, Zhang F, Mohammed MK, Haydon RC, Luu HH, Bi Y, He TC. The evolving roles of canonical WNT signaling in stem cells and tumorigenesis: implications in targeted cancer therapies. Lab Invest 2016;96:116-36. [PMID: 26618721 DOI: 10.1038/labinvest.2015.144] [Cited by in Crossref: 104] [Cited by in F6Publishing: 99] [Article Influence: 17.3] [Reference Citation Analysis]
455 Phesse TJ, Buchert M, Stuart E, Flanagan DJ, Faux M, Afshar-Sterle S, Walker F, Zhang HH, Nowell CJ, Jorissen R, Tan CW, Hirokawa Y, Eissmann MF, Poh AR, Malaterre J, Pearson HB, Kirsch DG, Provero P, Poli V, Ramsay RG, Sieber O, Burgess AW, Huszar D, Vincan E, Ernst M. Partial inhibition of gp130-Jak-Stat3 signaling prevents Wnt-β-catenin-mediated intestinal tumor growth and regeneration. Sci Signal 2014;7:ra92. [PMID: 25270258 DOI: 10.1126/scisignal.2005411] [Cited by in Crossref: 54] [Cited by in F6Publishing: 47] [Article Influence: 7.7] [Reference Citation Analysis]
456 Ma X, Sun P, Zhao J. Multi-Objective Optimization Algorithm to Discover Condition-Specific Modules in Multiple Networks. Molecules 2017;22:E2228. [PMID: 29240706 DOI: 10.3390/molecules22122228] [Reference Citation Analysis]
457 Moor AE, Anderle P, Cantù C, Rodriguez P, Wiedemann N, Baruthio F, Deka J, André S, Valenta T, Moor MB. BCL9/9L-β-catenin Signaling is Associated With Poor Outcome in Colorectal Cancer. EBioMedicine. 2015;2:1932-1943. [PMID: 26844272 DOI: 10.1016/j.ebiom.2015.10.030] [Cited by in Crossref: 38] [Cited by in F6Publishing: 32] [Article Influence: 6.3] [Reference Citation Analysis]
458 Contaldi F, Capuano F, Fulgione A, Aiese Cigliano R, Sanseverino W, Iannelli D, Medaglia C, Capparelli R. The hypothesis that Helicobacter pylori predisposes to Alzheimer's disease is biologically plausible. Sci Rep 2017;7:7817. [PMID: 28798312 DOI: 10.1038/s41598-017-07532-x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
459 Motawi TK, El-maraghy SA, Elmeshad AN, Nady OM, Hammam OA. Cromolyn chitosan nanoparticles as a novel protective approach for colorectal cancer. Chemico-Biological Interactions 2017;275:1-12. [DOI: 10.1016/j.cbi.2017.07.013] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 3.8] [Reference Citation Analysis]
460 Li R, Zhang L, Qin Z, Wei Y, Deng Z, Zhu C, Tang J, Ma L. High LINC00536 expression promotes tumor progression and poor prognosis in bladder cancer. Exp Cell Res 2019;378:32-40. [PMID: 30851243 DOI: 10.1016/j.yexcr.2019.03.009] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
461 Paul I, Bhattacharya S, Chatterjee A, Ghosh MK. Current Understanding on EGFR and Wnt/β-Catenin Signaling in Glioma and Their Possible Crosstalk. Genes Cancer 2013;4:427-46. [PMID: 24386505 DOI: 10.1177/1947601913503341] [Cited by in Crossref: 98] [Cited by in F6Publishing: 80] [Article Influence: 14.0] [Reference Citation Analysis]
462 Hwang SY, Deng X, Byun S, Lee C, Lee SJ, Suh H, Zhang J, Kang Q, Zhang T, Westover KD, Mandinova A, Lee SW. Direct Targeting of β-Catenin by a Small Molecule Stimulates Proteasomal Degradation and Suppresses Oncogenic Wnt/β-Catenin Signaling. Cell Rep 2016;16:28-36. [PMID: 27320923 DOI: 10.1016/j.celrep.2016.05.071] [Cited by in Crossref: 47] [Cited by in F6Publishing: 41] [Article Influence: 9.4] [Reference Citation Analysis]
463 Zhu Y, Gu L, Lin X, Cui K, Liu C, Lu B, Zhou F, Zhao Q, Shen H, Li Y. LINC00265 promotes colorectal tumorigenesis via ZMIZ2 and USP7-mediated stabilization of β-catenin. Cell Death Differ 2020;27:1316-27. [PMID: 31527801 DOI: 10.1038/s41418-019-0417-3] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
464 Blomain ES, Pattison AM, Waldman SA. GUCY2C ligand replacement to prevent colorectal cancer. Cancer Biol Ther 2016;17:713-8. [PMID: 27104761 DOI: 10.1080/15384047.2016.1178429] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
465 Wickström M, Dyberg C, Milosevic J, Einvik C, Calero R, Sveinbjörnsson B, Sandén E, Darabi A, Siesjö P, Kool M, Kogner P, Baryawno N, Johnsen JI. Wnt/β-catenin pathway regulates MGMT gene expression in cancer and inhibition of Wnt signalling prevents chemoresistance. Nat Commun 2015;6:8904. [PMID: 26603103 DOI: 10.1038/ncomms9904] [Cited by in Crossref: 110] [Cited by in F6Publishing: 97] [Article Influence: 18.3] [Reference Citation Analysis]
466 Puvirajesinghe TM, Bertucci F, Jain A, Scerbo P, Belotti E, Audebert S, Sebbagh M, Lopez M, Brech A, Finetti P, Charafe-Jauffret E, Chaffanet M, Castellano R, Restouin A, Marchetto S, Collette Y, Gonçalvès A, Macara I, Birnbaum D, Kodjabachian L, Johansen T, Borg JP. Identification of p62/SQSTM1 as a component of non-canonical Wnt VANGL2-JNK signalling in breast cancer. Nat Commun 2016;7:10318. [PMID: 26754771 DOI: 10.1038/ncomms10318] [Cited by in Crossref: 55] [Cited by in F6Publishing: 44] [Article Influence: 11.0] [Reference Citation Analysis]
467 Xue G, Romano E, Massi D, Mandalà M. Wnt/β-catenin signaling in melanoma: Preclinical rationale and novel therapeutic insights. Cancer Treat Rev 2016;49:1-12. [PMID: 27395773 DOI: 10.1016/j.ctrv.2016.06.009] [Cited by in Crossref: 58] [Cited by in F6Publishing: 47] [Article Influence: 11.6] [Reference Citation Analysis]
468 Li Z, Kang Y. Emerging therapeutic targets in metastatic progression: A focus on breast cancer. Pharmacol Ther 2016;161:79-96. [PMID: 27000769 DOI: 10.1016/j.pharmthera.2016.03.003] [Cited by in Crossref: 31] [Cited by in F6Publishing: 27] [Article Influence: 6.2] [Reference Citation Analysis]
469 Semaan A, Uhl B, Branchi V, Lingohr P, Bootz F, Kristiansen G, Kalff JC, Matthaei H, Pantelis D, Dietrich D. Significance of PITX2 Promoter Methylation in Colorectal Carcinoma Prognosis. Clin Colorectal Cancer 2018;17:e385-93. [PMID: 29580650 DOI: 10.1016/j.clcc.2018.02.008] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
470 Zong D, Yin L, Zhong Q, Guo WJ, Xu JH, Jiang N, Lin ZR, Li MZ, Han P, Xu L, He X, Zeng MS. ZNF488 Enhances the Invasion and Tumorigenesis in Nasopharyngeal Carcinoma Via the Wnt Signaling Pathway Involving Epithelial Mesenchymal Transition. Cancer Res Treat 2016;48:334-44. [PMID: 25779368 DOI: 10.4143/crt.2014.311] [Cited by in Crossref: 14] [Cited by in F6Publishing: 17] [Article Influence: 2.3] [Reference Citation Analysis]
471 Yang J, Zhang K, Wu J, Shi J, Xue J, Li J, Chen J, Zhu Y, Wei J, He J, Liu X. Wnt5a Increases Properties of Lung Cancer Stem Cells and Resistance to Cisplatin through Activation of Wnt5a/PKC Signaling Pathway. Stem Cells Int 2016;2016:1690896. [PMID: 27895670 DOI: 10.1155/2016/1690896] [Cited by in Crossref: 15] [Cited by in F6Publishing: 18] [Article Influence: 3.0] [Reference Citation Analysis]
472 Eskander RN, Ali S, Dellinger T, Lankes HA, Randall LM, Ramirez NC, Monk BJ, Walker JL, Eisenhauer E, Hoang BH. Expression Patterns of the Wnt Pathway Inhibitors Dickkopf3 and Secreted Frizzled-Related Proteins 1 and 4 in Endometrial Endometrioid Adenocarcinoma: An NRG Oncology/Gynecologic Oncology Group Study. Int J Gynecol Cancer 2016;26:125-32. [PMID: 26397159 DOI: 10.1097/IGC.0000000000000563] [Cited by in Crossref: 11] [Cited by in F6Publishing: 3] [Article Influence: 2.2] [Reference Citation Analysis]
473 Lepore S, Lettini G, Condelli V, Sisinni L, Piscazzi A, Simeon V, Zoppoli P, Pedicillo MC, Natalicchio MI, Pietrafesa M, Landriscina M. Comparative Gene Expression Profiling of Tobacco-Associated HPV-Positive versus Negative Oral Squamous Carcinoma Cell Lines. Int J Med Sci 2020;17:112-24. [PMID: 31929745 DOI: 10.7150/ijms.35133] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
474 Schmitz Y, Rateitschak K, Wolkenhauer O. Analysing the impact of nucleo-cytoplasmic shuttling of β-catenin and its antagonists APC, Axin and GSK3 on Wnt/β-catenin signalling. Cell Signal 2013;25:2210-21. [PMID: 23872074 DOI: 10.1016/j.cellsig.2013.07.005] [Cited by in Crossref: 42] [Cited by in F6Publishing: 35] [Article Influence: 5.3] [Reference Citation Analysis]
475 Li Z, Wang Q, Peng S, Yao K, Chen J, Tao Y, Gao Z, Wang F, Li H, Cai W, Lai Y, Li K, Chen X, Huang H. The metastatic promoter DEPDC1B induces epithelial-mesenchymal transition and promotes prostate cancer cell proliferation via Rac1-PAK1 signaling. Clin Transl Med 2020;10:e191. [PMID: 33135357 DOI: 10.1002/ctm2.191] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
476 Zhang W, Lu W, Ananthan S, Suto MJ, Li Y. Discovery of novel frizzled-7 inhibitors by targeting the receptor's transmembrane domain. Oncotarget 2017;8:91459-70. [PMID: 29207657 DOI: 10.18632/oncotarget.20665] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 3.5] [Reference Citation Analysis]
477 Park HW, Kim YC, Yu B, Moroishi T, Mo JS, Plouffe SW, Meng Z, Lin KC, Yu FX, Alexander CM, Wang CY, Guan KL. Alternative Wnt Signaling Activates YAP/TAZ. Cell. 2015;162:780-794. [PMID: 26276632 DOI: 10.1016/j.cell.2015.07.013] [Cited by in Crossref: 336] [Cited by in F6Publishing: 302] [Article Influence: 67.2] [Reference Citation Analysis]
478 Toruń A, Szymańska E, Castanon I, Wolińska-Nizioł L, Bartosik A, Jastrzębski K, Miętkowska M, González-Gaitán M, Miaczynska M. Endocytic Adaptor Protein Tollip Inhibits Canonical Wnt Signaling. PLoS One 2015;10:e0130818. [PMID: 26110841 DOI: 10.1371/journal.pone.0130818] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.2] [Reference Citation Analysis]
479 Adams R, Nicke B, Pohlenz HD, Sohler F. Deciphering Seed Sequence Based Off-Target Effects in a Large-Scale RNAi Reporter Screen for E-Cadherin Expression. PLoS One 2015;10:e0137640. [PMID: 26361354 DOI: 10.1371/journal.pone.0137640] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
480 Cardona-Echeverry A, Prada-Arismendy J. Deciphering the role of Wnt signaling in acute myeloid leukemia prognosis: how alterations in DNA methylation come into play in patients' prognosis. J Cancer Res Clin Oncol 2020;146:3097-109. [PMID: 32980885 DOI: 10.1007/s00432-020-03407-3] [Reference Citation Analysis]
481 Bandeira L, Lewiecki EM, Bilezikian JP. Romosozumab for the treatment of osteoporosis. Expert Opin Biol Ther 2017;17:255-63. [PMID: 28064540 DOI: 10.1080/14712598.2017.1280455] [Cited by in Crossref: 42] [Cited by in F6Publishing: 32] [Article Influence: 10.5] [Reference Citation Analysis]
482 García-Jiménez C, García-Martínez JM, Chocarro-Calvo A, De la Vieja A. A new link between diabetes and cancer: enhanced WNT/β-catenin signaling by high glucose. J Mol Endocrinol. 2014;52:R51-R66. [PMID: 24049067 DOI: 10.1530/jme-13-0152] [Cited by in Crossref: 75] [Cited by in F6Publishing: 39] [Article Influence: 9.4] [Reference Citation Analysis]
483 Sandsmark E, Hansen AF, Selnæs KM, Bertilsson H, Bofin AM, Wright AJ, Viset T, Richardsen E, Drabløs F, Bathen TF, Tessem MB, Rye MB. A novel non-canonical Wnt signature for prostate cancer aggressiveness. Oncotarget 2017;8:9572-86. [PMID: 28030815 DOI: 10.18632/oncotarget.14161] [Cited by in Crossref: 30] [Cited by in F6Publishing: 28] [Article Influence: 10.0] [Reference Citation Analysis]
484 Henry CE, Llamosas E, Djordjevic A, Hacker NF, Ford CE. Migration and invasion is inhibited by silencing ROR1 and ROR2 in chemoresistant ovarian cancer. Oncogenesis. 2016;5:e226. [PMID: 27239958 DOI: 10.1038/oncsis.2016.32] [Cited by in Crossref: 29] [Cited by in F6Publishing: 24] [Article Influence: 5.8] [Reference Citation Analysis]
485 Gęca T, Kwiatek M, Krzyżanowski A, Kwaśniewska A. C1q/TNF-Related Protein-3 (CTRP-3) and Pigment Epithelium-Derived Factor (PEDF) Concentrations in Patients with Gestational Diabetes Mellitus: A Case-Control Study. J Clin Med 2020;9:E2587. [PMID: 32785102 DOI: 10.3390/jcm9082587] [Reference Citation Analysis]
486 Dai G, Zheng D, Wang Q, Yang J, Liu G, Song Q, Sun X, Tao C, Hu Q, Gao T, Yu L, Guo W. Baicalein inhibits progression of osteosarcoma cells through inactivation of the Wnt/β-catenin signaling pathway. Oncotarget 2017;8:86098-116. [PMID: 29156780 DOI: 10.18632/oncotarget.20987] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
487 Ren L, Zhou T, Wang Y, Wu Y, Xu H, Liu J, Dong X, Yi F, Guo Q, Wang Z, Li X, Bai N, Guo W, Guo M, Jiang B, Wu X, Feng Y, Song X, Zhang S, Zhao Y, Cao L, Han S, Xing C. RNF8 induces β-catenin-mediated c-Myc expression and promotes colon cancer proliferation. Int J Biol Sci 2020;16:2051-62. [PMID: 32549753 DOI: 10.7150/ijbs.44119] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
488 Pavlov K, Meijer C, van den Berg A, Peters FT, Kruyt FA, Kleibeuker JH. Embryological signaling pathways in Barrett's metaplasia development and malignant transformation; mechanisms and therapeutic opportunities. Crit Rev Oncol Hematol 2014;92:25-37. [PMID: 24935219 DOI: 10.1016/j.critrevonc.2014.05.002] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
489 Brisken C. Progesterone signalling in breast cancer: a neglected hormone coming into the limelight. Nat Rev Cancer 2013;13:385-96. [PMID: 23702927 DOI: 10.1038/nrc3518] [Cited by in Crossref: 157] [Cited by in F6Publishing: 128] [Article Influence: 19.6] [Reference Citation Analysis]
490 Quackenbush KS, Bagby S, Tai WM, Messersmith WA, Schreiber A, Greene J, Kim J, Wang G, Purkey A, Pitts TM, Nguyen A, Gao D, Blatchford P, Capasso A, Schuller AG, Eckhardt SG, Arcaroli JJ. The novel tankyrase inhibitor (AZ1366) enhances irinotecan activity in tumors that exhibit elevated tankyrase and irinotecan resistance. Oncotarget 2016;7:28273-85. [PMID: 27070088 DOI: 10.18632/oncotarget.8626] [Cited by in Crossref: 22] [Cited by in F6Publishing: 16] [Article Influence: 5.5] [Reference Citation Analysis]
491 Alicea D, Perez M, Maldonado C, Dominicci-Cotto C, Marie B. Cortactin Is a Regulator of Activity-Dependent Synaptic Plasticity Controlled by Wingless. J Neurosci 2017;37:2203-15. [PMID: 28123080 DOI: 10.1523/JNEUROSCI.1375-16.2017] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 3.3] [Reference Citation Analysis]
492 Salomon A, Keramidas M, Maisin C, Thomas M. Loss of β-catenin in adrenocortical cancer cells causes growth inhibition and reversal of epithelial-to-mesenchymal transition. Oncotarget 2015;6:11421-33. [PMID: 25823656 DOI: 10.18632/oncotarget.3222] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 4.8] [Reference Citation Analysis]
493 Koch S, Acebron SP, Herbst J, Hatiboglu G, Niehrs C. Post-transcriptional Wnt Signaling Governs Epididymal Sperm Maturation. Cell 2015;163:1225-36. [DOI: 10.1016/j.cell.2015.10.029] [Cited by in Crossref: 109] [Cited by in F6Publishing: 87] [Article Influence: 18.2] [Reference Citation Analysis]
494 Li D, Lin C, Li N, Du Y, Yang C, Bai Y, Feng Z, Su C, Wu R, Song S, Yan P, Chen M, Jain A, Huang L, Zhang Y, Li X. PLAGL2 and POFUT1 are regulated by an evolutionarily conserved bidirectional promoter and are collaboratively involved in colorectal cancer by maintaining stemness. EBioMedicine 2019;45:124-38. [PMID: 31279780 DOI: 10.1016/j.ebiom.2019.06.051] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 3.5] [Reference Citation Analysis]
495 Tan T, Chen J, Hu Y, Wang N, Chen Y, Yu T, Lin D, Yang S, Luo J, Luo X. Dihydrotanshinone I inhibits the growth of osteosarcoma through the Wnt/β-catenin signaling pathway. Onco Targets Ther 2019;12:5111-22. [PMID: 31308689 DOI: 10.2147/OTT.S204574] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 6.0] [Reference Citation Analysis]
496 Li H, Li T, Huang D, Zhang P. Long noncoding RNA SNHG17 induced by YY1 facilitates the glioma progression through targeting miR-506-3p/CTNNB1 axis to activate Wnt/β-catenin signaling pathway. Cancer Cell Int 2020;20:29. [PMID: 32009853 DOI: 10.1186/s12935-019-1088-3] [Cited by in Crossref: 15] [Cited by in F6Publishing: 8] [Article Influence: 15.0] [Reference Citation Analysis]
497 Shimozaki S, Yamamoto N, Domoto T, Nishida H, Hayashi K, Kimura H, Takeuchi A, Miwa S, Igarashi K, Kato T, Aoki Y, Higuchi T, Hirose M, Hoffman RM, Minamoto T, Tsuchiya H. Efficacy of glycogen synthase kinase-3β targeting against osteosarcoma via activation of β-catenin. Oncotarget 2016;7:77038-51. [PMID: 27780915 DOI: 10.18632/oncotarget.12781] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
498 Feng T, Zhou L, Wang Z, Li C, Zhang Y, Lin J, Lu D, Huang P. Dual-stimuli responsive nanotheranostics for mild hyperthermia enhanced inhibition of Wnt/β-catenin signaling. Biomaterials 2020;232:119709. [DOI: 10.1016/j.biomaterials.2019.119709] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 11.0] [Reference Citation Analysis]
499 Ruess DA, Görgülü K, Wörmann SM, Algül H. Pharmacotherapeutic Management of Pancreatic Ductal Adenocarcinoma: Current and Emerging Concepts. Drugs Aging 2017;34:331-57. [PMID: 28349415 DOI: 10.1007/s40266-017-0453-y] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
500 Marcucci F, Rumio C, Lefoulon F. Anti-Cancer Stem-like Cell Compounds in Clinical Development - An Overview and Critical Appraisal. Front Oncol 2016;6:115. [PMID: 27242955 DOI: 10.3389/fonc.2016.00115] [Cited by in Crossref: 31] [Cited by in F6Publishing: 29] [Article Influence: 6.2] [Reference Citation Analysis]
501 Yin L, Gao Y, Zhang X, Wang J, Ding D, Zhang Y, Zhang J, Chen H. Niclosamide sensitizes triple-negative breast cancer cells to ionizing radiation in association with the inhibition of Wnt/β-catenin signaling. Oncotarget 2016;7:42126-38. [PMID: 27363012 DOI: 10.18632/oncotarget.9704] [Cited by in Crossref: 24] [Cited by in F6Publishing: 17] [Article Influence: 8.0] [Reference Citation Analysis]
502 Kim HJ, Moon SJ, Kim SH, Heo K, Kim JH. DBC1 regulates Wnt/β-catenin-mediated expression of MACC1, a key regulator of cancer progression, in colon cancer. Cell Death Dis 2018;9:831. [PMID: 30082743 DOI: 10.1038/s41419-018-0899-9] [Cited by in Crossref: 15] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
503 Valenti F, Ibetti J, Komiya Y, Baxter M, Lucchese AM, Derstine L, Covaciu C, Rizzo V, Vento R, Russo G, Macaluso M, Cotelli F, Castiglia D, Gottardi CJ, Habas R, Giordano A, Bellipanni G. The increase in maternal expression of axin1 and axin2 contribute to the zebrafish mutant ichabod ventralized phenotype. J Cell Biochem 2015;116:418-30. [PMID: 25335865 DOI: 10.1002/jcb.24993] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
504 Wu S, Yue Y, Gu Y, Wang Q, Liu T, Li L, Wang X, Chang LS, He D, Wu K. MUC15 loss facilitates epithelial-mesenchymal transition and cancer stemness for prostate cancer metastasis through GSK3β/β-catenin signaling. Cell Signal 2021;84:110015. [PMID: 33894313 DOI: 10.1016/j.cellsig.2021.110015] [Reference Citation Analysis]
505 Luna JM, Barajas JM, Teng KY, Sun HL, Moore MJ, Rice CM, Darnell RB, Ghoshal K. Argonaute CLIP Defines a Deregulated miR-122-Bound Transcriptome that Correlates with Patient Survival in Human Liver Cancer. Mol Cell 2017;67:400-410.e7. [PMID: 28735896 DOI: 10.1016/j.molcel.2017.06.025] [Cited by in Crossref: 36] [Cited by in F6Publishing: 42] [Article Influence: 9.0] [Reference Citation Analysis]
506 Felix S, Sandjo LP, Opatz T, Erkel G. SF002-96-1, a new drimane sesquiterpene lactone from an Aspergillus species, inhibits survivin expression. Beilstein J Org Chem 2013;9:2866-76. [PMID: 24367452 DOI: 10.3762/bjoc.9.323] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
507 Luan M, Yu L, Li Y, Pan W, Gao X, Wan X, Li N, Tang B. Visualizing Breast Cancer Cell Proliferation and Invasion for Assessing Drug Efficacy with a Fluorescent Nanoprobe. Anal Chem 2017;89:10601-7. [DOI: 10.1021/acs.analchem.7b03146] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 4.8] [Reference Citation Analysis]
508 Schneider JA, Logan SK. Revisiting the role of Wnt/β-catenin signaling in prostate cancer. Mol Cell Endocrinol 2018;462:3-8. [PMID: 28189566 DOI: 10.1016/j.mce.2017.02.008] [Cited by in Crossref: 45] [Cited by in F6Publishing: 36] [Article Influence: 11.3] [Reference Citation Analysis]
509 Cordero D, Solé X, Crous-Bou M, Sanz-Pamplona R, Paré-Brunet L, Guinó E, Olivares D, Berenguer A, Santos C, Salazar R, Biondo S, Moreno V. Large differences in global transcriptional regulatory programs of normal and tumor colon cells. BMC Cancer 2014;14:708. [PMID: 25253512 DOI: 10.1186/1471-2407-14-708] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 3.1] [Reference Citation Analysis]
510 Sharifian R, Okamura DM, Denisenko O, Zager RA, Johnson A, Gharib SA, Bomsztyk K. Distinct patterns of transcriptional and epigenetic alterations characterize acute and chronic kidney injury. Sci Rep 2018;8:17870. [PMID: 30552397 DOI: 10.1038/s41598-018-35943-x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 3.3] [Reference Citation Analysis]
511 Majchrzak-Celińska A, Misiorek JO, Kruhlenia N, Przybyl L, Kleszcz R, Rolle K, Krajka-Kuźniak V. COXIBs and 2,5-dimethylcelecoxib counteract the hyperactivated Wnt/β-catenin pathway and COX-2/PGE2/EP4 signaling in glioblastoma cells. BMC Cancer 2021;21:493. [PMID: 33941107 DOI: 10.1186/s12885-021-08164-1] [Reference Citation Analysis]
512 Zhong Z, Virshup DM. Wnt Signaling and Drug Resistance in Cancer. Mol Pharmacol. 2020;97:72-89. [PMID: 31787618 DOI: 10.1124/mol.119.117978] [Cited by in Crossref: 46] [Cited by in F6Publishing: 38] [Article Influence: 23.0] [Reference Citation Analysis]
513 Hu X, Tang Z, Ma S, Yu Y, Chen X, Zang G. Tripartite motif-containing protein 7 regulates hepatocellular carcinoma cell proliferation via the DUSP6/p38 pathway. Biochemical and Biophysical Research Communications 2019;511:889-95. [DOI: 10.1016/j.bbrc.2019.02.001] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 6.5] [Reference Citation Analysis]
514 Maftouh M, Belo AI, Avan A, Funel N, Peters GJ, Giovannetti E, Van Die I. Galectin-4 expression is associated with reduced lymph node metastasis and modulation of Wnt/β-catenin signalling in pancreatic adenocarcinoma. Oncotarget 2014;5:5335-49. [PMID: 24977327 DOI: 10.18632/oncotarget.2104] [Cited by in Crossref: 36] [Cited by in F6Publishing: 33] [Article Influence: 6.0] [Reference Citation Analysis]
515 Li M, Yue GG, Luo L, Tsui SK, Fung KP, Ng SS, Lau CB. Turmeric Is Therapeutic in Vivo on Patient-Derived Colorectal Cancer Xenografts: Inhibition of Growth, Metastasis, and Tumor Recurrence. Front Oncol 2020;10:574827. [PMID: 33552955 DOI: 10.3389/fonc.2020.574827] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
516 Bian P, Dou Z, Jia Z, Li W, Pan D. Activated Wnt/β-Catenin signaling contributes to E3 ubiquitin ligase EDD-conferred docetaxel resistance in prostate cancer. Life Sci 2020;254:116816. [PMID: 31472148 DOI: 10.1016/j.lfs.2019.116816] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
517 Xu Q, Krause M, Samoylenko A, Vainio S. Wnt Signaling in Renal Cell Carcinoma. Cancers (Basel) 2016;8:E57. [PMID: 27322325 DOI: 10.3390/cancers8060057] [Cited by in Crossref: 43] [Cited by in F6Publishing: 41] [Article Influence: 8.6] [Reference Citation Analysis]
518 He W, Yan Q, Fu L, Han Y. A five-gene signature to predict the overall survival time of patients with esophageal squamous cell carcinoma. Oncol Lett 2019;18:1381-7. [PMID: 31423201 DOI: 10.3892/ol.2019.10449] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
519 Zhang X, MacDonald BT, Gao H, Shamashkin M, Coyle AJ, Martinez RV, He X. Characterization of Tiki, a New Family of Wnt-specific Metalloproteases. J Biol Chem 2016;291:2435-43. [PMID: 26631728 DOI: 10.1074/jbc.M115.677807] [Cited by in Crossref: 20] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
520 Li Y, Li PK, Roberts MJ, Arend RC, Samant RS, Buchsbaum DJ. Multi-targeted therapy of cancer by niclosamide: A new application for an old drug. Cancer Lett. 2014;349:8-14. [PMID: 24732808 DOI: 10.1016/j.canlet.2014.04.003] [Cited by in Crossref: 199] [Cited by in F6Publishing: 166] [Article Influence: 28.4] [Reference Citation Analysis]
521 Lee YC, Patil S, Golz C, Strohmann C, Ziegler S, Kumar K, Waldmann H. A ligand-directed divergent catalytic approach to establish structural and functional scaffold diversity. Nat Commun 2017;8:14043. [PMID: 28195128 DOI: 10.1038/ncomms14043] [Cited by in Crossref: 44] [Cited by in F6Publishing: 18] [Article Influence: 11.0] [Reference Citation Analysis]
522 Jin J, Zhan P, Qian H, Wang X, Katoh M, Phan K, Chung JH, Lv T, Song Y; Written on behalf of the AME Lung Cancer Collaborative Group. Prognostic value of wingless-type proteins in non-small cell lung cancer patients: a meta-analysis. Transl Lung Cancer Res 2016;5:436-42. [PMID: 27652206 DOI: 10.21037/tlcr.2016.08.08] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
523 Ghoshal A, Ghosh SS. Antagonizing canonical Wnt signaling pathway by recombinant human sFRP4 purified from E. coli and its implications in cancer therapy. Mol Cell Biochem 2016;418:119-35. [PMID: 27334754 DOI: 10.1007/s11010-016-2738-6] [Cited by in F6Publishing: 8] [Reference Citation Analysis]
524 Riva G, Cilibrasi C, Bazzoni R, Cadamuro M, Negroni C, Butta V, Strazzabosco M, Dalprà L, Lavitrano M, Bentivegna A. Valproic Acid Inhibits Proliferation and Reduces Invasiveness in Glioma Stem Cells Through Wnt/β Catenin Signalling Activation. Genes (Basel) 2018;9:E522. [PMID: 30373123 DOI: 10.3390/genes9110522] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 3.7] [Reference Citation Analysis]
525 Johnsen JI, Dyberg C, Wickström M. Neuroblastoma-A Neural Crest Derived Embryonal Malignancy. Front Mol Neurosci 2019;12:9. [PMID: 30760980 DOI: 10.3389/fnmol.2019.00009] [Cited by in Crossref: 51] [Cited by in F6Publishing: 41] [Article Influence: 25.5] [Reference Citation Analysis]
526 Xiao JH, Zhang Y, Liang GY, Liu RM, Li XG, Zhang LT, Chen DX, Zhong JJ. Synergistic antitumor efficacy of antibacterial helvolic acid from Cordyceps taii and cyclophosphamide in a tumor mouse model. Exp Biol Med (Maywood) 2017;242:214-22. [PMID: 27604096 DOI: 10.1177/1535370216668051] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
527 Li X, Ortiz MA, Kotula L. The physiological role of Wnt pathway in normal development and cancer. Exp Biol Med (Maywood) 2020;245:411-26. [PMID: 31996036 DOI: 10.1177/1535370220901683] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 6.0] [Reference Citation Analysis]
528 Kajino-Sakamoto R, Fujishita T, Taketo MM, Aoki M. Synthetic lethality between MyD88 loss and mutations in Wnt/β-catenin pathway in intestinal tumor epithelial cells. Oncogene 2021;40:408-20. [PMID: 33177648 DOI: 10.1038/s41388-020-01541-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
529 Ara H, Takagishi M, Enomoto A, Asai M, Ushida K, Asai N, Shimoyama Y, Kaibuchi K, Kodera Y, Takahashi M. Role for Daple in non-canonical Wnt signaling during gastric cancer invasion and metastasis. Cancer Sci 2016;107:133-9. [PMID: 26577606 DOI: 10.1111/cas.12848] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 4.3] [Reference Citation Analysis]
530 Yi H, Wang Z, Li X, Yin M, Wang L, Aldalbahi A, El-Sayed NN, Wang H, Chen N, Fan C, Song H. Silica Nanoparticles Target a Wnt Signal Transducer for Degradation and Impair Embryonic Development in Zebrafish. Theranostics 2016;6:1810-20. [PMID: 27570552 DOI: 10.7150/thno.16127] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 4.0] [Reference Citation Analysis]
531 Sun Y, Wang W, Zhao C. Frizzled Receptors in Tumors, Focusing on Signaling, Roles, Modulation Mechanisms, and Targeted Therapies. Oncol Res 2021;28:661-74. [PMID: 32998794 DOI: 10.3727/096504020X16014648664459] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
532 Katayama C, Yokobori T, Ozawa N, Suga K, Shiraishi T, Okada T, Osone K, Katoh R, Suto T, Motegi Y, Ogawa H, Sano A, Sakai M, Sohda M, Erkhem-Ochir B, Gombodorj N, Katayama A, Oyama T, Shirabe K, Kuwano H, Saeki H. Low level of stromal lectin-like oxidized LDL receptor 1 and CD8+ cytotoxic T-lymphocytes indicate poor prognosis of colorectal cancer. Cancer Rep (Hoboken) 2021;4:e1364. [PMID: 33675293 DOI: 10.1002/cnr2.1364] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
533 Song Z, Zhao D, Zhao H, Yang L. NRSF: an Angel or a Devil in Neurogenesis and Neurological Diseases. J Mol Neurosci 2015;56:131-44. [DOI: 10.1007/s12031-014-0474-5] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 2.4] [Reference Citation Analysis]
534 Tiwary S, Xu L. FRIZZLED7 Is Required for Tumor Initiation and Metastatic Growth of Melanoma Cells. PLoS One 2016;11:e0147638. [PMID: 26808375 DOI: 10.1371/journal.pone.0147638] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.8] [Reference Citation Analysis]
535 Huang J, Shi Y, Li H, Tan D, Yang M, Wu X. Knockdown of receptor tyrosine kinase-like orphan receptor 2 inhibits cell proliferation and colony formation in osteosarcoma cells by inducing arrest in cell cycle progression. Oncol Lett 2015;10:3705-11. [PMID: 26788194 DOI: 10.3892/ol.2015.3797] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
536 Cisternas P, Salazar P, Silva-Álvarez C, Barros LF, Inestrosa NC. Wnt5a Increases the Glycolytic Rate and the Activity of the Pentose Phosphate Pathway in Cortical Neurons. Neural Plast 2016;2016:9839348. [PMID: 27688915 DOI: 10.1155/2016/9839348] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
537 Song Z, Zhu T, Zhou X, Barrow P, Yang W, Cui Y, Yang L, Zhao D. REST alleviates neurotoxic prion peptide-induced synaptic abnormalities, neurofibrillary degeneration and neuronal death partially via LRP6-mediated Wnt-β-catenin signaling. Oncotarget 2016;7:12035-52. [PMID: 26919115 DOI: 10.18632/oncotarget.7640] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 4.0] [Reference Citation Analysis]
538 Venkatesh J, Rishi AK, Reddy KB. Novel strategies to target chemoresistant triple-negative breast cancer. Genes Cancer 2020;11:95-105. [PMID: 33488948 DOI: 10.18632/genesandcancer.204] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
539 Geng Q, Deng H, Fu J, Cui F. SOX18 exerts tumor-suppressive functions in papillary thyroid carcinoma through inhibition of Wnt/β-catenin signaling. Exp Cell Res 2020;396:112249. [PMID: 32858034 DOI: 10.1016/j.yexcr.2020.112249] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
540 Cheng H, Li X, Wang C, Chen Y, Li S, Tan J, Tan B, He Y. Inhibition of tankyrase by a novel small molecule significantly attenuates prostate cancer cell proliferation. Cancer Lett 2019;443:80-90. [PMID: 30472184 DOI: 10.1016/j.canlet.2018.11.013] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 4.7] [Reference Citation Analysis]
541 Kahn M. Wnt Signaling in Stem Cells and Cancer Stem Cells: A Tale of Two Coactivators. Prog Mol Biol Transl Sci 2018;153:209-44. [PMID: 29389517 DOI: 10.1016/bs.pmbts.2017.11.007] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 5.8] [Reference Citation Analysis]
542 Cheong JK, Virshup DM. CK1δ: a pharmacologically tractable Achilles' heel of Wnt-driven cancers? Ann Transl Med 2016;4:433. [PMID: 27942524 DOI: 10.21037/atm.2016.11.07] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
543 Kim MJ, Huang Y, Park JI. Targeting Wnt Signaling for Gastrointestinal Cancer Therapy: Present and Evolving Views. Cancers (Basel). 2020;12. [PMID: 33291655 DOI: 10.3390/cancers12123638] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
544 Chen H, Wong CC, Liu D, Go MYY, Wu B, Peng S, Kuang M, Wong N, Yu J. APLN promotes hepatocellular carcinoma through activating PI3K/Akt pathway and is a druggable target. Theranostics 2019;9:5246-60. [PMID: 31410213 DOI: 10.7150/thno.34713] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 7.5] [Reference Citation Analysis]
545 He J, Zhou M, Chen X, Yue D, Yang L, Qin G, Zhang Z, Gao Q, Wang D, Zhang C, Huang L, Wang L, Zhang B, Yu J, Zhang Y. Inhibition of SALL4 reduces tumorigenicity involving epithelial-mesenchymal transition via Wnt/β-catenin pathway in esophageal squamous cell carcinoma. J Exp Clin Cancer Res 2016;35:98. [PMID: 27329034 DOI: 10.1186/s13046-016-0378-z] [Cited by in Crossref: 36] [Cited by in F6Publishing: 38] [Article Influence: 7.2] [Reference Citation Analysis]
546 Ho JY, Hsu RJ, Wu CL, Chang WL, Cha TL, Yu DS, Yu CP. Ovatodiolide Targets β -Catenin Signaling in Suppressing Tumorigenesis and Overcoming Drug Resistance in Renal Cell Carcinoma. Evid Based Complement Alternat Med 2013;2013:161628. [PMID: 23781255 DOI: 10.1155/2013/161628] [Cited by in Crossref: 14] [Cited by in F6Publishing: 17] [Article Influence: 1.8] [Reference Citation Analysis]
547 Azad AK, Lawen A, Keith JM. Prediction of signaling cross-talks contributing to acquired drug resistance in breast cancer cells by Bayesian statistical modeling. BMC Syst Biol 2015;9:2. [PMID: 25599599 DOI: 10.1186/s12918-014-0135-x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
548 Liu M, Yan Q, Sun Y, Nam Y, Hu L, Loong JH, Ouyang Q, Zhang Y, Li HL, Kong FE, Li L, Li Y, Li MM, Cheng W, Jiang LX, Fang S, Yang XD, Mo JQ, Gong YF, Tang YQ, Li Y, Yuan YF, Ma NF, Lin G, Ma S, Wang JG, Guan XY. A hepatocyte differentiation model reveals two subtypes of liver cancer with different oncofetal properties and therapeutic targets. Proc Natl Acad Sci U S A 2020;117:6103-13. [PMID: 32123069 DOI: 10.1073/pnas.1912146117] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
549 Fu X, Cheng D, Ouyang Y, Li Y, Li R, Peng S, Fu L. Integrated Analysis of Long Noncoding RNA Expression Profiles in Acute-on-Chronic Liver Failure. Biomed Res Int 2021;2021:5387856. [PMID: 34104647 DOI: 10.1155/2021/5387856] [Reference Citation Analysis]
550 Song JL, Nigam P, Tektas SS, Selva E. microRNA regulation of Wnt signaling pathways in development and disease. Cell Signal 2015;27:1380-91. [PMID: 25843779 DOI: 10.1016/j.cellsig.2015.03.018] [Cited by in Crossref: 72] [Cited by in F6Publishing: 67] [Article Influence: 12.0] [Reference Citation Analysis]
551 Nagaraj AB, Joseph P, Kovalenko O, Singh S, Armstrong A, Redline R, Resnick K, Zanotti K, Waggoner S, DiFeo A. Critical role of Wnt/β-catenin signaling in driving epithelial ovarian cancer platinum resistance. Oncotarget 2015;6:23720-34. [PMID: 26125441 DOI: 10.18632/oncotarget.4690] [Cited by in Crossref: 120] [Cited by in F6Publishing: 97] [Article Influence: 24.0] [Reference Citation Analysis]
552 Gavagan M, Fagnan E, Speltz EB, Zalatan JG. The Scaffold Protein Axin Promotes Signaling Specificity within the Wnt Pathway by Suppressing Competing Kinase Reactions. Cell Syst 2020;10:515-525.e5. [PMID: 32553184 DOI: 10.1016/j.cels.2020.05.002] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
553 Mahendram S, Kelly KF, Paez-Parent S, Mahmood S, Polena E, Cooney AJ, Doble BW. Ectopic γ-catenin expression partially mimics the effects of stabilized β-catenin on embryonic stem cell differentiation. PLoS One 2013;8:e65320. [PMID: 23724138 DOI: 10.1371/journal.pone.0065320] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
554 van Lidth de Jeude JF, Meijer BJ, Wielenga MCB, Spaan CN, Baan B, Rosekrans SL, Meisner S, Shen YH, Lee AS, Paton JC, Paton AW, Muncan V, van den Brink GR, Heijmans J. Induction of endoplasmic reticulum stress by deletion of Grp78 depletes Apc mutant intestinal epithelial stem cells. Oncogene 2017;36:3397-405. [PMID: 27819675 DOI: 10.1038/onc.2016.326] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 3.8] [Reference Citation Analysis]
555 Geng X, Xu T, Niu Z, Zhou X, Zhao L, Xie Z, Xue D, Zhang F, Xu C. Differential proteome analysis of the cell differentiation regulated by BCC, CRH, CXCR4, GnRH, GPCR, IL1 signaling pathways in Chinese fire-bellied newt limb regeneration. Differentiation 2014;88:85-96. [DOI: 10.1016/j.diff.2014.10.002] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
556 Olivon F, Allard PM, Koval A, Righi D, Genta-Jouve G, Neyts J, Apel C, Pannecouque C, Nothias LF, Cachet X, Marcourt L, Roussi F, Katanaev VL, Touboul D, Wolfender JL, Litaudon M. Bioactive Natural Products Prioritization Using Massive Multi-informational Molecular Networks. ACS Chem Biol 2017;12:2644-51. [PMID: 28829118 DOI: 10.1021/acschembio.7b00413] [Cited by in Crossref: 70] [Cited by in F6Publishing: 51] [Article Influence: 17.5] [Reference Citation Analysis]
557 Sang P, Zhang M, Shi Y, Li C, Abdulkadir S, Li Q, Ji H, Cai J. Inhibition of β-catenin/B cell lymphoma 9 protein-protein interaction using α-helix-mimicking sulfono-γ-AApeptide inhibitors. Proc Natl Acad Sci U S A 2019;116:10757-62. [PMID: 31088961 DOI: 10.1073/pnas.1819663116] [Cited by in Crossref: 32] [Cited by in F6Publishing: 25] [Article Influence: 16.0] [Reference Citation Analysis]
558 Zwamborn RA, Snijders C, An N, Thomson A, Rutten BP, de Nijs L. Wnt Signaling in the Hippocampus in Relation to Neurogenesis, Neuroplasticity, Stress and Epigenetics. Neuroepigenetics and Mental Illness. Elsevier; 2018. pp. 129-57. [DOI: 10.1016/bs.pmbts.2018.04.005] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
559 Liu J, Zhang K, Cheng L, Zhu H, Xu T. Progress in Understanding the Molecular Mechanisms Underlying the Antitumour Effects of Ivermectin. Drug Des Devel Ther 2020;14:285-96. [PMID: 32021111 DOI: 10.2147/DDDT.S237393] [Cited by in Crossref: 11] [Cited by in F6Publishing: 4] [Article Influence: 11.0] [Reference Citation Analysis]
560 Fiore D, Ramesh P, Proto MC, Piscopo C, Franceschelli S, Anzelmo S, Medema JP, Bifulco M, Gazzerro P. Rimonabant Kills Colon Cancer Stem Cells without Inducing Toxicity in Normal Colon Organoids. Front Pharmacol 2017;8:949. [PMID: 29354056 DOI: 10.3389/fphar.2017.00949] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 6.0] [Reference Citation Analysis]
561 Shang S, Hua F, Hu Z. The regulation of β-catenin activity and function in cancer: therapeutic opportunities. Oncotarget 2017;8:33972-89. [DOI: 10.18632/oncotarget.15687] [Cited by in Crossref: 209] [Cited by in F6Publishing: 170] [Article Influence: 69.7] [Reference Citation Analysis]
562 Fu L, Kettner NM. The circadian clock in cancer development and therapy. Prog Mol Biol Transl Sci 2013;119:221-82. [PMID: 23899600 DOI: 10.1016/B978-0-12-396971-2.00009-9] [Cited by in Crossref: 126] [Cited by in F6Publishing: 69] [Article Influence: 18.0] [Reference Citation Analysis]
563 Wu X, Huang C, He X, Tian Y, Zhou D, He Y, Liu X, Li J. Feedback regulation of telomerase reverse transcriptase: new insight into the evolving field of telomerase in cancer. Cellular Signalling 2013;25:2462-8. [DOI: 10.1016/j.cellsig.2013.08.009] [Cited by in Crossref: 37] [Cited by in F6Publishing: 28] [Article Influence: 4.6] [Reference Citation Analysis]
564 Li X, Bai B, Liu L, Ma P, Kong L, Yan J, Zhang J, Ye Z, Zhou H, Mao B, Zhu H, Li Y. Novel β-carbolines against colorectal cancer cell growth via inhibition of Wnt/β-catenin signaling. Cell Death Discov 2015;1:15033. [PMID: 27551464 DOI: 10.1038/cddiscovery.2015.33] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]
565 Alemohammad H, Asadzadeh Z, Motafakker Azad R, Hemmat N, Najafzadeh B, Vasefifar P, Najafi S, Baradaran B. Signaling pathways and microRNAs, the orchestrators of NANOG activity during cancer induction. Life Sci 2020;260:118337. [PMID: 32841661 DOI: 10.1016/j.lfs.2020.118337] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
566 Pio R, Ajona D, Lambris JD. Complement inhibition in cancer therapy. Semin Immunol 2013;25:54-64. [PMID: 23706991 DOI: 10.1016/j.smim.2013.04.001] [Cited by in Crossref: 90] [Cited by in F6Publishing: 78] [Article Influence: 11.3] [Reference Citation Analysis]
567 Wang H, Xi Q, Wu G. Fatty acid synthase regulates invasion and metastasis of colorectal cancer via Wnt signaling pathway. Cancer Med 2016;5:1599-606. [PMID: 27139420 DOI: 10.1002/cam4.711] [Cited by in Crossref: 37] [Cited by in F6Publishing: 37] [Article Influence: 7.4] [Reference Citation Analysis]
568 Zhu Y, Cai L, Guo J, Chen N, Yi X, Zhao Y, Cai J, Wang Z. Depletion of Dicer promotes epithelial ovarian cancer progression by elevating PDIA3 expression. Tumour Biol 2016;37:14009-23. [PMID: 27492604 DOI: 10.1007/s13277-016-5218-4] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
569 Nath J, Paul R, Ghosh SK, Paul J, Singha B, Debnath N. Drug repurposing and relabeling for cancer therapy: Emerging benzimidazole antihelminthics with potent anticancer effects. Life Sciences 2020;258:118189. [DOI: 10.1016/j.lfs.2020.118189] [Cited by in Crossref: 11] [Cited by in F6Publishing: 5] [Article Influence: 11.0] [Reference Citation Analysis]
570 McCubrey JA, Steelman LS, Bertrand FE, Davis NM, Sokolosky M, Abrams SL, Montalto G, D'Assoro AB, Libra M, Nicoletti F, Maestro R, Basecke J, Rakus D, Gizak A, Demidenko ZN, Cocco L, Martelli AM, Cervello M. GSK-3 as potential target for therapeutic intervention in cancer. Oncotarget 2014;5:2881-911. [PMID: 24931005 DOI: 10.18632/oncotarget.2037] [Cited by in Crossref: 280] [Cited by in F6Publishing: 251] [Article Influence: 46.7] [Reference Citation Analysis]
571 Mafakher L, Rismani E, Rahimi H, Enayatkhani M, Azadmanesh K, Teimoori-toolabi L. Computational design of antagonist peptides based on the structure of secreted frizzled-related protein-1 (SFRP1) aiming to inhibit Wnt signaling pathway. Journal of Biomolecular Structure and Dynamics. [DOI: 10.1080/07391102.2020.1835718] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
572 Abdelmonsif DA, Sultan AS, El-hadidy WF, Abdallah DM. Targeting AMPK, mTOR and β-Catenin by Combined Metformin and Aspirin Therapy in HCC: An Appraisal in Egyptian HCC Patients. Mol Diagn Ther 2018;22:115-27. [DOI: 10.1007/s40291-017-0307-7] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 3.3] [Reference Citation Analysis]
573 Saito T, Mitomi H, Imamhasan A, Hayashi T, Mitani K, Takahashi M, Kajiyama Y, Yao T. Downregulation of sFRP-2 by epigenetic silencing activates the β-catenin/Wnt signaling pathway in esophageal basaloid squamous cell carcinoma. Virchows Arch. 2014;464:135-143. [PMID: 24464051 DOI: 10.1007/s00428-014-1538-1] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 3.6] [Reference Citation Analysis]
574 Moore JC, Langenau DM. Allograft Cancer Cell Transplantation in Zebrafish. Adv Exp Med Biol 2016;916:265-87. [PMID: 27165358 DOI: 10.1007/978-3-319-30654-4_12] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 3.6] [Reference Citation Analysis]
575 Duquet A, Melotti A, Mishra S, Malerba M, Seth C, Conod A, Ruiz i Altaba A. A novel genome-wide in vivo screen for metastatic suppressors in human colon cancer identifies the positive WNT-TCF pathway modulators TMED3 and SOX12. EMBO Mol Med 2014;6:882-901. [PMID: 24920608 DOI: 10.15252/emmm.201303799] [Cited by in Crossref: 44] [Cited by in F6Publishing: 44] [Article Influence: 7.3] [Reference Citation Analysis]
576 Hussain M, Xu C, Lu M, Wu X, Tang L, Wu X. Wnt/β-catenin signaling links embryonic lung development and asthmatic airway remodeling. Biochim Biophys Acta Mol Basis Dis 2017;1863:3226-42. [PMID: 28866134 DOI: 10.1016/j.bbadis.2017.08.031] [Cited by in Crossref: 29] [Cited by in F6Publishing: 29] [Article Influence: 7.3] [Reference Citation Analysis]
577 Meder L, König K, Ozretić L, Schultheis AM, Ueckeroth F, Ade CP, Albus K, Boehm D, Rommerscheidt-Fuss U, Florin A, Buhl T, Hartmann W, Wolf J, Merkelbach-Bruse S, Eilers M, Perner S, Heukamp LC, Buettner R. NOTCH, ASCL1, p53 and RB alterations define an alternative pathway driving neuroendocrine and small cell lung carcinomas. Int J Cancer 2016;138:927-38. [PMID: 26340530 DOI: 10.1002/ijc.29835] [Cited by in Crossref: 82] [Cited by in F6Publishing: 75] [Article Influence: 13.7] [Reference Citation Analysis]
578 Zhao A, Zhang Z, Zhou Y, Li X, Li X, Ma B, Zhang Q. β-Elemonic acid inhibits the growth of human Osteosarcoma through endoplasmic reticulum (ER) stress-mediated PERK/eIF2α/ATF4/CHOP activation and Wnt/β-catenin signal suppression. Phytomedicine 2020;69:153183. [PMID: 32113150 DOI: 10.1016/j.phymed.2020.153183] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 9.0] [Reference Citation Analysis]
579 Batlle E, Clevers H. Cancer stem cells revisited. Nat Med. 2017;23:1124-1134. [PMID: 28985214 DOI: 10.1038/nm.4409] [Cited by in Crossref: 886] [Cited by in F6Publishing: 749] [Article Influence: 221.5] [Reference Citation Analysis]
580 Zeng J, Liu X, Li X, Zheng Y, Liu B, Xiao Y. Daucosterol Inhibits the Proliferation, Migration, and Invasion of Hepatocellular Carcinoma Cells via Wnt/β-Catenin Signaling. Molecules 2017;22:E862. [PMID: 28574485 DOI: 10.3390/molecules22060862] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
581 Wang W, Smits R, Hao H, He C. Wnt/β-Catenin Signaling in Liver Cancers. Cancers (Basel) 2019;11:E926. [PMID: 31269694 DOI: 10.3390/cancers11070926] [Cited by in Crossref: 32] [Cited by in F6Publishing: 29] [Article Influence: 16.0] [Reference Citation Analysis]
582 Zhang D, Ma S, Zhang C, Li P, Mao B, Guan X, Zhou W, Peng J, Wang X, Li S, Jia W. MicroRNA-935 Directly Targets FZD6 to Inhibit the Proliferation of Human Glioblastoma and Correlate to Glioma Malignancy and Prognosis. Front Oncol 2021;11:566492. [PMID: 33791198 DOI: 10.3389/fonc.2021.566492] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
583 Kwon YJ, Leibovitch BA, Bansal N, Pereira L, Chung CY, Ariztia EV, Zelent A, Farias EF, Waxman S. Targeted interference of SIN3A-TGIF1 function by SID decoy treatment inhibits Wnt signaling and invasion in triple negative breast cancer cells. Oncotarget 2017;8:88421-36. [PMID: 29179446 DOI: 10.18632/oncotarget.11381] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 2.2] [Reference Citation Analysis]
584 Liu Z, Han L, Dong Y, Tan Y, Li Y, Zhao M, Xie H, Ju H, Wang H, Zhao Y, Zheng Q, Wang Q, Su J, Fang C, Fu S, Jiang T, Liu J, Li X, Kang C, Ren H. EGFRvIII/integrin β3 interaction in hypoxic and vitronectinenriching microenvironment promote GBM progression and metastasis. Oncotarget 2016;7:4680-94. [PMID: 26717039 DOI: 10.18632/oncotarget.6730] [Cited by in Crossref: 31] [Cited by in F6Publishing: 25] [Article Influence: 6.2] [Reference Citation Analysis]
585 Dongre A, Weinberg RA. New insights into the mechanisms of epithelial-mesenchymal transition and implications for cancer. Nat Rev Mol Cell Biol. 2019;20:69-84. [PMID: 30459476 DOI: 10.1038/s41580-018-0080-4] [Cited by in Crossref: 762] [Cited by in F6Publishing: 650] [Article Influence: 381.0] [Reference Citation Analysis]
586 Abancens M, Bustos V, Harvey H, McBryan J, Harvey BJ. Sexual Dimorphism in Colon Cancer. Front Oncol 2020;10:607909. [PMID: 33363037 DOI: 10.3389/fonc.2020.607909] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
587 Vilchez V, Turcios L, Marti F, Gedaly R. Targeting Wnt/β-catenin pathway in hepatocellular carcinoma treatment. World J Gastroenterol 2016;22:823-32. [PMID: 26811628 DOI: 10.3748/wjg.v22.i2.823] [Cited by in CrossRef: 131] [Cited by in F6Publishing: 111] [Article Influence: 32.8] [Reference Citation Analysis]
588 Angelopoulou E, Paudel YN, Piperi C. Emerging Pathogenic and Prognostic Significance of Paired Box 3 (PAX3) Protein in Adult Gliomas. Transl Oncol 2019;12:1357-63. [PMID: 31352198 DOI: 10.1016/j.tranon.2019.07.001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
589 Park HY, Toume K, Arai MA, Sadhu SK, Ahmed F, Ishibashi M. Calotropin: a cardenolide from calotropis gigantea that inhibits Wnt signaling by increasing casein kinase 1α in colon cancer cells. Chembiochem 2014;15:872-8. [PMID: 24644251 DOI: 10.1002/cbic.201300786] [Cited by in Crossref: 29] [Cited by in F6Publishing: 23] [Article Influence: 4.1] [Reference Citation Analysis]
590 Prgomet Z, Axelsson L, Lindberg P, Andersson T. Migration and invasion of oral squamous carcinoma cells is promoted by WNT5A, a regulator of cancer progression. J Oral Pathol Med 2015;44:776-84. [PMID: 25459554 DOI: 10.1111/jop.12292] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 2.9] [Reference Citation Analysis]
591 Dyberg C, Fransson S, Andonova T, Sveinbjörnsson B, Lännerholm-Palm J, Olsen TK, Forsberg D, Herlenius E, Martinsson T, Brodin B, Kogner P, Johnsen JI, Wickström M. Rho-associated kinase is a therapeutic target in neuroblastoma. Proc Natl Acad Sci U S A 2017;114:E6603-12. [PMID: 28739902 DOI: 10.1073/pnas.1706011114] [Cited by in Crossref: 26] [Cited by in F6Publishing: 22] [Article Influence: 6.5] [Reference Citation Analysis]
592 Huang M, Zhang D, Wu JY, Xing K, Yeo E, Li C, Zhang L, Holland E, Yao L, Qin L, Binder ZA, O'Rourke DM, Brem S, Koumenis C, Gong Y, Fan Y. Wnt-mediated endothelial transformation into mesenchymal stem cell-like cells induces chemoresistance in glioblastoma. Sci Transl Med 2020;12:eaay7522. [PMID: 32102932 DOI: 10.1126/scitranslmed.aay7522] [Cited by in Crossref: 19] [Cited by in F6Publishing: 13] [Article Influence: 19.0] [Reference Citation Analysis]
593 Huang T, Alvarez AA, Pangeni RP, Horbinski CM, Lu S, Kim SH, James CD, J Raizer J, A Kessler J, Brenann CW, Sulman EP, Finocchiaro G, Tan M, Nishikawa R, Lu X, Nakano I, Hu B, Cheng SY. A regulatory circuit of miR-125b/miR-20b and Wnt signalling controls glioblastoma phenotypes through FZD6-modulated pathways. Nat Commun 2016;7:12885. [PMID: 27698350 DOI: 10.1038/ncomms12885] [Cited by in Crossref: 40] [Cited by in F6Publishing: 41] [Article Influence: 8.0] [Reference Citation Analysis]
594 Wang M, Marco P, Capra V, Kibar Z. Update on the Role of the Non-Canonical Wnt/Planar Cell Polarity Pathway in Neural Tube Defects. Cells 2019;8:E1198. [PMID: 31590237 DOI: 10.3390/cells8101198] [Cited by in Crossref: 19] [Cited by in F6Publishing: 11] [Article Influence: 9.5] [Reference Citation Analysis]
595 Liang G, Liu M, Wang Q, Shen Y, Mei H, Li D, Liu W. Itraconazole exerts its anti-melanoma effect by suppressing Hedgehog, Wnt, and PI3K/mTOR signaling pathways. Oncotarget 2017;8:28510-25. [PMID: 28212537 DOI: 10.18632/oncotarget.15324] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 9.3] [Reference Citation Analysis]
596 Wu C, Ding X, Li Z, Huang Y, Xu Q, Zou R, Zhao M, Chang H, Jiang C, La X, Lin G, Li W, Xue L. CtBP modulates Snail-mediated tumor invasion in Drosophila. Cell Death Discov 2021;7:202. [PMID: 34349099 DOI: 10.1038/s41420-021-00516-x] [Reference Citation Analysis]
597 Zou FW, Yang SZ, Li WY, Liu CY, Liu XH, Hu CH, Liu ZH, Xu S. circRNA_001275 upregulates Wnt7a expression by competitively sponging miR‑370‑3p to promote cisplatin resistance in esophageal cancer. Int J Oncol 2020;57:151-60. [PMID: 32319613 DOI: 10.3892/ijo.2020.5050] [Cited by in Crossref: 2] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
598 Yang Y, Sun Y, Wu Y, Tang D, Ding X, Xu W, Su B, Gao W. Downregulation of miR-3127-5p promotes epithelial-mesenchymal transition via FZD4 regulation of Wnt/β-catenin signaling in non-small-cell lung cancer. Mol Carcinog 2018;57:842-53. [PMID: 29566281 DOI: 10.1002/mc.22805] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 7.0] [Reference Citation Analysis]
599 Feng H, Wang X, Zhang Z, Tang C, Ye H, Jones L, Lou F, Zhang D, Jiang S, Sun H. Identification of Genetic Mutations in Human Lung Cancer by Targeted Sequencing. Cancer Inform. 2015;14:83-93. [PMID: 26244006 DOI: 10.4137/cin.s22941] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
600 Zhang C, Zhang F. The Multifunctions of WD40 Proteins in Genome Integrity and Cell Cycle Progression. J Genomics 2015;3:40-50. [PMID: 25653723 DOI: 10.7150/jgen.11015] [Cited by in Crossref: 42] [Cited by in F6Publishing: 36] [Article Influence: 7.0] [Reference Citation Analysis]
601 Duffy DJ, Krstic A, Schwarzl T, Halasz M, Iljin K, Fey D, Haley B, Whilde J, Haapa-Paananen S, Fey V, Fischer M, Westermann F, Henrich KO, Bannert S, Higgins DG, Kolch W. Wnt signalling is a bi-directional vulnerability of cancer cells. Oncotarget 2016;7:60310-31. [PMID: 27531891 DOI: 10.18632/oncotarget.11203] [Cited by in Crossref: 26] [Cited by in F6Publishing: 18] [Article Influence: 8.7] [Reference Citation Analysis]
602 Kishore C, Sundaram S, Karunagaran D. Vitamin K3 (menadione) suppresses epithelial-mesenchymal-transition and Wnt signaling pathway in human colorectal cancer cells. Chemico-Biological Interactions 2019;309:108725. [DOI: 10.1016/j.cbi.2019.108725] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 6.0] [Reference Citation Analysis]
603 Yong CQY, Tang BL. Cancer-driving mutations and variants of components of the membrane trafficking core machinery. Life Sci 2021;264:118662. [PMID: 33127517 DOI: 10.1016/j.lfs.2020.118662] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
604 Wu X, Liu W, Tang D, Xiao H, Wu Z, Chen C, Yao X, Liu F, Li G. Prognostic values of four Notch receptor mRNA expression in gastric cancer. Sci Rep 2016;6:28044. [PMID: 27363496 DOI: 10.1038/srep28044] [Cited by in Crossref: 23] [Cited by in F6Publishing: 18] [Article Influence: 4.6] [Reference Citation Analysis]
605 Hong SA, Yoo SH, Lee HH, Sun S, Won HS, Kim O, Ko YH. Prognostic value of Dickkopf-1 and ß-catenin expression in advanced gastric cancer. BMC Cancer 2018;18:506. [PMID: 29720122 DOI: 10.1186/s12885-018-4420-8] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
606 Kraboth Z, Galik B, Tompa M, Kajtar B, Urban P, Gyenesei A, Miseta A, Kalman B. DNA CpG methylation in sequential glioblastoma specimens. J Cancer Res Clin Oncol 2020;146:2885-96. [PMID: 32779022 DOI: 10.1007/s00432-020-03349-w] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
607 Gao YF, Shu Y, Yang L, He YC, Li LP, Huang G, Li HP, Jiang Y. A graphic method for identification of novel glioma related genes. Biomed Res Int 2014;2014:891945. [PMID: 25050377 DOI: 10.1155/2014/891945] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
608 Liu APY, Priesterbach-Ackley LP, Orr BA, Li BK, Gudenas B, Reddingius RE, Suñol M, Lavarino CE, Olaciregui NG, Santa-María López V, Fisher MJ, Hazrati LN, Bouffet E, Huang A, Robinson GW, Wesseling P, Northcott PA, Gajjar A. WNT-activated embryonal tumors of the pineal region: ectopic medulloblastomas or a novel pineoblastoma subgroup? Acta Neuropathol 2020;140:595-7. [PMID: 32772175 DOI: 10.1007/s00401-020-02208-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
609 Peng L, Huang YT, Zhang F, Chen JY, Huo X. Chronic cadmium exposure aggravates malignant phenotypes of nasopharyngeal carcinoma by activating the Wnt/β-catenin signaling pathway via hypermethylation of the casein kinase 1α promoter. Cancer Manag Res 2019;11:81-93. [PMID: 30588112 DOI: 10.2147/CMAR.S171200] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 2.7] [Reference Citation Analysis]
610 Yun EJ, Zhou J, Lin CJ, Hernandez E, Fazli L, Gleave M, Hsieh JT. Targeting Cancer Stem Cells in Castration-Resistant Prostate Cancer. Clin Cancer Res 2016;22:670-9. [PMID: 26490309 DOI: 10.1158/1078-0432.CCR-15-0190] [Cited by in Crossref: 55] [Cited by in F6Publishing: 36] [Article Influence: 9.2] [Reference Citation Analysis]
611 Tang Y, Zhou X, Gao B, Xu X, Sun J, Cheng L, Zhou X, Zheng L. Modulation of Wnt/β-catenin Signaling Attenuates Periapical Bone Lesions. J Dent Res 2014;93:175-82. [DOI: 10.1177/0022034513512507] [Cited by in Crossref: 29] [Cited by in F6Publishing: 25] [Article Influence: 3.6] [Reference Citation Analysis]
612 Mathur R, Sehgal L, Braun FK, Berkova Z, Romaguerra J, Wang M, Rodriguez MA, Fayad L, Neelapu SS, Samaniego F. Targeting Wnt pathway in mantle cell lymphoma-initiating cells. J Hematol Oncol 2015;8:63. [PMID: 26048374 DOI: 10.1186/s13045-015-0161-1] [Cited by in Crossref: 27] [Cited by in F6Publishing: 23] [Article Influence: 4.5] [Reference Citation Analysis]
613 Hsu CC, Liao WY, Chang KY, Chan TS, Huang PJ, Chiang CT, Shan YS, Cheng LH, Liao TY, Tsai KK. A multi-mode Wnt- and stemness-regulatory module dictated by FOXM1 and ASPM isoform I in gastric cancer. Gastric Cancer 2021;24:624-39. [PMID: 33515163 DOI: 10.1007/s10120-020-01154-5] [Reference Citation Analysis]
614 Hsu JM, Xia W, Hsu YH, Chan LC, Yu WH, Cha JH, Chen CT, Liao HW, Kuo CW, Khoo KH, Hsu JL, Li CW, Lim SO, Chang SS, Chen YC, Ren GX, Hung MC. STT3-dependent PD-L1 accumulation on cancer stem cells promotes immune evasion. Nat Commun. 2018;9:1908. [PMID: 29765039 DOI: 10.1038/s41467-018-04313-6] [Cited by in Crossref: 116] [Cited by in F6Publishing: 113] [Article Influence: 38.7] [Reference Citation Analysis]
615 He W, Wang S, Yan J, Qu Y, Jin L, Sui F, Li Y, You W, Yang G, Yang Q, Ji M, Shao Y, Ma PX, Lu W, Hou P. Self-Assembly of Therapeutic Peptide into Stimuli-Responsive Clustered Nanohybrids for Cancer-Targeted Therapy. Adv Funct Mater 2019;29:1807736. [PMID: 32982625 DOI: 10.1002/adfm.201807736] [Cited by in Crossref: 25] [Cited by in F6Publishing: 20] [Article Influence: 12.5] [Reference Citation Analysis]
616 Gao Y, Li L, Hou L, Niu B, Ru X, Zhang D. SOX12 promotes the growth of multiple myeloma cells by enhancing Wnt/β-catenin signaling. Exp Cell Res 2020;388:111814. [PMID: 31904384 DOI: 10.1016/j.yexcr.2020.111814] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
617 Lan Y, Xiao X, Luo Y, He Z, Song X. FEZF1 is an Independent Predictive Factor for Recurrence and Promotes Cell Proliferation and Migration in Cervical Cancer. J Cancer 2018;9:3929-38. [PMID: 30410597 DOI: 10.7150/jca.26073] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
618 Tauriello DV, Calon A, Lonardo E, Batlle E. Determinants of metastatic competency in colorectal cancer. Mol Oncol. 2017;11:97-119. [PMID: 28085225 DOI: 10.1002/1878-0261.12018] [Cited by in Crossref: 70] [Cited by in F6Publishing: 59] [Article Influence: 17.5] [Reference Citation Analysis]
619 Santhosh S, Kumar P, Ramprasad V, Chaudhuri A. Evolution of targeted therapies in cancer: opportunities and challenges in the clinic. Future Oncology 2015;11:279-93. [DOI: 10.2217/fon.14.198] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
620 Borcherding N, Kusner D, Kolb R, Xie Q, Li W, Yuan F, Velez G, Askeland R, Weigel RJ, Zhang W. Paracrine WNT5A Signaling Inhibits Expansion of Tumor-Initiating Cells. Cancer Res 2015;75:1972-82. [PMID: 25769722 DOI: 10.1158/0008-5472.CAN-14-2761] [Cited by in Crossref: 39] [Cited by in F6Publishing: 24] [Article Influence: 6.5] [Reference Citation Analysis]
621 Yu DH, Zhang X, Wang H, Zhang L, Chen H, Hu M, Dong Z, Zhu G, Qian Z, Fan J. The essential role of TNIK gene amplification in gastric cancer growth. Oncogenesis. 2014;2:e89. [PMID: 24566388 DOI: 10.1038/oncsis.2014.2] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
622 Wang H, Lou C, Ma N. Forskolin exerts anticancer roles in non-Hodgkin's lymphomas via regulating Axin/β-catenin signaling pathway. Cancer Manag Res 2019;11:1685-96. [PMID: 30863177 DOI: 10.2147/CMAR.S180754] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
623 Lu M, Muers MR, Lu X. Introducing STRaNDs: shuttling transcriptional regulators that are non-DNA binding. Nat Rev Mol Cell Biol 2016;17:523-32. [PMID: 27220640 DOI: 10.1038/nrm.2016.41] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 2.4] [Reference Citation Analysis]
624 Liang X, Dong Z, Bin W, Dekang N, Xuhang Z, Shuyuan Z, Liwen L, Kai J, Caixing S. PAX3 Promotes Proliferation of Human Glioma Cells by WNT/β-Catenin Signaling Pathways. J Mol Neurosci 2019;68:66-77. [PMID: 30826985 DOI: 10.1007/s12031-019-01283-2] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
625 Li F, Dai L, Niu J. GPX2 silencing relieves epithelial-mesenchymal transition, invasion, and metastasis in pancreatic cancer by downregulating Wnt pathway. J Cell Physiol 2020;235:7780-90. [PMID: 31774184 DOI: 10.1002/jcp.29391] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
626 Rahmani F, Avan A, Hashemy SI, Hassanian SM. Role of Wnt/β‐catenin signaling regulatory microRNAs in the pathogenesis of colorectal cancer. J Cell Physiol 2018;233:811-7. [DOI: 10.1002/jcp.25897] [Cited by in Crossref: 47] [Cited by in F6Publishing: 43] [Article Influence: 11.8] [Reference Citation Analysis]
627 Lindskog C, Edlund K, Mattsson JSM, Micke P. Immunohistochemistry-based prognostic biomarkers in NSCLC: novel findings on the road to clinical use? Expert Review of Molecular Diagnostics 2015;15:471-90. [DOI: 10.1586/14737159.2015.1002772] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 2.5] [Reference Citation Analysis]
628 Zhou S, Chen L, Mashrah M, Zhu Y, Liu J, Yang X, He Z, Wang L, Xiang T, Yao Z, Guo F, Yang W, Zhang C. Deregulation of secreted frizzled-related proteins is associated with aberrant β-catenin activation in the carcinogenesis of oral submucous fibrosis. Onco Targets Ther 2015;8:2923-31. [PMID: 26508877 DOI: 10.2147/OTT.S91460] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
629 Ghoshal A, Goswami U, Sahoo AK, Chattopadhyay A, Ghosh SS. Targeting Wnt Canonical Signaling by Recombinant sFRP1 Bound Luminescent Au-Nanocluster Embedded Nanoparticles in Cancer Theranostics. ACS Biomater Sci Eng 2015;1:1256-66. [DOI: 10.1021/acsbiomaterials.5b00305] [Cited by in Crossref: 19] [Cited by in F6Publishing: 14] [Article Influence: 3.2] [Reference Citation Analysis]
630 Weekes MP, Tomasec P, Huttlin EL, Fielding CA, Nusinow D, Stanton RJ, Wang ECY, Aicheler R, Murrell I, Wilkinson GWG, Lehner PJ, Gygi SP. Quantitative temporal viromics: an approach to investigate host-pathogen interaction. Cell 2014;157:1460-72. [PMID: 24906157 DOI: 10.1016/j.cell.2014.04.028] [Cited by in Crossref: 277] [Cited by in F6Publishing: 221] [Article Influence: 39.6] [Reference Citation Analysis]
631 Wu Y, Yang Y, Xian YS. HCRP1 inhibits cell proliferation and invasion and promotes chemosensitivity in esophageal squamous cell carcinoma. Chem Biol Interact 2019;308:357-63. [PMID: 31152734 DOI: 10.1016/j.cbi.2019.05.032] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
632 Yin Q, Wyatt CJ, Han T, Smalley KSM, Wan L. ITCH as a potential therapeutic target in human cancers. Semin Cancer Biol 2020;67:117-30. [PMID: 32165318 DOI: 10.1016/j.semcancer.2020.03.003] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
633 Melotti A, Mas C, Kuciak M, Lorente-Trigos A, Borges I, Ruiz i Altaba A. The river blindness drug Ivermectin and related macrocyclic lactones inhibit WNT-TCF pathway responses in human cancer. EMBO Mol Med 2014;6:1263-78. [PMID: 25143352 DOI: 10.15252/emmm.201404084] [Cited by in Crossref: 65] [Cited by in F6Publishing: 53] [Article Influence: 10.8] [Reference Citation Analysis]
634 Eterno V, Zambelli A, Villani L, Tuscano A, Manera S, Spitaleri A, Pavesi L, Amato A. AurkA controls self-renewal of breast cancer-initiating cells promoting wnt3a stabilization through suppression of miR-128. Sci Rep 2016;6:28436. [PMID: 27341528 DOI: 10.1038/srep28436] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.8] [Reference Citation Analysis]
635 Suryawanshi A, Manicassamy S. Tumors induce immune tolerance through activation of β-catenin/TCF4 signaling in dendritic cells: A novel therapeutic target for cancer immunotherapy. Oncoimmunology 2015;4:e1052932. [PMID: 26587326 DOI: 10.1080/2162402X.2015.1052932] [Cited by in Crossref: 19] [Cited by in F6Publishing: 10] [Article Influence: 3.2] [Reference Citation Analysis]
636 Devarasetty M, Skardal A, Cowdrick K, Marini F, Soker S. Bioengineered Submucosal Organoids for In Vitro Modeling of Colorectal Cancer. Tissue Eng Part A 2017;23:1026-41. [PMID: 28922975 DOI: 10.1089/ten.tea.2017.0397] [Cited by in Crossref: 24] [Cited by in F6Publishing: 18] [Article Influence: 8.0] [Reference Citation Analysis]
637 Merhi A, De Mees C, Abdo R, Victoria Alberola J, Marini AM. Wnt/β-Catenin Signaling Regulates the Expression of the Ammonium Permease Gene RHBG in Human Cancer Cells. PLoS One 2015;10:e0128683. [PMID: 26029888 DOI: 10.1371/journal.pone.0128683] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
638 Prabhakar K, Rodrίguez CI, Jayanthy AS, Mikheil DM, Bhasker AI, Perera RJ, Setaluri V. Role of miR-214 in regulation of β-catenin and the malignant phenotype of melanoma. Mol Carcinog 2019;58:1974-84. [PMID: 31338875 DOI: 10.1002/mc.23089] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
639 Kettner NM, Katchy CA, Fu L. Circadian gene variants in cancer. Ann Med 2014;46:208-20. [PMID: 24901356 DOI: 10.3109/07853890.2014.914808] [Cited by in Crossref: 66] [Cited by in F6Publishing: 43] [Article Influence: 9.4] [Reference Citation Analysis]
640 Wang W, Pan Q, Fuhler GM, Smits R, Peppelenbosch MP. Action and function of Wnt/β-catenin signaling in the progression from chronic hepatitis C to hepatocellular carcinoma. J Gastroenterol 2017;52:419-31. [PMID: 28035485 DOI: 10.1007/s00535-016-1299-5] [Cited by in Crossref: 34] [Cited by in F6Publishing: 28] [Article Influence: 6.8] [Reference Citation Analysis]
641 Sharma M, Castro-Piedras I, Simmons GE Jr, Pruitt K. Dishevelled: A masterful conductor of complex Wnt signals. Cell Signal 2018;47:52-64. [PMID: 29559363 DOI: 10.1016/j.cellsig.2018.03.004] [Cited by in Crossref: 60] [Cited by in F6Publishing: 45] [Article Influence: 20.0] [Reference Citation Analysis]
642 Sheikh A, Niazi AK, Ahmed MZ, Iqbal B, Anwer SM, Khan HH. The role of Wnt signaling pathway in carcinogenesis and implications for anticancer therapeutics. Hered Cancer Clin Pract 2014;12:13. [PMID: 24817919 DOI: 10.1186/1897-4287-12-13] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 1.1] [Reference Citation Analysis]
643 Varghese RT, Young S, Pham L, Liang Y, Pridham KJ, Guo S, Murphy S, Kelly DF, Sheng Z. Casein Kinase 1 Epsilon Regulates Glioblastoma Cell Survival. Sci Rep 2018;8:13621. [PMID: 30206363 DOI: 10.1038/s41598-018-31864-x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 4.3] [Reference Citation Analysis]
644 Chakravadhanula M, Hampton CN, Chodavadia P, Ozols V, Zhou L, Catchpoole D, Xu J, Erdreich-Epstein A, Bhardwaj RD. Wnt pathway in atypical teratoid rhabdoid tumors. Neuro Oncol 2015;17:526-35. [PMID: 25246426 DOI: 10.1093/neuonc/nou229] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 2.3] [Reference Citation Analysis]
645 Fox Ramos AE, Evanno L, Poupon E, Champy P, Beniddir MA. Natural products targeting strategies involving molecular networking: different manners, one goal. Nat Prod Rep 2019;36:960-80. [PMID: 31140509 DOI: 10.1039/c9np00006b] [Cited by in Crossref: 61] [Cited by in F6Publishing: 21] [Article Influence: 30.5] [Reference Citation Analysis]
646 Rahmani B, Hamedi Asl D, Naserpour Farivar T, Azad M, Sahmani M, Gheibi N. Omega-3 PUFA Alters the Expression Level but Not the Methylation Pattern of the WIF1 Gene Promoter in a Pancreatic Cancer Cell Line (MIA PaCa-2). Biochem Genet 2019;57:477-86. [PMID: 30649640 DOI: 10.1007/s10528-018-9895-0] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 2.5] [Reference Citation Analysis]
647 Guan H, Liu C, Fang F, Huang Y, Tao T, Ling Z, You Z, Han X, Chen S, Xu B, Chen M. MicroRNA-744 promotes prostate cancer progression through aberrantly activating Wnt/β-catenin signaling. Oncotarget 2017;8:14693-707. [PMID: 28107193 DOI: 10.18632/oncotarget.14711] [Cited by in Crossref: 29] [Cited by in F6Publishing: 25] [Article Influence: 7.3] [Reference Citation Analysis]
648 Zheng S, Liu J, Wu Y, Huang TL, Wang G. Small-molecule inhibitors of Wnt signaling pathway: towards novel anticancer therapeutics. Future Med Chem 2015;7:2485-505. [PMID: 26670195 DOI: 10.4155/fmc.15.159] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
649 Zhan T, Ambrosi G, Wandmacher AM, Rauscher B, Betge J, Rindtorff N, Häussler RS, Hinsenkamp I, Bamberg L, Hessling B, Müller-Decker K, Erdmann G, Burgermeister E, Ebert MP, Boutros M. MEK inhibitors activate Wnt signalling and induce stem cell plasticity in colorectal cancer. Nat Commun 2019;10:2197. [PMID: 31097693 DOI: 10.1038/s41467-019-09898-0] [Cited by in Crossref: 47] [Cited by in F6Publishing: 37] [Article Influence: 23.5] [Reference Citation Analysis]
650 Suwala AK, Hanaford A, Kahlert UD, Maciaczyk J. Clipping the Wings of Glioblastoma: Modulation of WNT as a Novel Therapeutic Strategy. J Neuropathol Exp Neurol 2016;75:388-96. [PMID: 26979081 DOI: 10.1093/jnen/nlw013] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 4.4] [Reference Citation Analysis]
651 Pan FF, Zheng YB, Shi CJ, Zhang FW, Zhang JF, Fu WM. H19-Wnt/β-catenin regulatory axis mediates the suppressive effects of apigenin on tumor growth in hepatocellular carcinoma. Eur J Pharmacol 2021;893:173810. [PMID: 33345859 DOI: 10.1016/j.ejphar.2020.173810] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
652 Nakata S, Phillips E, Goidts V. Emerging role for leucine-rich repeat-containing G-protein-coupled receptors LGR5 and LGR4 in cancer stem cells. Cancer Manag Res. 2014;6:171-180. [PMID: 24711713 DOI: 10.2147/cmar.s57846] [Cited by in Crossref: 6] [Cited by in F6Publishing: 15] [Article Influence: 0.9] [Reference Citation Analysis]
653 Knudsen ES, O'Reilly EM, Brody JR, Witkiewicz AK. Genetic Diversity of Pancreatic Ductal Adenocarcinoma and Opportunities for Precision Medicine. Gastroenterology. 2016;150:48-63. [PMID: 26385075 DOI: 10.1053/j.gastro.2015.08.056] [Cited by in Crossref: 63] [Cited by in F6Publishing: 55] [Article Influence: 10.5] [Reference Citation Analysis]
654 Wu Z, Guan KL. Hippo Signaling in Embryogenesis and Development. Trends Biochem Sci 2021;46:51-63. [PMID: 32928629 DOI: 10.1016/j.tibs.2020.08.008] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 9.0] [Reference Citation Analysis]
655 Xu X, Dai Y, Feng L, Zhang H, Hu Y, Xu L, Zhu X, Jiang Y. Knockdown of Nav1.5 inhibits cell proliferation, migration and invasion via Wnt/β-catenin signaling pathway in oral squamous cell carcinoma. Acta Biochim Biophys Sin (Shanghai) 2020;52:527-35. [PMID: 32400862 DOI: 10.1093/abbs/gmaa021] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
656 Baruah MM, Khandwekar AP, Sharma N. Quercetin modulates Wnt signaling components in prostate cancer cell line by inhibiting cell viability, migration, and metastases. Tumor Biol 2016;37:14025-34. [DOI: 10.1007/s13277-016-5277-6] [Cited by in Crossref: 33] [Cited by in F6Publishing: 27] [Article Influence: 6.6] [Reference Citation Analysis]
657 Arensman MD, Telesca D, Lay AR, Kershaw KM, Wu N, Donahue TR, Dawson DW. The CREB-binding protein inhibitor ICG-001 suppresses pancreatic cancer growth. Mol Cancer Ther. 2014;13:2303-2314. [PMID: 25082960 DOI: 10.1158/1535-7163.mct-13-1005] [Cited by in Crossref: 65] [Cited by in F6Publishing: 33] [Article Influence: 9.3] [Reference Citation Analysis]
658 Kerekes K, Bányai L, Trexler M, Patthy L. Structure, function and disease relevance of Wnt inhibitory factor 1, a secreted protein controlling the Wnt and hedgehog pathways. Growth Factors 2019;37:29-52. [PMID: 31210071 DOI: 10.1080/08977194.2019.1626380] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
659 Zhou W, Li Y, Gou S, Xiong J, Wu H, Wang C, Yan H, Liu T. MiR-744 increases tumorigenicity of pancreatic cancer by activating Wnt/β-catenin pathway. Oncotarget 2015;6:37557-69. [PMID: 26485754 DOI: 10.18632/oncotarget.5317] [Cited by in Crossref: 42] [Cited by in F6Publishing: 39] [Article Influence: 8.4] [Reference Citation Analysis]
660 Cheng Y, Phoon YP, Jin X, Chong SY, Ip JC, Wong BW, Lung ML. Wnt-C59 arrests stemness and suppresses growth of nasopharyngeal carcinoma in mice by inhibiting the Wnt pathway in the tumor microenvironment. Oncotarget 2015;6:14428-39. [PMID: 25980501 DOI: 10.18632/oncotarget.3982] [Cited by in Crossref: 30] [Cited by in F6Publishing: 30] [Article Influence: 6.0] [Reference Citation Analysis]
661 Shrestha R, Johnson E, Byrne FL. Exploring the therapeutic potential of mitochondrial uncouplers in cancer. Mol Metab 2021;51:101222. [PMID: 33781939 DOI: 10.1016/j.molmet.2021.101222] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
662 Lee NK, Zhang Y, Su Y, Bidlingmaier S, Sherbenou DW, Ha KD, Liu B. Cell-type specific potent Wnt signaling blockade by bispecific antibody. Sci Rep 2018;8:766. [PMID: 29335534 DOI: 10.1038/s41598-017-17539-z] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
663 Huang Z, Zhang M, Burton SD, Katsakhyan LN, Ji H. Targeting the Tcf4 G13ANDE17 binding site to selectively disrupt β-catenin/T-cell factor protein-protein interactions. ACS Chem Biol 2014;9:193-201. [PMID: 24191653 DOI: 10.1021/cb400795x] [Cited by in Crossref: 34] [Cited by in F6Publishing: 29] [Article Influence: 4.3] [Reference Citation Analysis]
664 Sengupta S, Pomeranz Krummel D, Pomeroy S. The evolution of medulloblastoma therapy to personalized medicine. F1000Res 2017;6:490. [PMID: 28713553 DOI: 10.12688/f1000research.10859.1] [Cited by in Crossref: 21] [Cited by in F6Publishing: 14] [Article Influence: 5.3] [Reference Citation Analysis]
665 Zhu X, Wen L, Wang W, Xiao Q, Li B, He K. PCV2 inhibits the Wnt signalling pathway in vivo and in vitro. Vet Microbiol 2020;247:108787. [PMID: 32768231 DOI: 10.1016/j.vetmic.2020.108787] [Reference Citation Analysis]
666 Lee SY, Jeon HM, Ju MK, Jeong EK, Kim CH, Park HG, Han SI, Kang HS. Dlx-2 and glutaminase upregulate epithelial-mesenchymal transition and glycolytic switch. Oncotarget 2016;7:7925-39. [PMID: 26771232 DOI: 10.18632/oncotarget.6879] [Cited by in Crossref: 37] [Cited by in F6Publishing: 33] [Article Influence: 7.4] [Reference Citation Analysis]
667 Khatua S, Song A, Citla Sridhar D, Mack SC. Childhood Medulloblastoma: Current Therapies, Emerging Molecular Landscape and Newer Therapeutic Insights. Curr Neuropharmacol 2018;16:1045-58. [PMID: 29189165 DOI: 10.2174/1570159X15666171129111324] [Cited by in Crossref: 13] [Cited by in F6Publishing: 3] [Article Influence: 4.3] [Reference Citation Analysis]
668 Lee SY, Ju MK, Jeon HM, Lee YJ, Kim CH, Park HG, Han SI, Kang HS. Oncogenic Metabolism Acts as a Prerequisite Step for Induction of Cancer Metastasis and Cancer Stem Cell Phenotype. Oxid Med Cell Longev. 2018;2018:1027453. [PMID: 30671168 DOI: 10.1155/2018/1027453] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 9.3] [Reference Citation Analysis]
669 Arensman MD, Nguyen P, Kershaw KM, Lay AR, Ostertag-Hill CA, Sherman MH, Downes M, Liddle C, Evans RM, Dawson DW. Calcipotriol Targets LRP6 to Inhibit Wnt Signaling in Pancreatic Cancer. Mol Cancer Res. 2015;13:1509-1519. [PMID: 26224368 DOI: 10.1158/1541-7786.mcr-15-0204] [Cited by in Crossref: 22] [Cited by in F6Publishing: 13] [Article Influence: 3.7] [Reference Citation Analysis]
670 Moon JH, Lee SH, Lim YC. Wnt/β-catenin/Slug pathway contributes to tumor invasion and lymph node metastasis in head and neck squamous cell carcinoma. Clin Exp Metastasis 2021;38:163-74. [PMID: 33630219 DOI: 10.1007/s10585-021-10081-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
671 Farber BA, Lalazar G, Simon EP, Hammond WJ, Requena D, Bhanot UK, La Quaglia MP, Simon SM. Non coding RNA analysis in fibrolamellar hepatocellular carcinoma. Onc